# ========================================================================================
# List of the protein-protein complexes with binding data in PDBbind v.2020R1
# 2798 complexes in total, sorted by their release year. Latest update: Aug 2025
# PDB code, resolution, release year, binding data, reference
# The first part in brackets indicates the peptide chains forming the "receptor",
# while the second part indicates the peptide chains forming the "ligand".
# ========================================================================================
1fc2  2.80  1981  Kd=22.5nM     // 1fc2.pdf (C|D) Human Fc fragment, Kd=22.5+/-4.6nM, SpAb-1 and Fc gamma-1, pKd=7.65
3sgb  1.80  1983  Kd=17.9pM     // 3sgb.pdf (E|I) TURKEY OVOMUCOID INHIBITOR (OMTKY3), 1.79 x 10-11M
2tgp  1.90  1983  Kd=2.4uM      // 2tgp.pdf (Z|I) TRYPSIN INHIBITOR, 2.4 x 10-6M
2ptc  1.90  1983  Kd=60fM       // 2ptc.pdf (E|I) Kd=6x10-14M is for trypsin and the pancreatic trypsin inhibitor
2sni  2.10  1988  Kd=2pM        // 2sni.pdf (E|I) CHYMOTRYPSIN INHIBITOR 2, Kd=2 x 10-12M
1atn  2.80  1992  Kd=0.45nM     // 1atn.pdf (A|D) bovine pancreatic deoxyribonuclease I, Dnase I; Kd=0.45nM
1gla  2.60  1993  Kd=0.18uM     // 1gla.pdf (F|G) Glucose specific phosphocarrier, 1.8 x 10-7M
1acb  2.00  1993  Kd=0.2nM      // 1acb.pdf (E|I) leech (Hirudo medicinalis) protein proteinase inhibitor eglin c, 2 x 10-10M
2pcc  2.30  1993  Kd=1.6uM      // 2pcc.pdf (C|D) yeast iso-1-cytochrome c, Kd=1.6uM, not found in reference
2pcb  2.80  1993  Kd=10uM       // 2pcb.pdf (A|B) cytochrome c, Ka=10^5M-1, Kd=10-5M
2sic  1.80  1993  Kd=71.2pM     // 2sic.pdf (E|I) Streptomyces Subtilisin Inhibitor, Kd=7.12 x 10-11M
2cpk  2.70  1993  Ki=2.3nM      // 2cpk.pdf (E|I) a 20-amino acid substrate analog inhibitor, Ki=2.3nM
2iff  2.65  1994  Kd=10nM       // 2iff.pdf (HL|Y) Kd(HyHEL-5/Lysozyme-R68K)=1 E-8 M, Kd(HyHEL-5/Lysozyme-WT)=2.5 E-11M
1brs  2.00  1994  Kd=13fM       // 1brs.pdf (C|F) barstar(C40, 82A), barnase-barstar complex, calculated Kd=1.3 E-14 M
2btf  2.55  1994  Kd=2.3uM      // 2btf.pdf (A|P) beta-actin, Kd=2.3+/-0.9uM for wildtype Profilin
1vfb  1.80  1994  Kd=3.03nM     // 1vfb.pdf (BA|C) hen egg white lysozyme, Kb=3.3x10^8M-1, get Kd=3.03x10-9M
1hrt  2.80  1994  Kd=3pM        // 1hrt.pdf (H|I) noncovalent equimolar complex of hirudin with bovine thrombin, Kd=3pM
1ppe  2.00  1994  Kd=3pM        // 1ppe.pdf (E|I) CMTI-squash inhibitor, Association constant 3.3x10^11 M-1, Kd=3pM
2mta  2.40  1994  Kd=4.5uM      // 2mta.pdf (HL|A) Kd=4.5x10-6M for methylamine dehydrogenase and amicyanin; structure is ternary complex with C-type cytochrome C551I
1nca  2.50  1994  Kd=8.3nM      // 1nca.pdf (HL|N) antigen-binding fragment (Fab) of monoclonal antibody NC41, fluorescence quenching Ka=12x10^7M-1, get Kd=8.3x10-9M
1smf  2.10  1994  Ki=0.12uM     // 1smf.pdf (E|I) incomplete ligand structure
1ihs  2.00  1994  Ki=0.3nM      // 1ihs.pdf (H|I) hirutonin-2 with human a-thrombin, led to Ki=0.3nM
1nsn  2.80  1995  Kd=0.1nM      // 1nsn.pdf (HL|S) staphylococcal nuclease (SNase), Ka=1x10^10M-1, Kd=10 x 10-11M
1bql  2.60  1995  Kd=0.1uM      // 1bql.pdf (HL|Y) ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME, Kd=1 E-7 M
1nma  3.00  1995  Kd=14nM       // 1nma.pdf (HL|N) N9 NEURAMINIDASE COMPLEXE WITH ANTIBODIE NC10 Fab, Kd=1.4 E-8 M
1mlc  2.50  1995  Kd=91nM       // 1mlc.pdf (DC|F) HEN EGG WHITE LYSOZYME, Kd=9.1 x 10-8M
1rlb  3.10  1996  Kd=0.8uM      // 1rlb.pdf (A|F) all-trans retinoic acid-RBP, Kd=0.8uM
1mah  3.20  1996  Kd=25pM       // 1mah.pdf (A|F) Fasciculin 2, 2.5 x 10-11M
1mtn  2.80  1996  Kd=9.5nM      // 1mtn.pdf (BC|D) BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION, Kd=9.5 E-9 M
1tbr  2.60  1996  Ki=0.2pM      // 1tbq.pdf (K|S) INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN, monoclinic crystals, ki=2 E-13 M
1tbq  3.10  1996  Ki=0.2pM      // 1tbq.pdf (H|R) INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN, orthorhombic crystals, ki=2 E-13 M
1dit  2.30  1996  Ki=1pM        // 1dit.pdf (H|P) A DIVALENT PEPTIDE INHIBITOR CVS995, Ki=1pM
1efn  2.50  1997  Kd=0.38uM     // 1efn.pdf (C|D) HIV-1 NEF PROTEIN IN COMPLEX WITH Fyn(R96I) SH3 domain, Kd=0.38uM
1akj  2.65  1997  Kd=126uM      // 1akj.pdf (AB|DE) T-cell CD8 coreceptor, 1.26 x 10-4M
1ak4  2.36  1997  Kd=17uM       // 1ak4.pdf (A|D) AMINO-TERMINAL Domain of HIV-1 capsid(1-151), Kd=1.7 X 10-5M, unpublished data
1gua  2.00  1997  Kd=40nM       // 1gua.pdf (A|B) protein rap1a and protein C-RAF1; Kd for Rap double mutants/RafRBD
1ycs  2.20  1997  Kd~30nM       // 1ycs.pdf (A|B) P53 core domain and 53BP2 COMPLEX, Kd~30nM
1taw  1.80  1997  Ki<0.02nM     // 1taw.pdf (A|B) BOVINE TRYPSIN COMPLEXED TO APPI, Ki<0.02nM
1bth  2.30  1997  Ki=10nM       // 1bth.pdf (H|P) human thrombin mutant E192Q complex with BPTI, Ki=1 E-8 M
1hia  2.40  1997  Ki=13nM       // 1hia.pdf (AB|I) hirustasin-kallikrein complex, Ki of porcine kallikrein and hirustatin is 13nM
1cbw  2.60  1997  Ki=16nM       // 1cbw.pdf (BC|D)
1toc  3.10  1997  Ki=1pM        // 1toc.pdf (B|R) ornithodorin-thrombin complex, ki=1 E-12 M
1dhk  1.85  1997  Ki=35pM       // 1dhk.pdf (A|B) ALPHA-AMYLASE inhibitor, Ki=3.5 E-11 M
1dfj  2.50  1997  Ki=59fM       // 1dfj.pdf (E|I) Crystal is from Cattle/pig Rnase inhibitor, Ki=59fM yeast, 67fM porcine
1fle  1.90  1997  Ki=6nM        // 1fle.pdf (E|I) ELAFIN COMPLEXED WITH PORCINE PANCREATIC ELASTASE, Ki=6nM. Ki(elafin7-57/PPE)=10nM
1ca0  2.10  1997  Ki=7.1nM      // 1ca0.pdf (BC|D)
1b27  2.10  1998  Kd=0.01pM     // 1b27.pdf (C|F) WT, Kd=0.01pM, ligand mutation:C40A, C82A, it is referred to as peudo wild-type
1wej  1.80  1998  Kd=0.06uM     // 1wej.pdf (HL|F) FAB E8 COMPLEXED WITH HORSE CYTOCHROME C, Kd=0.6 E-7 M
1a22  2.60  1998  Kd=0.34nM     // 1a22.pdf (A|B) G120R mutant human growth hormone (hGH) and receptor, Kd=0.34+/-0.07nM
1a3b  1.80  1998  Kd=0.3nM      // 1a3b.pdf (H|I) incomplete ligand structure
1b2u  2.10  1998  Kd=100nM      // 1b27.pdf (A|D) bnK27A-bsD35A, Kd=1 E5pM. D35 in reference is D35 in structure
1xdt  2.65  1998  Kd=10nM       // 1xdt.pdf (T|R) DIPHTHERIA TOXIN AND HEPARIN-BINDING EPIDERMAL GROWTH FACTOR, Kd=E-8~E-9M
1b3s  2.39  1998  Kd=117pM      // 1b27.pdf (C|F) bnH102A-bsY29F, Kd=117pM. Y30 in reference is Y29 in structure
1jrh  2.80  1998  Kd=14.2nM     // 1jrh.pdf (HL|I) INTERFERON-GAMMA RECEPTOR ALPHA CHAIN(WT) and ANTIBODY A6 complex, Kd=14.2nM
1axi  2.10  1998  Kd=14nM       // 1axi.pdf (A|B) GROWTH HORMONE(W104A) and RECEPTOR(mutant) complex, Kd=14nM
1avz  3.00  1998  Kd=15.8uM     // 1avz.pdf (B|C) Fyn kinase SH3 domain, Kd=1.58 x 10-5M
1b2s  1.82  1998  Kd=157pM      // 1b27.pdf (B|E) bnK27A-bsT42A, Kd=157pM. T42 in reference should be T43
1wq1  2.50  1998  Kd=17uM       // 1wq1.pdf (R|G) Ras GAP, 1.7 x 10-5M
2vir  3.25  1998  Kd=1nM        // 2vir.pdf (BA|C) Neutralizing Antibody Immunoglobulin (Igg1, Lambda), Kd=1nM
2jel  2.50  1998  Kd=2.8nM      // 2jel.pdf (HL|P) JEL42 FAB/HPR COMPLEX, Kd=2.8nM
1avg  2.60  1998  Kd=3pM        // 1avg.pdf (H|I) Triabin and bovine alpha-thrombin complex, Kd=3pM
2vis  3.25  1998  Kd=4uM        // 2vis.pdf (BA|C) T131I BHA and Fab Kd=4uM, Wildtype HA Top and Fab Kd=5nM (code 2VIR)
1avx  1.90  1998  Kd=60fM       // 1avx.pdf (A|B) Soybean trypsin inhibitor (Kunitz), 6.00 x 10-14M
1buh  2.60  1998  Kd=77nM       // 1buh.pdf (A|B) CELL CYCLE-REGULATORY PROTEIN CKSHS1, HUMAN CDK2-CksHs1 complex, Kd=7.7 E-8 M
1a4y  2.00  1998  Ki<1fM        // 1a4y.pdf (A|B) RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX, Ki<1fM
1kig  3.00  1998  Ki=0.18nM     // 1kig.pdf (H|I) recombinant tick anticoagulant peptide (rTAP) complexed to bovine factor Xa, Ki=0.18nM
1an1  2.03  1998  Ki=0.9nM      // 1an1.pdf (E|I) LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX, Ki=0.9nM
1ldt  1.90  1998  Ki=1.8nM      // 1ldt.pdf (T|L) LEECH-DERIVED TRYPTASE INHIBITOR, Ki(bovine pancretic trypsin/rLDTI)=1.8nM
1fmo  2.20  1998  Ki=2.3nM      // 1fmo.pdf (E|I)
1ahw  3.00  1998  Ki=3.4nM      // 1ahw.pdf (BA|C) HUMAN TISSUE FACTOR WITH AN INHIBITORY FAB (5G9), ki=3.4+/-0.3nM
1azz  2.30  1998  Ki=510pM      // 1azz.pdf (B|D) FIDDLER CRAB COLLAGENASE COMPLEXED TO ECOTIN, Ki=510+/-60pM
1bvn  2.50  1998  Ki=9pM        // 1bvn.pdf (P|T) PIG PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH TENDAMISTAT, Ki=9 E-12 M
1ugh  1.90  1999  IC50=12pM     // 1ugh.pdf (E|I) inhibition of Human UDG by PBS2 Ugi, IC50=1.2 E-11 M
1vpp  1.90  1999  IC50=8.2uM    // 1vpp.pdf (V|X) A receptor blocking peptide V108, IC50=8.2uM
1b6c  2.60  1999  Kd=0.28uM     // 1b6c.pdf (E|F) 2.8 x 10-7M
1ibr  2.30  1999  Kd=0.3nM      // 1ibr.pdf (A|B) Importin beta-1 subunit, 3.0 x 10-10M
1flt  1.70  1999  Kd=1.356nM    // 1flt.pdf (W|X) VEGF IN COMPLEX WITH DOMAIN 2 OF THE FLT-1 RECEPTOR, Kd=113x12pM
1uug  2.40  1999  Kd=1.3uM      // 1uug.pdf (C|D) URACIL-DNA GLYCOSYLASE and Uracil-DNA glycosylase inhibitor, Kd=1.3uM
1lfd  2.10  1999  Kd=1.9uM      // 1lfd.pdf (C|D) Ras-Interacting Domain Of Ralgds, Kd=1.9x10-6M
1kac  2.60  1999  Kd=14.8nM     // 1kac.pdf (A|B) Adenovirus receptor, 1.48 x 10-8M
1sbb  2.40  1999  Kd=140uM      // 1sbb.pdf (C|D) T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH wt SUPERANTIGEN SEB, Kd=140uM
1bvk  2.70  1999  Kd=14nM       // 1bvk.pdf (ED|F) hen egg lysozyme, 1.4 x 10-8M
1eer  1.90  1999  Kd=1nM        // 1cn4.pdf (A|B) ERYTHROPOIETIN COMPLEXED WITH ERYTHROPOIETIN RECEPTOR, site 1 Kd=1nM
1tba   NMR  1999  Kd=1nM        // 1tba.pdf (A|B) TATA box-binding protein TBP-TAFII230 COMPLEX, about Kd=1nM
1ay7  1.70  1999  Kd=1uM        // 1ay7.pdf (A|B) RIBONUCLEASE SA COMPLEX WITH BARSTAR, Kd=1 E-6 M
1cn4  2.80  1999  Kd=1uM        // 1cn4.pdf (B|C) ERYTHROPOIETIN COMPLEXED WITH ERYTHROPOIETIN RECEPTOR, site 2 Kd=1uM
1qa9  3.20  1999  Kd=1uM        // 1qa9.pdf (C|D) hCD2-hCD58 complex, Kd=1uM, protein mutation:hCD2(K61E, F63L, T67A), hCD58(F1S, V9K, V21Q, V58K, T85S, L93G)
1bj1  2.40  1999  Kd=3.4nM      // 1bj1.pdf (KJ|V) VEGF IN COMPLEX WITH A NEUTRALIZING ANTIBODY, Kd=3.4+/-0.9nM, IC50=4.7+/-1.1nM
1grn  2.10  1999  Kd=388nM      // 1grn.pdf (A|B) CDC42 GAP, Kd=3.88 x 10-7M
1qfu  2.80  1999  Kd=3nM        // 1qfu.pdf (HL|A) X31 BHA-HC45 Fab complex, IgG Kd=3+/-1nM
1vrk  1.90  1999  Kd=6.8nM      // 1vrk.pdf (A|B) E84K-CALMODULIN and RS20 PEPTIDE COMPLEX, 6.8+/-5.2nM
1qse  2.80  1999  Kd=7.2uM      // 1qse.pdf (DE|AC) TCR-pMHC complex;
4thn  2.50  1999  Ki=0.09nM     // 4thn.pdf (H|I) incomplete ligand structure
1ava  1.90  1999  Ki=0.22nM     // 1ava.pdf (A|C) AMY2/BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR COMPLEX, ki=2.2 E-10 M, PH8
1qur  2.00  1999  Ki=0.29pM     // 1qur.pdf (H|I)
1fak  2.10  1999  Ki=0.4nM      // 1fak.pdf (H|I)
1cmx  2.25  1999  Ki=1.7uM      // 1cmx.pdf (A|B) yeast UCH yuh1 complex with ubiquitin aldehyde, ki=1.7+/-0.38uM
1es0  2.60  2000  IC50=0.08uM   // 1es0.pdf (A|B) I-A g7 complex with peptide from the autoantigen glutamic acid decarboxylase (GAD) 65, IC50=0.08uM
1fg9  2.90  2000  Kd=0.10nM     // 1fg9.pdf (A|C) IFN-gamma Receptor alpha chain binds IFN-gamma, Kd=1 E-10M
1cz8  2.40  2000  Kd=0.11nM     // 1cz8.pdf (HL|W) VEGF(109):Y0317 Fab complex, Kd=0.11+/-0.02nM. protein residue:4-107
1g9i  2.20  2000  Kd=0.12uM     // 1g9i.pdf (E|I) BOWMAN-BIRK TYPE TRYPSIN INHIBITOR, SPC1 with bovine beta-trypsin, Ki=1.2 X 10-7M
1d6r  2.30  2000  Kd=0.13nM     // 1d6r.pdf (A|I) bovine TRYPSIN COMPLEXED WITH soybean Bowman-Birk inhibitor, Ki=0.13nM
1fsk  2.90  2000  Kd=0.24nM     // 1fsk.pdf (FE|D) major allergen from birch pollen Bet v 1-A, 2.4 x 10-10M
1ffx  3.95  2000  Kd=0.2uM      // 1ffx.pdf (ABCD|E) PROTEIN (STATHMIN-LIKE DOMAIN OF RB3); Kd for tubulin/stathmin
1dee  2.70  2000  Kd=0.4uM      // 1dee.pdf (DC|G) domain D of SpA complex with the Fab fragment of IgM antibody, Kd=0.4-5.0uM
1e4k  3.20  2000  Kd=1.7uM      // 1e4k.pdf (B|C) Immobilized HUMAN IGG1 FC FRAGMENT and FC-GAMMA RECEPTOR III COMPLEX
1qfw  3.50  2000  Kd=10nM       // 1qfw.pdf (HL|A) ternary complex of hCG and Fv2, Anti alpha Kd=1E-8M, Anti beta Kd=1E-10M
1qty  2.70  2000  Kd=10pM       // 1qty.pdf (S|T) VEGF and Flt-1D2 complex, Kd=10pM
1du3  2.20  2000  Kd=15.9nM     // 1du3.pdf (C|F) wild type TNF-RELATED APOPTOSIS INDUCING LIGAND-sDR5 complex, Kd=1.59+/-0.23 E-8M
1e96  2.40  2000  Kd=2.7uM      // 1e96.pdf (A|B) NEUTROPHIL CYTOSOL FACTOR 2 (NCF-2) TPR DOMAIN
1dqj  2.00  2000  Kd=2.8nM      // 1dqj.pdf (BA|C) hen egg white lysozyme
1ees   NMR  2000  Kd=20nM       // 1ees.pdf (A|B) Cdc42Hs and PBD46 complex, Kd=20nM
1emv  1.70  2000  Kd=24fM       // 1emv.pdf (A|B) cognate immunity protein Im9, Kd=2.4+/-0.4x10-14M
1de4  2.80  2000  Kd=24nM       // 1de4.pdf (AB|C) Transferrin receptor ectodomain, 2.4 x 10-8M
1e6j  3.00  2000  Kd=29nM       // 1e6j.pdf (HL|P) HIV-capsid protein 24, 2.9 x 10-8M
1djs  2.40  2000  Kd=41nM       // 1djs.pdf (A|B) 1:1 FGF1:FGFR2 complex, compatible with FGF2:FGFR1 complex, Kd=41nM
1dzb  2.00  2000  Kd=520nM      // 1dzb.pdf (A|X) Fv 1F9 in complex with turkey egg-white lysozyme (TEL), Kd=5.2 E-7 M
1f3v  2.00  2000  Kd=7.8uM      // 1f3v.pdf (A|B) native TRADD-N/TRAF2 Complex, Kd=7.8+/-3.6uM
1g6v  3.50  2000  Kd=72nM       // 1g6v.pdf (A|K) CAB-CA05 binds to bovine carbonic anhydrase, Kd=72nM
1eo8  2.80  2000  Kd=8.9nM      // 1eo8.pdf (HL|A) X31 HA with the Fab fragment of antibody BH151 Complex, Kd=8.9+/-2nM
1efx  3.00  2000  Kd=9.5uM      // 1efx.pdf (AC|D) Kd value measured for kir2dl2/hla-cw3
1clv  2.00  2000  Kd~1nM        // 1clv.pdf (A|I) complex between TMA andalpha-amylase inhibitor (AAI); Kd estimated to be in nanomolar range
1ezu  2.40  2000  Ki=0.08nM     // 1ezs.pdf (B|C) Ecotin Y69F, D70P BOUND TO RAT ANIONIC TRYPSIN II, Ki=0.08nM
1ezs  2.30  2000  Ki=0.18nM     // 1ezs.pdf (B|C) Ecotin 67-70A, M84R BOUND TO RAT ANIONIC TRYPSIN II, Ki=0.18nM
1dp5  2.20  2000  Ki=0.9nM      // 1dp5.pdf (A|B) PROTEINASE A COMPLEXED WITH IA3 MUTANT INHIBITOR(K31M, K32M), Ki=0.9+/-0.3nM
1c9t  3.30  2000  Ki~1nM        // 1c9p.pdf (C|I) BDELLASTASIN WITH BOVINE TRYPSIN, Ki estimated in nanomolar range
1c9p  2.80  2000  Ki~1nM        // 1c9p.pdf (A|B) BDELLASTASIN WITH PORCINE TRYPSIN, Ki estimated in nanomolar range
1icf  2.00  2000  Ki=1.7pM      // 1icf.pdf (A|I) P41 II FRAGMENT binds to CATHEPSIN L, Ki=1.7pM
1dpj  1.80  2000  Ki=3nM        // 1dpj.pdf (A|B) IA3 residues 2-34, ki=3+/-0.6nM
1fy8  1.70  2000  Ki=9uM        // 1f5r.pdf (E|I) BPTI complexes of rat Delta I16V17 trypsinogen, Ki=9uM
1hqr  3.20  2001  Kd=0.10uM     // 1hqr.pdf (ABC|D) MHC class II binds bacterial SAGs on beta chain, Kd=1 E-7M
1i4e  3.00  2001  Kd=0.12uM     // 1i4e.pdf (A|B) EARLY P35 KDA PROTEIN, Kd=1.16+/-0.01 X 10-7M, with caspase-3
1hez  2.70  2001  Kd=0.145uM    // 1hez.pdf (BA|E) PpL domain C(D55A-Y64W mutant) Complexed with Human IgM Fab 2A2, Kd=0.145uM
1f34  2.45  2001  Kd=0.1nM      // 1f34.pdf (A|B) pepsin inhibitor-3 (PI-3) from Ascaris suum, KI=0.10x10-9M
1i8l  3.00  2001  Kd=0.2uM      // 1i8l.pdf (A|C) HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX, Kd=0.2-0.4uM
1hxy  2.60  2001  Kd=0.5nM      // 1hxy.pdf (ABC|D) SEH IN COMPLEX WITH HLA-DR1, Kd=0.5nM, Bmax, 1/2=0.5nM
1g5j   NMR  2001  Kd=0.6nM      // 1g5j.pdf (A|B) Kd=0.6nM, 25-mer peptide from Bad
1e6e  2.30  2001  Kd=0.86uM     // 1e6e.pdf (A|B) Adrenoxin, 0.86 x 10-6M
1ffw  2.70  2001  Kd=1.2uM      // 1ffw.pdf (A|B) kinase cheA(124-257)
1iqd  2.00  2001  Kd=14pM       // 1iqd.pdf (BA|C) human monoclonal BO2C11 Fab, 1.4 x 10-11M
1gcq  1.68  2001  Kd=16.8uM     // 1gcq.pdf (B|C) VAV PROTO-ONCOGENE; Kd=16.8+/-0.5uM
1e3u  1.66  2001  Kd=1uM        // 1e3u.pdf (B|D) MAD phasing OXA10, dimeric; KD~1uM
1i2m  1.76  2001  Kd=2.5pM      // 1i2m.pdf (A|B) chromosome condensation (RCC1), Kinetics constant K2=4x10^11 M-1, Kd=2.5pM
1he8  3.00  2001  Kd=2.5uM      // 1he8.pdf (A|B) phosphoinositide 3-kinase gamma, 2.5 x 10-6M
1hcf  2.70  2001  Kd=260pM      // 1hcf.pdf (A|X) TrkB-d5:neurotrophin-4/5 complex, with BDNF Kd=790nM
1fe8  2.03  2001  Kd=2uM        // 1fe8.pdf (IM|B) Multimeric vWF binds RU5(collagen inhibitor), collagen Kd=1-7nM. recombinant A3 binds RU5, Kd=2uM
1ewy  2.38  2001  Kd=3.57uM     // 1ewy.pdf (A|C) Ferredoxin
1ib1  2.70  2001  Kd=350uM      // 1ib1.pdf (A|E) 14-3-3 ZETA:SEROTONIN N-ACETYLTRANSFERASE COMPLEX(2:1), Kd=350+/-24uM
1j7v  2.90  2001  Kd=35pM       // 1j7v.pdf (L|R) HUMAN IL-10/IL-10R1 COMPLEX, Kd=35-200pM
1i4d  2.50  2001  Kd=3uM        // 1i4d.pdf (A|D) protein RAS-RELATED C3 BOTULINUM TOXIN SUBSTRATE 1
1i5k  2.70  2001  Kd=42nM       // 1i5k.pdf (B|D) Kd=42+/-5nM, mK2pg complex with VEK-30
1jiw  1.74  2001  Kd=4pM        // 1jiw.pdf (P|I) APR-alkaline protease inhibitor complex, Kd=4pM
1fqj  2.02  2001  Kd=67nM       // 1fqj.pdf (BC|A) ligand is complex of GAMMA SUBUNIT OF PHOSPHODIESTERASE and GT/I1 CHIMERA ALPHA SUBUNIT, Kd=6.7 x 10-8M
1j7d  1.85  2001  Kd~2uM        // 1j7d.pdf (A|B) UBIQUITIN-CONJUGATING ENZYME E2-17 KDA  and hMms2 (Uev1), Kd~2uM
1g0v  2.00  2001  Ki<0.1nM      // 1g0v.pdf (A|B) PROTEASE A INHIBITOR 3, K24M MUTANT OF IA3, ki=1.3+/-0.4nM (pH=3.1); ki<0.1nM (pH=4.7)
1jtg  1.73  2001  Ki=0.11nM     // 1jtd.pdf (A|B) inhibition of TEM-1 by beta-lactamase inhibitor protein, Ki=0.11nM
1gl1  2.10  2001  Ki=0.13nM     // 1gl0.pdf (C|K) BOVINE ALPHA-CHYMOTRYPSIN AND PMP-C, Ki=0.13nM
1gl0  3.00  2001  Ki=0.8nM      // 1gl0.pdf (E|I) BOVINE ALPHA-CHYMOTRYPSIN AND PMP(R29L), Ki=0.8nM; Ki(PMP, K30M)=2nM
1i3o  2.70  2001  Ki=0.97nM     // 1i3o.pdf (CD|F) Inhibition of XIAP BIR2 on Caspase-3, Ki=9.7+/-5.0 E-10M
1eja  2.70  2001  Ki=1.0nM      // 1eja.pdf (A|B) PORCINE beta TRYPSIN COMPLEXED WITH BDELLASTASIN, Ki=1.0nM
1id5  2.50  2001  Ki=1.5nM      // 1id5.pdf (H|I) bovine thrombin in complex with ecotin M84R mutant, Ki=1.5nM
1f7z  1.55  2001  Ki=12.4uM     // 1f5r.pdf (A|I) BPTI complexes of rat K15A trypsinogen, Ki=12.4uM
3tgk  1.70  2001  Ki=12uM       // 3tgk.pdf (E|I) ligand is BPTI, ITC Ki=12uM, enzyme inhibition Ki=29uM
1jtd  2.30  2001  Ki=27.2pM     // 1jtd.pdf (A|B) inhibition of TEM-1 by beta-lactamase inhibitor protein II, Ki=0.0272nM
1f5r  1.65  2001  Ki=65uM       // 1f5r.pdf (A|I) BPTI complexes of rat Delta I16V17/Q156K trypsinogen, Ki=65uM
1gpw  2.40  2002  Kd=0.019uM    // 1gpw.pdf (A|B) AMIDOTRANSFERASE HISH, Kd=0.019+/-0.009uM
1jmo  2.20  2002  Kd=0.115uM    // 1jmo.pdf (H|A) wild type recombinant Heparin Cofactor II with thrombin, Kd=kd/ka=1.5x10-3/1.3x104=1.15x10-7M
1jps  1.85  2002  Kd=0.1nM      // 1jps.pdf (HL|T) tissue factor in complex with humanized Fab D3h44, Kd=0.1nM
1lm8  1.85  2002  Kd=0.22uM     // 1lm8.pdf (H|V) intact HIF-1a-pVHL-ElonginB-ElonginC Complex, Kd=0.22+/-0.04uM
1lzw  2.50  2002  Kd=0.33uM     // 1lzw.pdf (A|B) wild type ClpS with N-Ternimal domain of ClpA, Kd=3.3 X 10-7M; structure is H66A mutant ClpS and ClpA;Kd=1uM is for E79A, K84A double mutant ClpS
1l2w  2.00  2002  Kd=0.3nM      // 1l2w.pdf (A|I) SycE-YopE complex, Kd=0.3nM
1i51  2.45  2002  Kd=0.63uM     // 1i51.pdf (AB|E) structure is CASPASE-7 with XIAP; binding data is for caspase-7 and GST-linker peptide (residues 124-157); Kd=0.63+/-0.04uM
1go4  2.05  2002  Kd=1.04uM     // 1go4.pdf (B|F) MAD1 (MITOTIC ARREST DEFICIENT)-LIKE 1, mad1-mad2 complex
1jwh  3.10  2002  Kd=12.6nM     // 1jwh.pdf (A|D) ligand is Human Protein Kinase CK2 Holoenzyme beta chain, 1.26 x 10-8M
1l4z  2.80  2002  Kd=196.6nM    // 1l4d.pdf (A|B) SKa delta-Plasminogen uPg(R561A, S741A) complex(Form II) in presence of CADMIUM IONS, Kd=196.6+/-2.4nM
1l4d  2.30  2002  Kd=196.6nM    // 1l4d.pdf (A|B) SKa delta- PLASMINOGEN u Pg(S741A) complex(Form I), Kd=196.6+/-2.4nM
1kxp  2.10  2002  Kd=1nM        // 1kxp.pdf (A|D) HUMAN VITAMIN D-BINDING PROTEIN with actin
1mxe  1.70  2002  Kd=1pM        // 1mxe.pdf (B|F) complex between Calcium-saturated calmodulin (CaM) and CaMKIp
1k5d  2.70  2002  Kd=1uM        // 1k5d.pdf (A|C) Kd between Ran-GppNHp-RanBP1 and RanGAP in buffer containing 0M NaCl
1k93  2.95  2002  Kd=20nM       // 1k93.pdf (A|D) anthrax edema factor (EF) in complex with calmodulin(CaM), Kd=20nM
1ktk  3.00  2002  Kd=20uM       // 1ktk.pdf (A|E) SpeC(C13A, C191A) with T cell receptor beta chain, Kd=2 E-5M
1i8k  1.80  2002  Kd=22nM       // 1i8i.pdf (BA|C) DSFV MR1 binds to EGFRVIII PEPTIDE ANTIGEN(Liquid Nitrogen Temp), Kd=22nM
1kxt  2.00  2002  Kd=235nM      // 1kxt.pdf (A|B) PPA/IMMUNOGLOBULIN VHH FRAGMENT AMB7 complexs, Kd=235nM
1ijk  2.60  2002  Kd=23nM       // 1ijk.pdf (BC|A) vWF A1 domain-botrocetin Complex, Kd=23nM
1kgy  2.70  2002  Kd=25nM       // 1kgy.pdf (A|E) EphB receptor 2-ephrinB2 complex, Kd=25nM
1kxv  1.60  2002  Kd=25nM       // 1kxt.pdf (B|D) PPA/CAMELID VHH DOMAIN CAB10, AMD10 complexs
1lj2  2.38  2002  Kd=27uM       // 1lj2.pdf (B|D) PABP.NSP3-C with eukaryotic protein synthesis initiation factor, eIF4G
1ktz  2.15  2002  Kd=290nM      // 1ktz.pdf (A|B) ligand is TGF-beta3, 2.9 x 10-7M
1lw6  1.50  2002  Kd=2pM        // 1lw6.pdf (E|I) subtilisin BPN-Chymotrypsin Inhibitor 2(E45A) complex, Kd=2 E-12M
1kxq  1.60  2002  Kd=3.5nM      // 1kxq.pdf (D|E) porcine pancreatic alpha-amylase PPA, with AMD9 VHH
1lqb  2.00  2002  Kd=31nM       // 1lqb.pdf (C|D) Binding of VCB to HIF-1a peptides, Kd=3.1 E-8M
1kbh   NMR  2002  Kd=34nM       // 1kbh.pdf (A|B) nuclear receptor coactivator ACTR, Kd=3.4 X 10-8M
1h59  2.10  2002  Kd=37nM       // 1h59.pdf (A|B) COMPLEX OF IGFBP-5 WITH IGF-I, Kd=37nM
1gng  2.60  2002  Kd=39nM       // 1gng.pdf (B|Y) 
1kkl  2.80  2002  Kd=45nM       // 1kkl.pdf (C|H) B.subtilis phosphocarrier protein HPr
1eaw  2.93  2002  Kd=49.7pM     // 1eaw.pdf (C|D) BPTI
1lqs  2.70  2002  Kd=4nM        // 1lqs.pdf (R|L) INTERLEUKIN-10-LIKE PROTEIN cmvIL-10 bound to sIL-10R1, Kd=4nM
1gxd  3.10  2002  Kd=5.2nM      // 1gxd.pdf (B|D) tissue inhibitor of metalloproteinase 2, high affinity site Kd=5.2nM, low affinity site Kd=0.19uM
1m10  3.10  2002  Kd=5.8nM      // 1m10.pdf (A|B) complex of Glycoprotein Ib- alpha  (M239V)and vWF A1 Domain(R543Q), Kd=5.8nM
1jsp   NMR  2002  Kd=50uM       // 1jsp.pdf (A|B) CBP bromodomain/p53 peptide complex, Kd~50uM
1l0x  2.80  2002  Kd=6uM        // 1l0x.pdf (C|D) Exotoxin type A SpeA without zinc, Kd~6 X 10-6M
1l8c   NMR  2002  Kd=7nM        // 1l8c.pdf (A|B) Hypoxia-inducible factor 1 alpha Hifa, ITC Kd=7+/-1nM
1m1e  2.10  2002  Kd~1nM        // 1m1e.pdf (A|B) ICAT protein, approximately interaction Kd~1nM
1l0y  2.50  2002  Kd~6uM        // 1l0x.pdf (C|D) Exotoxin type A SpeA with zinc, Kd~6 X 10-6M
1ob1  2.90  2003  Kd=0.2nM      // 1ob1.pdf (ED|F) mAb G17.12 binds to PfMSP1-19, Kd=2 E-10 M
1jgn   NMR  2003  Kd=0.35uM     // 1jgn.pdf (A|B) PABP-interacting protein-2 (Paip2), Kd=3.5 X 10-7M
1ogy  3.20  2003  Kd=0.5nM      // 1ogy.pdf (O|P) di-heme cytochrome C NapB molecule cytochrome subunit, estimated Kd=0.1-1.5nM
1op9  1.86  2003  Kd=0.7nM      // 1op9.pdf (A|B) human lysozyme Complex with HL6 camel VHH fragment, Kd=0.7nM
1p27  2.00  2003  Kd=0.7nM      // 1p27.pdf (A|B) Human Y14/Magoh complex, Kd=0.7+/-0.1nM
1p9m  3.65  2003  Kd=0.8nM      // 1p9m.pdf (AC|B) for Interleukin-6 Receptor alpha with gp130 D2-D3, Kd=40nM
1lx5  3.30  2003  Kd=1.2nM      // 1lx5.pdf (A|B) Immobilized Receptor, bone morphogenetic protein 7 BMP7/ActRII Complex, Kd=1.2nM
1p3q  1.70  2003  Kd=1.2uM      // 1p3q.pdf (R|V) ubiquitin, Kd=1.2uM
1n64  2.34  2003  Kd=1.3nM      // 1n64.pdf (HL|P) Hepatitis C virus protein P13-40 bound to mAb 19D9D6, Kd=1.3+/-0.1nM
1j2j  1.60  2003  Kd=1.4uM      // 1j2j.pdf (A|B) ADP-ribosylation factor binding protein GGA1
1jh4   NMR  2003  Kd=1.5uM      // 1jgn.pdf (A|B) PABP-interacting protein-1 (Paip1), Kd=1.5 X 10-6M
1mzw  2.00  2003  Kd=1.97uM     // 1mzw.pdf (A|B) U4/U6-60K peptide bind to CypH, Kd=1.97uM
1oqe  2.50  2003  Kd=109nM      // 1oqd.pdf (I|Q) tumour necrosis factor (TNF) ligand sTALL-1 and eBAFF-R(1-62), Kd=109nM
1nys  3.05  2003  Kd=10nM       // 1nys.pdf (C|D) Activin A, space group p41 form, Kd<10nM
1nyu  3.10  2003  Kd=10nM       // 1nys.pdf (C|D) Activin A, space group p41212 form, Kd<10nM
1mi5  2.50  2003  Kd=10uM       // 1mi5.pdf (DE|AC) LC13 TcR in complex with HLAB8-EBV peptide complex
1p9d   NMR  2003  Kd=12.9uM     // 1p9d.pdf (S|U) Ubl:S5a-UIM-2 complex, Kd=12.9 E-6 M
1uad  2.10  2003  Kd=137nM      // 1uad.pdf (B|D) Exocyst complex component Sec5
1otr   NMR  2003  Kd=155uM      // 1otr.pdf (A|B) CUE2-1-ubiquitin complex, Kd=155+/-9uM
1pjm  2.50  2003  Kd=180nM      // 1pjm.pdf (A|B) Kd=180nM, for mouse Importin-alpha alone, with RB, human retinoblastoma protein
1mhh  2.10  2003  Kd=1nM        // 1mhh.pdf (BA|E) a protein L mutant complexed to an Fab fragment, Kd=1nM
1o9a   NMR  2003  Kd=1uM        // 1o9a.pdf (A|B) Kd=1.0+/-0.1uM
1m5n  2.90  2003  Kd=2.1nM      // 1m5n.pdf (S|Q) importin beta (1-485):PTHrP-ncNLS(67-94)
1psb   NMR  2003  Kd=20uM       // 1psb.pdf (A|C) S100B/NDR62-87 peptide complex, Kd=20+/-10uM
1pjn  2.50  2003  Kd=22nM       // 1pjm.pdf (A|B) Kd=22nM, for mouse Importin-alpha alone with X. laevis phosphoprotein N1N2
1h1v  3.00  2003  Kd=23nM       // 1h1v.pdf (A|G) GELSOLIN G4-G6 RESIDUES 412-742, Kd=2.3 x 10-8M
1q0w   NMR  2003  Kd=277uM      // 1q0w.pdf (A|B) Kd=277+/-8uM, for Vps27 UIM-2 and ubiquitin Kd=117+/-17uM
1r0r  1.10  2003  Kd=29.4pM     // 1r0r.pdf (E|I) Protein Inhibitor OMTKY3, Ka=3.4x10^10 M-1, Kd=2.94x10-11M
1uex  2.85  2003  Kd=2nM        // 1uex.pdf (B|C) von Willebrand Factor A1 domain complex with bitiscetin, Kd=2nM
1lp1  2.30  2003  Kd=2uM        // 1lp1.pdf (A|B) protein Z and the antiprotein A affibody ZSPA-1, Kd=2-6uM
1p4l  2.90  2003  Kd=3.0uM      // 1p4l.pdf (AB|D) peptide-selective receptor Ly49C
1ozs   NMR  2003  Kd=31uM       // 1ozs.pdf (A|B) cardiac troponin I-(128-147) (cIp), Kd=31+/-11uM
1mq8  3.30  2003  Kd=3uM        // 1mq8.pdf (C|D) alphaL I Domain(L161C, F299C) Binding to ICAM-1, Kd=3.0+/-0.44uM
1q68   NMR  2003  Kd=400nM      // 1q68.pdf (A|B) Src-family tyrosine kinase Lck, Kd=400nM
1p22  2.95  2003  Kd=480nM      // 1p22.pdf (A|C) beta-TrCP1-Skp1 and beta-catenin complex, Kd=480+/-40nM
1oey  2.00  2003  Kd=4nM        // 1oey.pdf (B|K) HETERODIMER OF P40PHOX AND P67PHOX PB1 DOMAINS, Kd=4nM
1o95  3.70  2003  Kd=5uM        // 1o94.pdf (B|C) TMADH:2 electron transferring flavoprotein (ETF) complex, Kd~5uM, X-ray space group p21
1h0t   NMR  2003  Kd=6uM        // 1h0t.pdf (A|B) ZSPA-1 AFFIBODY complex, Kd=6uM
1pvh  2.50  2003  Kd=80nM       // 1pvh.pdf (C|D) human leukemia inhibitory factor (LIF)/gp130-CHR Complex, Kd=80+/-6.2nM
1p1z  3.26  2003  Kd=80uM       // 1p1z.pdf (AB|D) LY49-C antigen; Kd for H-2Kb-OVAwt Ly49C
1q69   NMR  2003  Kd=900nM      // 1q68.pdf (A|B) Src-family tyrosine kinase Lck, Kd=900nM
1nez  2.10  2003  Kd~10uM       // 1nez.pdf (HG|A) TL, a non-classical MHC class I molecule/CD8 alpha  alpha  Complex, Kd~10uM
1oc0  2.28  2003  Kd~1nM        // 1oc0.pdf (A|B) Somatomedin B Domain Of Vitronectin
1nvu  2.20  2003  Kd~3.6uM      // 1nvu.pdf (Q|S) Son of sevenless protein homolog 1, residues 566-1046
1nf3  2.10  2003  Kd~50nM       // 1nf3.pdf (B|D) GTPase-binding domain of the cell polarity protein, Par6
1oph  2.30  2003  Kd~5nM        // 1oph.pdf (A|B) ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN, Kd=5nM. Ligand mutations:F51L, T59A, T68A, A70G, C232S, M358R, M274I, S381A, K387R
1o94  2.00  2003  Kd~5uM        // 1o94.pdf (A|CD) TMADH:2 electron transferring flavoprotein (ETF) complex, Kd~5uM, X-ray space group C2
1nw9  2.40  2003  Ki=0.013uM    // 1nw9.pdf (A|B) XIAP-BIR3, Ki=0.013uM
1pxv  1.80  2003  Ki=0.31nM     // 1pxv.pdf (A|C) cysteine protease Inhibitor, Staphostatins, Ki=3.1x10-10M
1p0s  2.80  2003  Ki=11pM       // 1p0s.pdf (H|E) Blood Coagulation Factor Xa Complex with Ecotin M84R, Ki=11pM
1nb5  2.40  2003  Ki=69pM       // 1nb5.pdf (A|I) stefin A and stefin B complex with cathepsin H, Ki=0.027nM and Ki=0.069nM, author confuse two data himself
1mcv  1.80  2003  Ki=98nM       // 1mcv.pdf (A|I) hybrid squash inhibitor HEI-TOE I and porcine pancreatic elastase complex, Ki=9.8 X 10-8M
1oyv  2.50  2003  Ki=9nM        // 1oyv.pdf (A|I) tomato inhibitor-II complex with subtilisin Carlsberg, Ki=9nM
1rpq  3.00  2004  IC50=0.032uM  // 1rpq.pdf (B|X) 
1rv6  2.45  2004  IC50=275nM    // 1rv6.pdf (W|X) FLT1 protein; IC50 for plgf/vegfr1
1xx9  2.20  2004  IC50=3nM      // 1xx9.pdf (B|D) rhFXI(370-607) and Ecotin M84R complex, IC50=3nM
1xu1  1.90  2004  IC50=5.9nM    // 1xu1.pdf (B|S) ligand APRIL, IC50=5.9+/-1.4nM
1xxd  2.91  2004  IC50=600nM    // 1xx9.pdf (A|C) rhFXI(370-607) and Ecotin D complex, IC50=600nM. Ligand mutation:P80N, V81D, S82F, M84R, M85V, A86V
1v7p  1.90  2004  IC50=6nM      // 1v7p.pdf (AB|C) EMS16 in complex with  alpha 2-I domain, IC50=6nM. protein mutation:Q138G, P139S, C140S
1ry7  3.20  2004  Kd=0.23uM     // 1ry7.pdf (A|B) 3 Ig form of FGFR3c in complex with full length FGF1, Kd=2.3 E-7 M
1u0s  1.90  2004  Kd=0.23uM     // 1u0s.pdf (Y|A) CheA P1-P2 domain and CheY for T. maritima, Temp.28 Kd=0.23+/-0.02uM, Temp.70 Kd=1.0+/-0.2uM
1xqh  1.75  2004  Kd=0.2uM      // 1xqh.pdf (E|F) incomplete ligand structure
1pd7   NMR  2004  Kd=0.3uM      // 1pd7.pdf (A|B) Mad1-SID length 24, Kd=0.3+/-0.2uM
1xd3  1.45  2004  Kd=0.3uM      // 1xd3.pdf (A|B) UBC protein, Kd=3 x 10-7M
1t6b  2.50  2004  Kd=0.4nM      // 1t6b.pdf (X|Y) Anthrax toxin receptor 2, 4.0 x 10-10M
1nl0  2.20  2004  Kd=1.6nM      // 1nl0.pdf (HL|G) human factor IX Gla domain complex with inhibitory antibody 10C12, Kd=1.6nM. one of the smallest interface between protein-anti body complexes
1tzh  2.60  2004  Kd=1.8nM      // 1tzh.pdf (HL|V) Fab YADS1 Complexed with h-VEGF, Kd=1.8+/-0.3nM
1us7  2.30  2004  Kd=1.8uM      // 1us7.pdf (A|B) COMPLEX OF yeast N-HSP90 AND C-P50
1tzi  2.80  2004  Kd=10nM       // 1tzh.pdf (BA|V) Fab YADS2 Complexed with h-VEGF, Kd=10+/-2nM
1xr0   NMR  2004  Kd=10uM       // 1xr0.pdf (A|B) FGFR signalling adaptor SNT-1 PTB domain, estimated Kd=10uM
1sv0  2.07  2004  Kd=11.1nM     // 1sv0.pdf (B|D) Yan-SAM A86R/Mae-SAM Complex, Kd=11.1+/-0.1nM
1vet  1.90  2004  Kd=12.8nM     // 1vet.pdf (A|B) Late endosomal/lysosomal Mp1 interacting protein, code 1veu is the same protein at 2.15A
1veu  2.15  2004  Kd=12.8nM     // 1veu.pdf (A|B) p14/MP1 complex, resolution=1.9 or 2.15 angstrom? Kd=12.8nM
1q5w   NMR  2004  Kd=126uM      // 1q5w.pdf (A|B) Ubiquitin Recognition by Npl4 Zinc-Fingers, Kd=126+/-26uM
1tdq  2.60  2004  Kd=12nM       // 1tdq.pdf (A|B) CLD:rat tenascin-R(TN3-5), Kd=12nM
1r8u   NMR  2004  Kd=13nM       // 1r8u.pdf (A|B) CBP TAZ1/CITED2 complex, Kd=13+/-10nM
1syq  2.42  2004  Kd=14.7nM     // 1syq.pdf (A|B) Kd for vinculin binding site 1 (VBS1)=14.7nM, VBS2=32.8nM, VBS3=3.1nM
1w72  2.15  2004  Kd=14nM       // 1w72.pdf (HL|AC) HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3
1sb0   NMR  2004  Kd=15uM       // 1sb0.pdf (A|B) Transactivation Domain of c-Myb, buffer tris Kd=15uM, phosphate Kd=12.5uM
1tzn  4.30  2004  Kd=170pM      // 1tzn.pdf (O|o) CMG2 VWA domain protein, Kd=170pM
1sg1  2.40  2004  Kd=186nM      // 1sg1.pdf (B|X) 2:1 Nerve Growth Factor/p75 complex, Kd=186nM
1t44  2.00  2004  Kd=1uM        // 1t44.pdf (G|A) actin with chimera of gelsolin domain 1 and c-terminal
1th1  2.50  2004  Kd=2.1nM      // 1th1.pdf (B|D) Beta-catenin(full length) complex with a phosphorylated APC-2, 3 , Kd=2.1nM
1sy6  2.10  2004  Kd=2.73uM     // 1sy6.pdf (HL|A) CD3 epsilon  gamma  Heterodimer in Complex with OKT3 Fab, Kd=27.3+/-4.74 E-7 M
1xt9  2.20  2004  Kd=200nM      // 1xt9.pdf (A|B) Den1 in complex with Nedd8, Kd=200nM
1vyt  2.60  2004  Kd=20nM       // 1vyt.pdf (A|E) alpha interaction domain 1, AID with beta subunit, Kd=20nM
1w1w  2.90  2004  Kd=260uM      // 1w1w.pdf (C|G) Kd value between two Smc1hd/Scc-C monomers
1u7v  2.70  2004  Kd=296nM      // 1u7f.pdf (A|B) Smad2/Smad4 heterotrimeric complex, Kd=296+/-165.8nM
1usu  2.15  2004  Kd=3.3uM      // 1usu.pdf (A|B) COMPLEX BETWEEN N-AHA1 AND M-HSP90, crystal form1, Kd=3.3+/-0.8uM
1usv  2.70  2004  Kd=3.3uM      // 1usu.pdf (E|F) COMPLEX BETWEEN N-AHA1 AND M-HSP90, crystal form2, Kd=3.3+/-0.8uM
1uel   NMR  2004  Kd=3.4uM      // 1uel.pdf (A|B) hHR23B UBl complexed with UIM wild type S5a, Kd=3.4+/-0.3uM
1tlh   NMR  2004  Kd=300uM      // 1tlh.pdf (A|B) T4 AsiA/sigma70 EcSR4 complex, Kd=300uM
1sq0  2.60  2004  Kd=30nM       // 1sq0.pdf (A|B) wt Von Willebrand Factor A1 domain and Glycoprotein Ib alpha, Kd=30nM
1p6a  2.90  2004  Kd=35nM       // 1p69.pdf (A|B) Ad12 knob mutants S489Y-CAR D1, Kd=35+/-4.4nM
1rkc  2.70  2004  Kd=39nM       // 1rkc.pdf (A|B) Vh domain in complex with talin vinculin-binding site3 VBS3, Kd=39nM
1t01  2.06  2004  Kd=39nM       // 1t01.pdf (A|B) still vh, talin 482-636, with talin (vinculin binding site 1)VBS1, IC50=3nM
1p4b  2.35  2004  Kd=40pM       // 1p4b.pdf (HL|P) sc Fv Fragment Complexed With The peptide GCN4(7P-14P), Kd=40pM
1oyh  2.62  2004  Kd=42nM       // 1oyh.pdf (I|L) Antithrombin-III beta glycoform, ionic strength=2, Kd=4.2+/-0.1 X 10-8M
1rvj  2.75  2004  Kd=4uM        // 1rvj.pdf (H|LM) RH(H177) revertant RC in the trigonal form, Kd=4+/-1uM
1rke  2.35  2004  Kd=50nM       // 1rke.pdf (A|B) vinculin head (1-258) complex with vinculin tail (879-1066), Kd=50-80nM
1u7f  2.60  2004  Kd=58nM       // 1u7f.pdf (A|B) Smad3/Smad4 heterotrimeric complex, Kd=58+/-2.9nM
1vg0  2.20  2004  Kd=5nM        // 1vg0.pdf (A|B) Kd measured for Rab7/REP-1
1ty4  2.20  2004  Kd=6.4nM      // 1ty4.pdf (B|D) EGL-1 with cell-killing caspase CED-9, Kd=6.4nM
1s4y  2.30  2004  Kd=6.87nM     // 1s4y.pdf (C|D) two ActRIIb-ECD, Kd=6.87nM
1u0i   NMR  2004  Kd=70nM       // 1u0i.pdf (A|B) IAAL-E3 K3 complex, Kd=70nM
1p69  3.10  2004  Kd=76nM       // 1p69.pdf (A|B) Ad12 knob mutants P417S-CAR D1, Kd=76+/-4.1nM
1shy  3.22  2004  Kd=90nM       // 1shy.pdf (A|B) HGF beta complex with Met ECD, Kd=90nM
1p2c  2.00  2004  Kd=98pM       // 1p2c.pdf (ED|F) Lysozyme C, Ka=1.02x10^10 M-1, Kd=0.98x10-10M
1s1q  2.00  2004  Kd~500uM      // 1s1q.pdf (A|B) TSG101 UEV-Ubiquitin complex, Kd~500uM
1nm5  2.40  2004  Kd~60nM       // 1nm5.pdf (B|C) (dI.Q132N)2(dIII)1 asymmetric complex, Kd~60nM
1tm7  1.59  2004  Ki=0.0033nM   // 1tm7.pdf (E|I) 
1tm1  1.70  2004  Ki=0.003nM    // 1tm1.pdf (E|I) 
1tm5  1.45  2004  Ki=0.017nM    // 1tm5.pdf (E|I) 
1tm3  1.57  2004  Ki=0.019nM    // 1tm3.pdf (E|I) 
1tm4  1.70  2004  Ki=0.13nM     // 1tm4.pdf (E|I) 
1to1  1.68  2004  Ki=0.46nM     // 1to1.pdf (E|I) 
1tt5  2.60  2004  Ki=22uM       // 1tt5.pdf (B|E) Ubc12 N-terminus Ubc12N26, Ki=22+/-5uM
1uuz  1.80  2004  Ki=25nM       // 1uuz.pdf (A|D) Ki app=25nM
1te1  2.50  2004  Ki=3.4nM      // 1ta3.pdf (A|B) family 11 xylanase (GH11) in complex with inhibitor (XIP-I), Ki=3.4nM
1ta3  1.70  2004  Ki=9nM        // 1ta3.pdf (A|B) xylanase (GH10) in complex with inhibitor (XIP), Ki=9nM
1zjd  2.60  2005  IC50=1.28nM   // 1zjd.pdf (A|B) wt PN2KPI domain inhibition of FXIac, IC50=1.28nM. protein mutation:S434A, T475A, C482S
1yc0  2.60  2005  IC50=4nM      // 1yc0.pdf (A|I) Kunitz-type protease inhibitor 1, IC50=4.0+/-0.3nM
2ass  3.00  2005  Kd=0.006uM    // 2ass.pdf (B|C) 
1vyh  3.40  2005  Kd=0.08uM     // 1vyh.pdf (A|C)
1z7x  1.95  2005  Kd=0.29fM     // 1z7x.pdf (Z|Y) Ribonuclease inhibitor-RNase 1 complex, Kd=2.9x10-16M
1zhi  2.70  2005  Kd=0.2uM      // 1zhi.pdf (A|B) Regulatory protein SIR1, 2 x 10-7M
1r6q  2.35  2005  Kd=0.33uM     // 1r6q.pdf (B|D) ligand is ATP-dependent Clp protease adaptor protein clpS, Kd=3.3 x 10-7M
1wlp   NMR  2005  Kd=0.64uM     // 1wlp.pdf (A|B) p47phox-(151-286) complex p22phox-(149-168), Kd for p22phox-(149-162)=8.67uM
1zm4  2.90  2005  Kd=0.98uM     // 1zm4.pdf (C|D) exotoxin A
1y8n  2.60  2005  Kd=1.17uM     // 1y8n.pdf (A|B) 
2c1m  2.20  2005  Kd=1.1nM      // 2c1m.pdf (A|B) NUP50(1-109):IMPORTIN-ALPHA(70-529) COMPLEX, Kd=1.1+/-0.2nM. Structure is not intact.
1ze3  1.84  2005  Kd=1.2uM      // 1ze3.pdf (CH|D) Complex of FimD N-terminal domain with FIMC and the Pilin Domain of FIMH, Kd=1.2uM
1uwx  2.20  2005  Kd=1.6uM      // 1uwx.pdf (HL|A) P1.2 SEROSUBTYPE ANTIGEN IN COMPLEX WITH FAB FRAGMENT, Kd=1.6+/-0.5uM
1ydi  1.80  2005  Kd=1.78nM     // 1ydi.pdf (A|B) ligand is Alpha-actinin 4, Kd=1.78nM
2b4j  2.02  2005  Kd=10.9nM     // 2b4j.pdf (A|D) IN-binding domain of lens epithelium-derived growth factor (LEDGF), 1.09 x 10-8M
2b0z  2.70  2005  Kd=100uM      // 2b0z.pdf (A|B) F82I cytochrome c and cytochrome c peroxidase, Kd=100uM
1v18  2.10  2005  Kd=10nM       // 1v18.pdf (A|B) BETA-CATENIN(full length) COMPLEXED WITH PHOSPHORYLATED APC R3, Kd=10+/-1.3nM
1z92  2.80  2005  Kd=10nM       // 1z92.pdf (A|B) Interleukin-2 Complexed with Its Alpha Receptor, low Kd=10nM
2ajf  2.90  2005  Kd=10nM       // 2ajf.pdf (A|E) SARS-CoV RBD and human ACE2 complex, Kd=1 E-8 M
2b5i  2.30  2005  Kd=10pM       // 2b5i.pdf (BCD|A) Interleukin-2 alpha beta gamma chain, quaternary complex, Kd=10pM. Protein mutation:alpha, N68Q; beta, N3, 17, 45Q; gamma, N53Q
2b10  2.80  2005  Kd=10uM       // 2b0z.pdf (A|B) F82S cytochrome c and cytochrome c peroxidase, Kd=10uM
1wa8   NMR  2005  Kd=11nM       // 1wa8.pdf (A|B) CFP-10 and ESAT-6 complex, Kd=1.1 X 10-8M
1x1y  1.90  2005  Kd=12.7uM     // 1x1y.pdf (A|D) barnase(Q2A)-barstar(D35A), Kd=1.27 E-7 M, ligand mutation:D35A, C40A, C82A
2a7u   NMR  2005  Kd=120nM      // 2a7u.pdf (A|B) E.coli F-ATPase delta subunit N-terminal domain complex with alpha subunit N-terminal 22 residues, strongest Kd~120nM
2aep  2.10  2005  Kd=12nM       // 2aep.pdf (HL|A) Memphis/98 NA-Mem5 fab complex, frozen crystals(-166 centigrade ), Kd=12nM
2aeq  3.00  2005  Kd=12nM       // 2aep.pdf (HL|A) Memphis/98 NA-Mem5 fab complex, room temperature(20 centigrade ), Kd=12nM
1x1u  2.30  2005  Kd=13.2nM     // 1x1u.pdf (A|D) barnase(wt)-barstar(pwt), Kd=1.32 E-10 M, ligand mutation:C40A, C82A
2bnr  1.90  2005  Kd=13.3uM     // 2bnr.pdf (DE|ABC) TCR-pMHC complex;
1wdw  3.00  2005  Kd=14.3nM     // 1wdw.pdf (C|D) Tryptophan synthase beta chain, K=0.7x10^8M-1, Kd=1.43x10-8M, temperature is 35 degree
1wr1   NMR  2005  Kd=14.8uM     // 1wr1.pdf (A|B) Dsk2p UBA with ubiquitin, Kd=14.8uM
1t63  2.07  2005  Kd=15uM       // 1t63.pdf (A|B) incomplete ligand structure
1x75  2.80  2005  Kd=17.5nM     // 1x75.pdf (B|D) GyrA14 protects against Cytotoxic protein ccdB, Kd=17.5nM
1y6m  2.80  2005  Kd=173nM      // 1y6m.pdf (L|R) Epstein-Barr virus IL-10 and sIL-10R1 complex, Kd=173nM
1yd8  2.80  2005  Kd=181uM      // 1yd8.pdf (U|H) ligand is GAT domain of GGA3, Kd=181+/-39uM
1y6k  2.52  2005  Kd=1nM        // 1y6k.pdf (L|R) ligand is Interleukin-10 receptor alpha chain, ITC Kd=1nM, solution affinity Kd=8nM
1yru  2.50  2005  Kd=1nM        // 1yrt.pdf (A|B) wild type CyaA-ACD and C-CaM complex with exogenous CaCl2, Kd=1nM
2bp7  2.90  2005  Kd=1nM        // 2bp7.pdf (A|B) the peripheral subunit binding domain (PSBD) E2, Kd less than 10-9M
2c1t  2.60  2005  Kd=2.0nM      // 2c1m.pdf (B|D) KAP60P:NUCLEOPORIN NUP2 COMPLEX, Kd=2.0+/-0.2nM
1yy9  2.60  2005  Kd=2.3nM      // 1yy9.pdf (DC|A) sEGFR binds to immobilized FabC225, Kd=2.3+/-0.5nM
2byk  2.40  2005  Kd=2.3uM      // 2byk.pdf (C|D) CHRAC14 and CHRAC16 HETERODIMER, crystal form I, Kd=2.3uM
2bym  2.80  2005  Kd=2.3uM      // 2byk.pdf (C|D) CHRAC14 and CHRAC16 HETERODIMER, crystal form II, Kd=2.3uM
2be6  2.00  2005  Kd=2.63nM     // 2be6.pdf (A|D) ligand is Ca2+/CaM  C lobe, for C lobe Kd=2.63+/-0.07nM, for N lobe Kd=57.6+/-35.5nM
1ri8  1.85  2005  Kd=2.9nM      // 1ri8.pdf (A|B) camelid ANTIBODY HEAVY CHAIN D2-L19 and HEWL, Kd=2.9nM
2b12  3.02  2005  Kd=20uM       // 2b0z.pdf (A|B) F82Y cytochrome c and cytochrome c peroxidase, Kd=20uM
2bqz  1.50  2005  Kd=20uM       // 2bqz.pdf (E|F) incomplete ligand structure
1wr6  2.60  2005  Kd=231uM      // 1wr6.pdf (C|G) GGA3 GAT domain in complex with ubiquitin, Kd=231+/-13uM
2aw2  2.80  2005  Kd=25nM       // 2aw2.pdf (X|Y) ligand is Tumor necrosis factor receptor superfamily member 14
1t0p  1.66  2005  Kd=25uM       // 1t0p.pdf (A|B) binding domains of ICAM-3 and  alpha L I domain, untreated Kd=25.0+/-2.80uM (ICAM-3 uncleaved, from 293T cell)
1x1w  2.10  2005  Kd=26.4nM     // 1x1w.pdf (A|D) barnase(wt)-barstar(E80A), Kd=2.64 E-10 M, ligand mutation:E80A, C40A, C82A
1y6n  2.70  2005  Kd=27nM       // 1y6m.pdf (L|R) Epstein-Barr virus IL-10 A87I/sIL-10R1 complex, Kd=27nM
1vrc   NMR  2005  Kd=28.4uM     // 1vrc.pdf (A|C) Binding of HPr to IIAMan, Kd=28.4+/-0.5uM
1z5s  3.01  2005  Kd=3.04uM     // 1z5s.pdf (AB|D) SUMO-RanGAP1-Ubc9 and Nup358/RanBP2, Kd=3.04+/-0.47uM
1t5z  2.30  2005  Kd=33uM       // 1t5z.pdf (A|B) incomplete ligand structure
1za3  3.35  2005  Kd=34nM       // 1za3.pdf (BA|S) YSd1:human death receptor Extra-cellular domain(hDR5-ECD) complex, Kd=34nM
1yx5   NMR  2005  Kd=350uM      // 1yx5.pdf (A|B) S5a UIM-1/Ubiquitin Complex, Kd=350uM
1xwd  2.92  2005  Kd=388uM      // 1xwd.pdf (AB|C) FSH-FSHRHB complex, monomer-dimer equilibrium Kd=388+/-120uM
1xj7  2.70  2005  Kd=39uM       // 1xj7.pdf (A|B) incomplete ligand structure
1u5s   NMR  2005  Kd=3mM        // 1u5s.pdf (A|B) complex between Nck-2 SH3 domain and PINCH-1 LIM4 domain, Kd=3XE-3M
1shz  2.85  2005  Kd=3uM        // 1shz.pdf (D|F) ligand is Rho guanine nucleotide exchange factor 1
1wrd  1.75  2005  Kd=409uM      // 1wrd.pdf (A|B) Tom1 GAT domain in complex with ubiquitin, Kd=409+/-13uM
1zc3  2.00  2005  Kd=42nM       // 1zc3.pdf (C|B) ligand is exocyst complex protein Exo84
1zc4  2.50  2005  Kd=42nM       // 1zc4.pdf (C|B) ligand is exocyst complex protein Exo84; same as 1zc3
1yyl  2.75  2005  Kd=4nM        // 1yyl.pdf (HL|G) CD4M33/core YU2 gp120/Fab 17b, Kd=4+/-1nM
1x1x  2.30  2005  Kd=53nM       // 1x1x.pdf (A|D) barnase(wt)-barstar(E76A), Kd=5.30 E-10 M, ligand mutation:E76A, C40A, C82A
1pk1  1.80  2005  Kd=54nM       // 1pk1.pdf (C|D) Hetero SAM domain structure of Ph and Scm, Kd=54+/-2nM
1xg2  1.90  2005  Kd=5nM        // 1xg2.pdf (A|B) pectin methylesterase complex with PME inhibitor protein, Kd=5nM(PH5.5)
1y76   NMR  2005  Kd=5uM        // 1y74.pdf (C|B) Patj/Pals1N L27 Domain Complex(tetramer), Kd value significantly <5uM
2b11  2.30  2005  Kd=5uM        // 2b0z.pdf (C|D) F82W cytochrome c and cytochrome c peroxidase, Kd=5uM
2b2w  2.40  2005  Kd=5uM        // 2b2t.pdf (AC|D) human CHD1 with Histone H3 Tail (trimethyllysine 4), Kd=5uM
2bnq  1.70  2005  Kd=5uM        // 2bnq.pdf (AC|B) TCR-pMHC complex
1xqs  2.90  2005  Kd=6.5uM      // 1xqs.pdf (B|D) ligand is Hsp70 ATPase domain, 5mM AMP ADP ATP, Kd=6.5uM
1ul1  2.90  2005  Kd=60nM       // 1ul1.pdf (X|A) human FEN1-Proliferating cell nuclear antigen (PCNA) complex, Kd=60nM
2a78  1.81  2005  Kd=60nM       // 2a78.pdf (A|B) ligand is Mono-ADP-ribosyltransferase C3
2a9k  1.73  2005  Kd=60nM       // 2a9k.pdf (A|B) RalA-GDP-C3bot complex, Kd=60+/-20nM
2c5d  3.30  2005  Kd=6nM        // 2c5d.pdf (A|C) human Gas6-LG/Axl-IG complex, Kd=6+/-2nM
1zsg   NMR  2005  Kd=7.5uM      // 1zsg.pdf (A|B) the PIX-SH3/PAK peptide complex, Kd=7.5+/-0.3uM
1zmy  3.00  2005  Kd=7.6nM      // 1zmy.pdf (A|L) cAbBCII-10 VHH with CDR loops of cAbLys3 complex with HEWL, Kd=7.6nM
1z0k  1.92  2005  Kd=7.7uM      // 1z0k.pdf (A|B) RAB4 binding domain of Rabenosyn, SPR Kd=7.7+/-1.9uM
1yx6   NMR  2005  Kd=73uM       // 1yx5.pdf (A|B) S5a UIM-2/Ubiquitin Complex, Kd=73uM
1rjc  1.40  2005  Kd=77pM       // 1ri8.pdf (A|B) camelid heavy chain antibody cAb-Lys2 and HEWL, Kd=77pM
1wve  1.85  2005  Kd=7nM        // 1wve.pdf (A|C) flavoprotein and cytochrome c subunit of 4-cresol dehydrogenase [hydroxylating], strong interaction Kd=7nM
2ast  2.30  2005  Kd=7uM        // 2ast.pdf (BC|D) incomplete ligand structure
1wqj  1.60  2005  Kd=865nM      // 1wqj.pdf (B|I) binary complex of NBP-4 and IGF-I, Kd=865+/-78nM
1yym  2.20  2005  Kd=9.48uM     // 1yyl.pdf (HL|G) F23/core YU2 gp120/Fab 17b, Kd=9480+/-440nM
1wa7   NMR  2005  Kd=9.58uM     // 1wa7.pdf (A|B) ligand is TYROSINE KINASE INTERACTION PROTEIN Tip, LYN-Tip Kd=9.58+/-0.95uM, LCK-Tip Kd=30.13+/-1.06uM
2ak4  2.50  2005  Kd=9.9uM      // 2ak4.pdf (CDE|A) SB27 TCR in complex with HLA-B*3508-LPEP, Kd=9.9uM
1y3c  1.69  2005  Ki=0.025nM    // 1y3c.pdf (E|I) 
1y3b  1.80  2005  Ki=0.31nM     // 1y3b.pdf (E|I) 
1y1k  1.56  2005  Ki=0.3nM      // 1y1k.pdf (E|I) 
1y34  1.55  2005  Ki=0.52nM     // 1y34.pdf (E|I) 
1y3d  1.80  2005  Ki=0.56nM     // 1y3d.pdf (E|I) 
1y4a  1.60  2005  Ki=1.2nM      // 1y4a.pdf (E|I) ligand is chymotrypsin inhibitor 2
1y4d  2.00  2005  Ki=1.2nM      // 1y4d.pdf (E|I) 
1zli  2.09  2005  Ki=1.3nM      // 1zli.pdf (A|B) Tick carboxypeptidase inhibitor, Ki=1.3+/-0.2nM
1y33  1.80  2005  Ki=1.7nM      // 1y33.pdf (E|I) 
1y48  1.84  2005  Ki=1.7nM      // 1y48.pdf (E|I) 
1wpx  2.70  2005  Ki=1.80nM     // 1wpx.pdf (A|B) carboxypeptidase Y complexed with cognate proteinase, Ki=1.80nM
1zr0  1.80  2005  Ki=13nM       // 1zr0.pdf (C|D) Tissue Factor Pathway Inhibitor-2 with Bovine Trypsin, Ki=13nM
2bo9  1.60  2005  Ki=3nM        // 2bo9.pdf (A|B) HUMAN CARBOXYPEPTIDASE A4 IN COMPLEX WITH HUMAN LATEXIN, ki=3+/-0.3nM
2hev  2.41  2006  IC50=62nM     // 2hev.pdf (F|R) complex between human OX40L(N90D, N114D) and OX40, IC50=62+/-2nM
2gng  1.87  2006  IC50=6uM      // 2gng.pdf (A|I) 2gng is just PKAR5 mutant, IC50 for Y-27632 is 6+/-0uM
2cmr  2.00  2006  Kd=0.05nM     // 2cmr.pdf (HL|A) HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX, Kd=0.05nM
2gww  2.72  2006  Kd=0.11nM     // 2gww.pdf (A|B) Vh1 IpaA-VBS complex, Kd=0.11nM
2nyy  2.61  2006  Kd=0.125nM    // 2nyy.pdf (DC|A) BoNT A complexed with monoclonal antibody CR1, Kd=0.125nM
2a6i  2.50  2006  Kd=0.12uM     // 2a6d.pdf (BA|P) germline antibody 36-65 complex with dodecapeptide KLASIPTHTSPL, Kd=0.12uM
2nz9  3.79  2006  Kd=0.136nM    // 2nyy.pdf (DC|A) BoNT A complexed with monoclonal antibody AR2, Kd=0.136nM
2a6d  2.90  2006  Kd=0.15uM     // 2a6d.pdf (BA|P) germline antibody 36-65 complex with dodecapeptide RLLIADPPSPRE, Kd=0.15uM
2cjs  1.78  2006  Kd=0.1uM      // 2cjs.pdf (A|C) Munc13-1 3-150(K32E) and Rim2a 82-142 complex, apparent Kd=0.10uM
2a6k  3.00  2006  Kd=0.21uM     // 2a6d.pdf (HL|P) germline antibody 36-65 complex with dodecapeptide SLGDNLTNHNLR, Kd=0.21uM
2d1k  2.50  2006  Kd=0.23uM     // 2d1k.pdf (AB|C) Dnase I is necessary to prevent actin polymerization during crystallization
2f6a  3.29  2006  Kd=0.2uM      // 2f6a.pdf (A|G) CNA31-344 and collagen peptide complex, Kd=0.2+/-0.02uM
2dx5  3.35  2006  Kd=0.33mM     // 2dx5.pdf (A|B) ligand is Ubiquitin, Kd=0.33+/-0.02mM
2gl7  2.60  2006  Kd=0.459uM    // 2gl7.pdf (BC|A) Kd( beta -catenin(Y142E)-BCL9)=0.459+/-0.053uM
2b7c  1.80  2006  Kd=0.4uM      // 2b7c.pdf (A|B) elongation factor-1 beta K1205A mutant in complex with eEF1A, Kd=0.4+/-0.1uM
2hfg  2.61  2006  Kd=0.6nM      // 2hfg.pdf (HL|R) hBR3 bound to CB3s-Fab, Kd=0.6nM
2f5z  2.18  2006  Kd=0.78nM     // 2f5z.pdf (B|K) E3-Binding Domain/E3 Complex, Kd=7.8 E-10 M
2fu5  2.00  2006  Kd=0.7nM      // 2fu5.pdf (A|D) MSS4 and Rab8 GTPase complex, Kd=0.7nM
2ixq   NMR  2006  Kd=0.7uM      // 2ixq.pdf (A|B) ligand is AFIMBRIAL ADHESIN AFA-III(AfaE), Kd=0.72+/-0.2uM
1yk0  2.40  2006  Kd=0.96nM     // 1yk0.pdf (B|E) atrial natriuretic peptide (ANP), NPR-C and ANP complex, Kd=0.96nM
2f9z  2.40  2006  Kd=0.9uM      // 2f9z.pdf (A|C) Complex between chemotaxis deamidase CheD and chemotaxis phosphatase CheC, Kd=0.9-1.4uM
2b42  2.50  2006  Kd=1.07nM     // 2b42.pdf (A|B) Xylanase inhibitor, 1.07 x 10-9M
2j1k  2.30  2006  Kd=1.1nM      // 2j1k.pdf (Z|S) CAV-2 FIBRE HEAD IN COMPLEX WITH Coxsackievirus and adenovirus receptor, CAR D1, Kd=1.1nM
2g2u  1.60  2006  Kd=1.25uM     // 2g2u.pdf (A|B) SHV-1 Beta-lactamase/inhibitor protein (BLIP) complex, Kd=1252+/-52nM
2i32  2.70  2006  Kd=1.3uM      // 2i32.pdf (A|E) the ASF1a N-terminal core domain (1-157) with Human HIRA, Kd=1.3uM
2fjg  2.80  2006  Kd=1.5nM      // 2fjg.pdf (BA|V) G6 Fab, in complex with human VEGF, Kd=1.5nM
2d10  2.50  2006  Kd=1.7nM      // 2d10.pdf (D|H) NHERF-1 Peptides with Radixin FERM Domain, Kd=1.69+/-0.4nM
2b2x  2.20  2006  Kd=1.9nM      // 2b2x.pdf (IM|B) VLA1 RdeltaH I-domain complex with H:T50V, K64E, L:S28Q, N52Y mutant Antibody AQC2 Fab; Kd=1.9nM
2iy0  2.77  2006  Kd=10.7nM     // 2iy0.pdf (AB|C) SENP1 (C603A)) and SUMO1 RANGAP complex, Kd=10.7+/-3.12nM
2b87   NMR  2006  Kd=100nM      // 2b87.pdf (A|B) ZTaq:anti-ZTaq Affibody:Affibody Complex, Kd=100nM
2f31  2.10  2006  Kd=102nM      // 2f31.pdf (A|B) ligand is FH2+DAD protein segment; DID-DAD complex, GST-DAD Kd=240nM, FH2+DAD Kd=102nM
2hth  2.70  2006  Kd=105uM      // 2hth.pdf (A|B) ubiquitin complex with human EAP45/ESCRT-II GLUE domain, Kd=105uM
2c0l  2.30  2006  Kd=109nM      // 2c0l.pdf (A|B) TPR DOMAIN OF HUMAN PEX5P IN COMPLEX WITH HUMAN MSCP2, Kd=109+/-34nM
1zv5  2.00  2006  Kd=10nM       // 1zv5.pdf (L|A) antibody D2-L29 complex with hen egg white lysozyme, Kd=10nM
2erj  3.00  2006  Kd=10pM       // 2erj.pdf (BC|D) Interleukin-2(C125A) and IL2 receptor alpha beta gamma chain, Kd=10pM
2aq2  1.80  2006  Kd=11nM       // 2aq1.pdf (A|B) TCR V beta A52V/S54N/K66E and SEC3-1D3 complex, Kd=1.1 E-8 M
2fjh  3.10  2006  Kd=12nM       // 2fjg.pdf (HL|V) B20-4 Fab, in complex with human VEGF, Kd=12nM
2fdb  2.28  2006  Kd=155nM      // 2fdb.pdf (M|P) Fibroblast growth factor 8b complex with FGF Receptor (FGFR)2c, Kd=1.55 E-7 M
2ftm  1.65  2006  Kd=16pM       // 2ftl.pdf (A|B) trypsin complexed with Y35G BPTI at 100K, Kd=1.6 E-11M
2den   NMR  2006  Kd=17uM       // 2den.pdf (A|B) BMSC-UbP UBA domain Complex with Ubiquitin, Kd=17uM
1yrt  2.10  2006  Kd=1nM        // 1yrt.pdf (A|B) wild type CyaA-ACD and C-CaM complex without exogenous CaCl2, Kd=1nM
2i5y  2.20  2006  Kd=2.7nM      // 2i5y.pdf (HL|G) ternary complexes of CD4M47 with HIV-1 gp120 and the 17b antibody, Kd=2.71+/-0.65nM
2g45  1.99  2006  Kd=2.82uM     // 2g45.pdf (A|B) znf ubp domain in complex with ubiquitin, Kd=2.82+/-0.09uM
2fyl   NMR  2006  Kd=2.8uM      // 2fyl.pdf (A|B) CR56 and receptor-associated protein domain 1, RAPd1 complex, Kd=2.8uM
2hd5  1.85  2006  Kd=2.8uM      // 2hd5.pdf (A|B) USP2 in complex with ubiquitin, ki=2.8+/-0.14uM
2dd8  2.30  2006  Kd=20nM       // 2dd8.pdf (HL|S) SARS-CoV Complex with Fab m396, Kd=20nM
2j12  1.50  2006  Kd=20nM       // 2j12.pdf (A|B) AD37 FIBRE HEAD IN COMPLEX WITH CAR D1, Kd=20nM
2hwn  1.60  2006  Kd=2nM        // 2hwn.pdf (A|E) RII alpha D/D domain and helical motif from d-AKAP2, typically Kd=2nM in 1-5nM
2few   NMR  2006  Kd=3.7mM      // 2few.pdf (A|B) IIAMtl(H554Q) and Phospho-IIBMtl(C384SEP), Kd=3.7+/-0.2mM
2fuh   NMR  2006  Kd=300uM      // 2fuh.pdf (A|B) UbcH5c/Ubiquitin Non-covalent Complex, Kd=300uM
2a24   NMR  2006  Kd=30uM       // 2a24.pdf (A|B) HIF-2a/ARNT PAS-B Heterodimer, similar Kd=30uM
2dsr  2.10  2006  Kd=317nM      // 2dsp.pdf (IB|G) ternary complex of N- and C-terminal domain fragments of IGFBP4 and IGF1, Kd=317+/-19nM
2dsp  2.50  2006  Kd=3uM        // 2dsp.pdf (B|I) binary complex of the N-terminal domains of IGFBP4 and IGF1, Kd=3020+/-410nM
2bdn  2.53  2006  Kd=4.6pM      // 2bdn.pdf (HL|A) human MCP-1 bound to a blocking antibody, 11K2, Kd=4.6pM
2aze  2.55  2006  Kd=4.9uM      // 2aze.pdf (A|B) ligand is Transcription factor E2F1CM-DP1CM heterodimer, Kd=4.9+/-3uM
2hle  2.05  2006  Kd=40nM       // 2hle.pdf (A|B) EphB4 in complex with the extracellular domain of ephrinB2, Kd=40+/-20nM
2djy   NMR  2006  Kd=40uM       // 2djy.pdf (A|B) The Smurf2 WW3 Domain Binds to the Smad7 PY Motif, Ka=40+/-0.1uM, not Kd
2h4m  3.05  2006  Kd=42nM       // 2h4m.pdf (B|D) Kap beta2-Transportin-M9NLS, ITC Kd=42+/-2nM, fluorescence titration Kd=2nM
2arp  2.00  2006  Kd=430nM      // 2arp.pdf (A|F) Activin A in complex with Fs12 fragment of follistatin, Kd=430nM
1yk1  2.90  2006  Kd=45.7nM     // 1yk0.pdf (A|E) brain natriuretic peptide (BNP), NPR-C and BNP complex, Kd=45.7nM
2fju  2.20  2006  Kd=5.3uM      // 2fju.pdf (A|B) Activated Rac1 bound to its effector phospholipase C beta 2
2aq1  2.10  2006  Kd=5.5nM      // 2aq1.pdf (C|D) TCR V beta H72Q-r and SEC3-1A4 complex, Kd=5.5 E-9 M
2dsq  2.80  2006  Kd=544nM      // 2dsp.pdf (IG|B) hybrid ternary complex using the C-terminal domain fragment of IGFBP1 instead of IGFBP4, Kd=544+/-45nM
2g2w  1.80  2006  Kd=582nM      // 2g2u.pdf (A|B) SHV D104K Beta-lactamase/inhibitor protein (BLIP) complex, Kd=582+/-42nM
2es4  1.85  2006  Kd=5nM        // 2es4.pdf (B|E) Lif-cognate lipase LipA complex, Kd=5nM
2h9g  2.32  2006  Kd=5nM        // 2h9g.pdf (BA|R) Fab-BDF1:hDR5 complex, Kd=5+/-1nM
2i60  2.40  2006  Kd=6.24nM     // 2i5y.pdf (HL|G) ternary complexes of [Phe23]M47 with HIV-1 gp120 and the 17b antibody, Kd=6.24+/-0.1nM
2c7m  2.40  2006  Kd=6.4uM      // 2c7m.pdf (A|B) RUZ-MIU:ubiquitin complex, crystal form I Kd=6.4uM
2c7n  2.10  2006  Kd=6.4uM      // 2c7m.pdf (C|D) RUZ-MIU:ubiquitin complex, crystal form II Kd=6.4uM
2hsq  3.97  2006  Kd=6.61nM     // 2gww.pdf (A|B) Vh1 IpaA-VBS2 complex, Kd=6.61nM
2ftl  1.62  2006  Kd=60fM       // 2ftl.pdf (E|I) trypsin complexed with wt BPTI at 100K, Kd=6 E-14M
2f4m  1.85  2006  Kd=65nM       // 2f4m.pdf (A|B) Mouse PNGase core and HR23B-XPCB domain Complex, Kd=65nM
2aq3  2.30  2006  Kd=7.6uM      // 2aq1.pdf (G|H) TCR V beta-SEC3 complex, Kd=7.6 E-6 M
1zvh  1.50  2006  Kd=70nM       // 1zv5.pdf (L|A) VHH domain D2-L24 in complex with hen egg white lysozyme, Kd=70nM
2iy1  2.46  2006  Kd=787nM      // 2iy0.pdf (A|B) SENP1 (MUTANT) with FULL LENGTH SUMO1, Kd=787+/-90.4nM
2bwe  3.10  2006  Kd=80uM       // 2bwe.pdf (D|T) The yeast protein Dsk2 UBA-UBL domain complex, Kd=80+/-15uM
2a9h   NMR  2006  Kd=900nM      // 2a9h.pdf (A|E) potassium channel KcsA(mutant) / charybdotoxin complex, Kd=900nM. protein mutation:Q58A, T61S, R64D, F103Y, T107F, L110V
2gh0  1.92  2006  Kd=90nM       // 2gh0.pdf (C|A) artemin, ARTN-GFR alpha3 complex, Kd=90nM
1zgu   NMR  2006  Kd=98uM       // 1zgu.pdf (A|B) human Mms2-Ubiquitin(K48R) complex, Kd=98+/-15uM
2hrk  2.05  2006  Kd=9nM        // 2hrk.pdf (A|B) Kd for Arc1p and full-length GluRS; structure is GluRS-N(1-207) and Arc1p-N(1-222)
2g9h  2.00  2006  Kd~0.1uM      // 2g9h.pdf (ABC|D) Staphylococcal Enterotoxin I Complex with a Human MHC class II Molecule(+peptide from HA), Zn2+ dependent, Kd~1E-7M
2j7p  1.97  2006  Kd~10nM       // 2j7p.pdf (A|D) GMPPNP-mediated assembly of the T. aquaticus Ffh NG:FtsY NGd20 heterodimer
2j0t  2.54  2006  Ki=0.4nM      // 2j0t.pdf (C|F) INHIBITORY DOMAIN OF TIMP-1 and MMP-1cd complex, Ki=0.4nM
2abz  2.16  2006  Ki=2.8nM      // 2abz.pdf (B|E) C19A/C43A LCI (Metallocarboxypeptidase inhibitor) in complex with bovine carboxypeptidase A, Ki=2.8+/-0.3nM
2o3b  2.30  2006  Ki=3.2pM      // 2o3b.pdf (A|B) NucA and intra-cellular inhibitor NuiA complex, Ki=3.2+/-1.9 E-12 M
1yvb  2.70  2006  Ki=6.5nM      // 1yvb.pdf (A|I) Cystatin, Ki=6.5 x 10-9M
2j8x  2.30  2006  Ki=8nM        // 2j8x.pdf (A|B) wt EBV UNG(delta24) and URACIL-DNA GLYCOSYLASE INHIBITOR complex, Ki=8nM
2jby  2.41  2007  IC50=50nM     // 2jby.pdf (A|B) M11L:Bak BH3 domain, IC50=50nM
2p5e  1.89  2007  Kd=0.048nM    // 2p5e.pdf (ABC|ED) human T-cell receptors bound to peptide MHC complex
2omy  1.70  2007  Kd=0.2uM      // 2omv.pdf (A|B) InlA S192N and N-terminal domain of human E-cadherin, hEC1 complex, InlA Kd=0.2+/-0.05uM
2uzi  2.00  2007  Kd=0.35nM     // 2uzi.pdf (HL|R) ligand is GTPASE HRAS(G12V) mutant; Kd=6.2nM(for ANTI-RAS FV VH#6 with HRAS)
2qxv  1.82  2007  Kd=0.38uM     // 2qxv.pdf (A|B) Enhancer of zeste homolog 2 recognition by EED, Kd=0.38uM
2oin  2.50  2007  Kd=0.51uM     // 2oin.pdf (B|D) NS4A co-factor peptide, enzymatic IC50=0.51+/-0.23uM, Replicon IC50=3.6+/-0.3uM
2odg   NMR  2007  Kd=0.59uM     // 2odg.pdf (B|C) Complex of barrier-to-autointegration factor(BAF) dimer and emerin-LEM domain, Kd=0.59+/-0.03uM
2j4w  2.50  2007  Kd=0.6nM      // 2j4w.pdf (HL|D) PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX, Kd=0.6nM
2omu  1.80  2007  Kd=0.6nM      // 2omt.pdf (A|B) Internalin-A G194S+S Y369S-HEC1 COMPLEX, Kd=0.6+/-0.2nM
2r0k  3.51  2007  Kd=0.6nM      // 2r0k.pdf (HL|A) inhibitor antibody Fab58:HGFA complex, Kd=0.6+/-0.1nM
2j6e  3.00  2007  Kd=0.6uM      // 2j6e.pdf (HL|A) RF61 Fab-IgG1 Fc complex, Kd=6 X 10-7M
2oje  3.00  2007  Kd=0.6uM      // 2oje.pdf (ABC|D) MAM/HLA-DR1/HA complex, Kd=0.6uM
2o98  2.70  2007  Kd=0.85nM     // 2o98.pdf (B|Q) ligand is T14-3cDeltaC, 1uM FC in presence, CT52 YDI, Kd=0.85nM, YTV Kd=41nM
2gox  2.20  2007  Kd=0.8nM      // 2gox.pdf (C|D) ligand is Complement C3-inhibitory domain, Kd(Efb-C/C3dg)=0.8+/-0.1nM
2i9b  2.80  2007  Kd=0.96nM     // 2i9b.pdf (B|F) ligand is Urokinase plasminogen activator
2ifg  3.40  2007  Kd=0.9nM      // 2ifg.pdf (B|F) Beta-nerve growth factor and receptor complex, Kd(TrkA-NGF)=0.9+/-0.3nM
2nyz  2.60  2007  Kd=0.9nM      // 2nyz.pdf (B|E) ligand is C-Chemokine XCL1, NaCl 0.2M, Kd=0.9+/-0.2nM
2pkg  3.30  2007  Kd=1.06uM     // 2pkg.pdf (A|C) binding between phosphatase 2A and the small t core domain, Kd=1.06+/-0.09uM, Kd(full-length ST/A subunit of PP2A)=2.14+/-0.08uM
2i25  1.80  2007  Kd=1.0nM      // 2i25.pdf (N|L) PBLA8 variable domain in complex with lysozyme, Kd=1.0nM
2qej  3.20  2007  Kd=1.1nM      // 2qej.pdf (B|C) Staphylococcus aureus protein (SSL7) in complex with Fc of human IgA1, Kd=0.0011 E-6 M
2omv  1.90  2007  Kd=1.2nM      // 2omv.pdf (A|B) InlA S192N Y369S and N-terminal domain of human E-cadherin, hEC1 complex, InlAm Kd=1.2+/-0.3nM
2pon   NMR  2007  Kd=1.4uM      // 2pon.pdf (A|B) ligand is Beclin-1, Kd=1.4uM
2ot3  2.10  2007  Kd=1.8uM      // 2ot3.pdf (A|B) rabex-5 VPS9 domain in complex with nucleotide free RAB21, Kd=1.8uM
2pms  2.91  2007  Kd=10.3nM     // 2pms.pdf (A|D) human lactoferrin N-lobe and PSPA complex, Kd=10.3+/-3.2nM
2ju0   NMR  2007  Kd=100nM      // 2ju0.pdf (A|B) Frq1 with Phosphatidylinositol 4-kinase PIK1 Residues(121-174), Kd~100nM
2omt  2.00  2007  Kd=100nM      // 2omt.pdf (A|B) Internalin-A G194S+S-HEC1 COMPLEX, Kd=100+/-30nM
2q7n  4.00  2007  Kd=10pM       // 2q7n.pdf (C|D) human Leukemia inhibitory factor binds to mLIFR, Kd=10-46pM, Kd(mLIF:mLIFR)1-4nM, Kd(hLIF:hLIFR)=300-900pM
2qc1  1.94  2007  Kd=10pM       // 2qc1.pdf (A|B) alpha-bungarotoxin, Endo-H not treated Kd=1.02 X10-11M, treated Kd=7.3 X10-9M
2nup  2.80  2007  Kd=10uM       // 2nup.pdf (AB|C) human Sec23a/24a heterodimer with the SNARE protein Sec22b, about Kd=10-50uM, Crystal I
2nut  2.30  2007  Kd=10uM       // 2nup.pdf (AB|C) human Sec23a/24a heterodimer with the SNARE protein Sec22b, about Kd=10-50uM, Crystal II
2omw  1.85  2007  Kd=10uM       // 2omv.pdf (A|B) InlA S192N Y369S and N-terminal domain of murine E-cadherin, mEC1 complex, InlAm Kd=10+/-2uM
2qiy  1.69  2007  Kd=119nM      // 2qiy.pdf (A|C) BRE5 with Ubiquitin carboxyl-terminal hydrolase 3, UBP3, Kd=119nM
2omx  1.70  2007  Kd=120nM      // 2omt.pdf (A|B) Internalin-A S192N G194S+S and HEC1 COMPLEX, Kd=120+/-40nM
2noj  2.70  2007  Kd=13nM       // 2noj.pdf (C|D) Ehp / C3d complex, Kd=13nM
2rf9  3.50  2007  Kd=13uM       // 2rf9.pdf (A|C) complex between the EGFR kinase domain and a Mig6 peptide, Kd=13+/-1.3uM
2r0l  2.20  2007  Kd=14.6nM     // 2r0k.pdf (HL|A) inhibitor antibody Fab75:HGFA complex, Kd=14.6+/-1.5nM
2q0o  2.00  2007  Kd=14.9nM     // 2q0o.pdf (A|C) ligand is Probable transcriptional repressor traM (chain C, D)
2h64  1.92  2007  Kd=140nM      // 2h62.pdf (A|B) ligand is BMPR-IA/ActR-IIB, Kd(BMP-2(L100K/N102D)/BMPR-IA)=22uM, Kd(BMP-2(L100K/N102D)/ActR-IIB)=140nM
2r9p  1.40  2007  Kd=14uM       // 2r9p.pdf (B|F) Mesotrypsin and bovine pancreatic trypsin inhibitor(BPTI), Kd=1.4 X10-5M
2jcc  2.50  2007  Kd=15.4uM     // 2j8u.pdf (EF|ABC) TCR-pMHC complex; W167A mutant protein; Kd(equilibrium)=15.4uM, Kd(kinetic)=14.8uM
2oor  2.32  2007  Kd=15.5nM     // 2oor.pdf (B|C) transhydrogenase (dI.NAD+)2(dIII.H2NADPH)1 asymmetric complex    mean value=15.5nM
2phe   NMR  2007  Kd=15uM       // 2phe.pdf (A|C) ligand is human transcriptional coactivator positive cofactor 4 (PC4); full length VP16 Kd=0.7+/-0.2uM, activation domain Kd=15+/-6uM
2rmk   NMR  2007  Kd=170nM      // 2rmk.pdf (A|B) Rac1 binding to the HR1a and HR1b domains  Kd~70-170nM
2ij0  2.25  2007  Kd=180pM      // 2ij0.pdf (A|E) TSST-1 with penultimate affinity-matured variant of hVbeta 2.1, D10, Kd=180pM
2p4a  1.90  2007  Kd=180pM      // 2p49.pdf (A|B) a camelid affinity matured single-domain vhh antibody fragment, affinity mature Kd=180+/-18pM
2p5t  3.20  2007  Kd=1nM        // 2p5t.pdf (A|B) ligand is fragment of PezA helix-turn-helix motif complex with PezT, Kd<1nM
2v2w  1.60  2007  Kd=2.2uM      // 2v2w.pdf (A|B) TCR-pMHC complex
2p1l  2.50  2007  Kd=2.3uM      // 2p1l.pdf (E|F) Bcl-XL:wild type Beclin 1 complex, Kd=2.3uM
2oza  2.70  2007  Kd=2.5nM      // 2oza.pdf (A|B) p38alpha MAPK and MAPK-activated protein kinase 2 (MK2), Kd=2.5nM, recent data Kd=0.5nM
2h62  1.85  2007  Kd=2.7uM      // 2h62.pdf (AB|C) ligand is BMPR-IA/ActR-IIB, Kd(BMP-2/ActR-IIB)=2.7uM, Kd(BMP-2/BMPR-IA)=24uM
2i3t  2.80  2007  Kd=2.7uM      // 2i3s.pdf (E|F) Bub3 complex with Mad3 (BubR1) GLEBS motif, Kd=2.7uM
2ot8  3.10  2007  Kd=20nM       // 2ot8.pdf (A|C) human Kapb2 bound to the bPY-NLS of human hnRNP M2, 6-8, Kd=20nM
2ra3  1.46  2007  Kd=20pM       // 2r9p.pdf (B|I) Cationic trypsin and bovine pancreatic trypsin inhibitor(BPTI), Kd=2.0 X10-11M
2v8s  2.22  2007  Kd=22uM       // 2v8s.pdf (E|V) Vti1b / human clathrin adaptor epsinR (EPNR) complex, Kd=22+/-3uM, n=6 (ITC)
2p49  1.38  2007  Kd=23nM       // 2p49.pdf (A|B) ligand is camelid single-domain vhh antibody fragment, Kd=23+/-3nM
2hqs  1.50  2007  Kd=27nM       // 2hqs.pdf (D|E) TolB and Peptidoglycan-associated lipoprotein (Pal) complex, Kd=27nM(PH7.5)
2j8s  2.54  2007  Kd=28nM       // 2j8s.pdf (B|D) DARPIN inhibitor 1108_19
2v6x  1.98  2007  Kd=28uM       // 2v6x.pdf (A|B) yeast Vps2 and Vps4 MIT-domain, Kd=28uM
2yvj  1.90  2007  Kd=294uM      // 2e4p.pdf (A|B) ligand is Biphenyl dioxygenase ferredoxin subunit, aerobic condition; Kd=14.6uM at reducing condition
2hqw  1.90  2007  Kd=2nM        // 2hqw.pdf (A|B) ligand is NR1C1 (peptide spanning 875-898), titrations Kd=2.0+/-0.1nM
2iou  3.16  2007  Kd=3.47uM     // 2iou.pdf (B|H) Mtd-P1 and Pertactin Extracellular Domain, Kd=3.47+/-0.13uM
2i3s  1.90  2007  Kd=3.6uM      // 2i3s.pdf (E|F) Bub3 complex with Bub1 GLEBS motif, Kd=3.6uM
2iyb  2.35  2007  Kd=3.6uM      // 2iyb.pdf (D|H) Lim3 and EVH1 domain of MENA, Kd=3.6+/-0.4uM
2jix  3.20  2007  Kd=30nM       // 2jix.pdf (DG|E) ligand is Erythropoietin receptor EPOR, unpublished Biacore Kd=30nM
2psm  2.19  2007  Kd=30pM       // 2psm.pdf (B|C) ligand is Interleukin-15 receptor alpha chain; Kd=30-100pM
2j8u  2.88  2007  Kd=31.8uM     // 2j8u.pdf (A|B) TCR-pMHC complex; K66A mutant protein; Kd(equilibrium)=31.8uM, Kd(kinetic)=34.0uM
2iwg  2.35  2007  Kd=37nM       // 2iwg.pdf (D|E) COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC
2z3q  1.85  2007  Kd=38pM       // 2z3q.pdf (C|D) IL-15/IL-15Ra complex, native 1 Kd=38pM
2z3r  2.00  2007  Kd=38pM       // 2z3q.pdf (A|B) Interleukin-15/IL-15Ra complex, native 2 Kd=38pM
2vda   NMR  2007  Kd=3uM        // 2vda.pdf (A|B) ligand is signal peptide KRR-LamB, Kd=3uM
2pop  3.10  2007  Kd=4.2uM      // 2pop.pdf (C|D) TAB1D and BIR1 complex, Kd=4.2+/-0.2uM
2z8w  2.45  2007  Kd=4.7nM      // 2z8v.pdf (A|D) New antigen receptor variable domain, IgNAR-AMA1 complex, 2Z8W (AMA1/14I1-M15), Kd=4.7+/-2.0nM
2uwe  2.40  2007  Kd=4.7uM      // 2j8u.pdf (A|B) TCR-pMHC complex; T163A mutant protein; Kd(equilibrium)=4.7uM, Kd(kinetic)=4.6uM
2z8v  2.35  2007  Kd=4.8nM      // 2z8v.pdf (B|C) New antigen receptor variable domain, 2Z8V (AMA1/14I-1), Kd=4.8+/-2.2nM
2omz  1.60  2007  Kd=400nM      // 2omt.pdf (A|B) Internalin-A Y369A-HEC1 COMPLEX, Kd=400+/-100nM
2ihs  2.20  2007  Kd=40nM       // 2ihs.pdf (B|D) 20-mer from ATP-dependent RNA helicase vasa, Kd about 40nM
2jt4   NMR  2007  Kd=40uM       // 2jt4.pdf (A|B) Sla1 SH3-3-Ubiquitin Complex, Kd=40uM
2ptt  1.63  2007  Kd=4uM        // 2ptt.pdf (A|B) NK cell receptor 2B4 (CD244) bound to its ligand CD48
2j59  2.10  2007  Kd=55nM       // 2j59.pdf (F|R) ligand is RHO-GTPASE ACTIVATING PROTEIN 10, in presence of GTP
2oob  1.90  2007  Kd=57uM       // 2oob.pdf (A|B) ligand is ubiquitin, Kd=57+/-3uM
2r56  2.80  2007  Kd=5uM        // 2r56.pdf (HL|A) beta-lactoglobulin (BLG, Bos d 5)
2v3b  2.45  2007  Kd=5uM        // 2v3b.pdf (A|B) RUBREDOXIN-RUBREDOXIN REDUCTASE complex(in presence of Fe3+), Kd=5+/-2uM
2qho  1.85  2007  Kd=60uM       // 2qho.pdf (E|F) ligand is ubiquitin, Kd=60+/-15uM
2onl  4.00  2007  Kd=6nM        // 2okr.pdf (A|C) full length p38a-MAPKAP kinase 2 Heterodimer group P41, Kd=6nM
2ibf  3.20  2007  Kd=7.8nM      // 2ibf.pdf (A|B) IpaA-VBS2, two binding sites Kd=7.8nM and 510nM
2qr0  3.50  2007  Kd=7.8nM      // 2qr0.pdf (XW|V) VEGF COMPLEXED TO FAB-D1, Kd=7.8nM
2j5l  2.90  2007  Kd=77nM       // 2j4w.pdf (CB|A) PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX, Kd=77nM
2v9t  1.70  2007  Kd=8.2nM      // 2v9t.pdf (A|B) Slit2 D2-Robo1 Ig complex, Kd=8.2nM
2pye  2.30  2007  Kd=81.6nM     // 2p5e.pdf (A|B) human T-cell receptors bound to peptide/MHC complex
2uyz  1.40  2007  Kd=82nM       // 2uyz.pdf (A|B) NON-COVALENT COMPLEX BETWEEN UBC9 AND SUMO1, Kd=82+/-23nM(PH8.0).previous Kd=250+/-70nM(PH7.5)
2px9   NMR  2007  Kd=87.4uM     // 2px9.pdf (A|B) ligand is SUMO-conjugating enzyme UBC9, Kd=87.4+/-23.6uM
2i26  2.50  2007  Kd=9.4nM      // 2i25.pdf (N|L) ancestral variable domain in complex with lysozyme, Kd=9.4nM
3biw  3.50  2007  Kd=97nM       // 3biw.pdf (D|H) Neuroligin-1, 3BIW, NL1/Nrx1b
2v1d  3.10  2007  Ki=0.05uM     // 2v1d.pdf (A|C) LSD1-CoREST in complex with pLys4Met H3 peptide, Ki=0.05+/-0.02uM
2o8v  3.00  2007  Ki=1.1uM      // 2o8v.pdf (A|B) PAPS reductase in a covalent complex with thioredoxin C35A, Ki=1.1uM
2uxn  2.72  2007  Ki=120nM      // 2uxn.pdf (A|B) N-methylpropargyl-K4 H3 1-21 compound CoREST inhibited LSD1
2g81  1.55  2007  Ki=13.6nM     // 2g81.pdf (E|I) Bowman-Birk inhibitor (BTCI), Ki=1.36+/-0.16 X 10-8M
2nz1  2.50  2007  Ki=18nM       // 2nyz.pdf (B|E) ligand is CC-Chemokine CCL2/MCP-1, competition with Heparin, Ki=18+/-7nM
2ijo  2.30  2007  Ki=24nM       // 2ijo.pdf (BI|A) NS2B-NS3(WT) protease complex with pancreatic trypsin inhibitor, Ki=24nM
2pw8  1.84  2007  Ki=25fM       // 2pw8.pdf (H|I) sulfo-hirudin complexed to thrombin, Ki=25fM
2jod   NMR  2007  Ki=350nM      // 2jod.pdf (A|B) Pac1-Rshort N-terminal EC domain Pacap(6-38) complex, Ki=350nM
2nqd  1.75  2007  Ki=39pM       // 2nqd.pdf (A|B) cysteine protease inhibitor, chagasin complex with human cathepsin L, Ki=39pM
2p3f  3.10  2007  Ki=43pM       // 2p3f.pdf (H|N) FACTOR XA-NAP5 COMPLEX, Ki=43pM
2uuy  1.15  2007  Ki=5.6nM      // 2uuy.pdf (A|B) Tick Tryptase Inhibitor, Ki=5.6+/-2.0nM
3c5t  2.10  2008  IC50=0.6nM    // 3c59.pdf (A|B) Exendin-4(9-39)
2z7f  1.70  2008  IC50=13nM     // 2z7f.pdf (E|I) human neutrophil elastase with 1/2SLPI, IC50=1.3 X 10-8M
2w2n  2.30  2008  IC50=140nM    // 2w2m.pdf (A|E) WT PCSK9-DELTAC BOUND TO EGF-A H306Y MUTANT OF LDLR, IC50=140+/-50nM
3brt  2.25  2008  IC50=36nM     // 3brt.pdf (A|D) NEMO and IKK alpha/beta hybrids complexes, IC50=36nM
3brv  2.20  2008  IC50=47nM     // 3brt.pdf (A|D) NEMO/IKK beta complexes, IC50=47nM
2qur  2.50  2008  IC50=500nM    // 2qur.pdf (A|B) IC50~500nM(RIIbeta subunit), 20-mer fragment from cAMP-dependent protein kinase inhibitor alpha
3c59  2.30  2008  IC50=5nM      // 3c59.pdf (A|B) Exendin-4(56-86)
3ehu  1.96  2008  IC50=6.6uM    // 3ehs.pdf (A|C) Corticotropin-releasing factor, CRF(22-41)
3bow  2.40  2008  IC50=64nM     // 3bow.pdf (AB|C) M-calpain in complex with Calpastatin, IC50=64nM
2za4  1.58  2008  Kd=0.14nM     // 2za4.pdf (C|D) Barnase (K98A) and barstar (D39A, C40A, C82A) Complex, Kd=1.4 X 10-10M
2vdb  2.52  2008  Kd=0.15nM     // 2vdb.pdf (A|B) ligand is PEPTOSTREPTOCOCCAL ALBUMIN-BINDING PROTEIN, Ka=6.7x10^9M-1, get Kd=1.5x10-10M
3dxc  2.10  2008  Kd=0.22uM     // 3dxc.pdf (C|D) APP intracellular domain / Fe65-PTB2 complexes, Kd=0.22+/-0.02uM
2k05   NMR  2008  Kd=0.2uM      // 2k03.pdf (A|B) fully sulfated SDF12 complex with C-X-C chemokine receptor type 4 (CXCR4 p38-sY3), Kd=0.2+/-0.2uM
3dvu  2.50  2008  Kd=0.2uM      // 3dvu.pdf (A|C) M11-Beclin 1 BH3 domain complex, Kd=0.2+/-0.1uM
2roz   NMR  2008  Kd=0.32uM     // 2roz.pdf (A|B) C-terminal PID Domain with the Cytoplasmic Tail of APP, Kd=0.32~0.79uM
3dxe  2.00  2008  Kd=0.33uM     // 3dxc.pdf (C|D) APP intracellular domain (T668A mutant) / Fe65-PTB2 complexes, Kd=0.33+/-0.01uM
3dxd  2.20  2008  Kd=0.34uM     // 3dxc.pdf (A|B) APP intracellular domain (T668E mutant) / Fe65-PTB2 complexes, Kd=0.34+/-0.02uM
2vlp  2.00  2008  Kd=0.543pM    // 2vln.pdf (A|B) R54A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=0.543+/-0.066pM
2jti   NMR  2008  Kd=0.588uM    // 2jti.pdf (A|B) ligand is yeast iso-1-cytochrome c (T12A); ITC equilibrium binding constant KB=1.7+/-1 x10^6M-1, Kd=0.588x10-6M
2jzn   NMR  2008  Kd=0.5mM      // 1vsq.pdf (B|C) ligand is Mannose-specific phosphotransferase enzyme IIB component, conformers 1, Kd=0.5mM
1vsq   NMR  2008  Kd=0.5mM      // 1vsq.pdf (B|C) ligand is Mannose-specific phosphotransferase enzyme IIB component, conformers 2, Kd=0.5mM
2pjy  3.00  2008  Kd=0.5uM      // 2pjy.pdf (AC|B) ternary complex, Transforming growth factor beta-3 with TGF-beta receptor type-1 and type-2
3ddc  1.80  2008  Kd=0.77uM     // 3ddc.pdf (A|B) ligand is NORE1A K302D
2vof  1.80  2008  Kd=0.7nM      // 2vof.pdf (C|D) ligand is Puma BH3-domain, Kd=0.7nM
2vlo  1.80  2008  Kd=0.892pM    // 2vln.pdf (A|B) K97A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=0.892+/-0.11pM
2z34  2.40  2008  Kd=0.89uM     // 2cu9.pdf (B|D) ligand is Hip1 B domain peptide, hir1; Kd=0.89+/-0.01uM
3c4m  1.95  2008  Kd=0.98uM     // 3c4m.pdf (B|D)
3f5c  3.00  2008  Kd=0.9uM      // 3f5c.pdf (A|B) Dax-1 bound to liver receptor homolog 1 (LRH-1), Kd=0.9+/-0.1uM
3dbr  3.05  2008  Kd=1.02uM     // 3dbh.pdf (EF|K) APPBP1-UBA3Arg190Gln complex with NEDD8 Ala72Arg mutant, Kd=1020+/-10nM
3b2u  2.58  2008  Kd=1.0nM      // 3b2u.pdf (WX|V) ligand is Fab fragment of IMC-11F8, Kd=1.0+/-0.1nM
2v51  2.35  2008  Kd=1.0uM      // 2v51.pdf (B|F) Kd=1.0+/-0.3uM, G-actin bound to RPEL1-MAL peptide
2qja  2.60  2008  Kd=1.1nM      // 2qj9.pdf (B|D) ligand is Bone morphogenetic protein 2, BMP2, Kd=1.1nM
2voi  2.10  2008  Kd=1.1nM      // 2vof.pdf (A|B) ligand is Bid BH3-domain, Kd=1.1nM
2v4z  2.80  2008  Kd=1.25uM     // 2v4z.pdf (A|B) ligand is REGULATOR OF G-PROTEIN SIGNALING 2, RGS2(C106S, N184D, E191K) triple mutant
2jjt  2.30  2008  Kd=1.2uM      // 2jjs.pdf (A|C) CD47 complex with HUMAN SIGNAL Human signal regulatory protein (SIRP) alpha, space group p21 21 21
2jjs  1.85  2008  Kd=1.2uM      // 2jjs.pdf (B|D) CD47 complex with Human signal regulatory protein (SIRP) alpha, space group p21
2jki  3.30  2008  Kd=1.64uM     // 2jki.pdf (B|T) COMPLEX OF HSP90 N-TERMINAL AND SGT1 CS DOMAIN, Kd=1.64uM
3dbh  2.85  2008  Kd=1.66uM     // 3dbh.pdf (CD|J) APPBP1-UBA3Arg190Ala complex with NEDD8 Ala72Arg mutant, Kd=1660+/-10nM
2vln  1.60  2008  Kd=1.68pM     // 2vln.pdf (A|B) N75A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=1.68+/-0.3pM
2v52  1.45  2008  Kd=1.9uM      // 2v51.pdf (B|M) Kd=1.9+/-0.1uM, G-actin bound to RPEL2-MAL peptide
3c8k  2.90  2008  Kd=102uM      // 3c8k.pdf (BD|A) Natural killer cell receptor Ly-49C recognize H-2 class I histocompatibility antigen
2vwe  3.40  2008  Kd=113.7pM    // 2vwe.pdf (LJ|B) Fab fragment of antibody (Fab-2H10) with VEGF-B
2p45  1.10  2008  Kd=116nM      // 2p42.pdf (A|B) cAb-RN05 VHH complexes with RNase A, SE5b-Orthol-1(clone 22) form, Kd=116+/-33nM
2p46  2.50  2008  Kd=116nM      // 2p42.pdf (A|B) cAb-RN05 VHH complexes with RNase A, SE5b-Orthol-2(clone 22) form, Kd=116+/-33nM
2p48  2.30  2008  Kd=116nM      // 2p42.pdf (A|B) cAb-RN05 VHH complexes with RNase A, SE5b-tetra(clone 22) form, Kd=116+/-33nM
2p47  2.50  2008  Kd=116nM      // 2p42.pdf (A|B) cAb-RN05 VHH complexes with RNase A, SE5b-tri(clone 22) form, Kd=116+/-33nM
3e3q  2.95  2008  Kd=116nM      // 3e2h.pdf (AQ|DE) m13 high-affinity mutant of the 2C TCR in complex with Ld/QL9
3ch5  2.10  2008  Kd=120uM      // 3ch5.pdf (A|B) ligand is mutant Nup153-ZnF2, Kd=120uM; Kd=60uM for wt ZnF2
3eg5  2.70  2008  Kd=1253nM     // 3eg5.pdf (C|D) Kd=1253+/-86nM, complex between Cdc42-Gpp(NH)p and the mDiaN-TSH mutant
3eab  2.50  2008  Kd=12uM       // 3eab.pdf (B|H) C-terminal tail of CHMP1B with the MIT domain of spastin, Kd=12uM
2ver   NMR  2008  Kd=13.1uM     // 2ver.pdf (A|N) AFIMBRIAL ADHESIN AFA-III, DraE adhesin, Kd=13.1+/-2.5uM
2rms   NMR  2008  Kd=134nM      // 2rms.pdf (A|B) mSin3A PAH1-SAP25 SID complex, Kd=134+/-13nM
2q5d  3.20  2008  Kd=15.6nM     // 2p8q.pdf (A|C) importin beta and Snurportin-1 sIBB-(25-65) complexes, crystal form II, Kd=15.6+/-6.8nM
2p8q  2.35  2008  Kd=15.6nM     // 2p8q.pdf (A|B) importin beta sIBB-(25-65) complexes, crystal form I, Kd=15.6+/-6.8nM
2rnr   NMR  2008  Kd=150nM      // 2rnr.pdf (A|B) hTFIIEa AC-D complex with hTFIIH p62 PH-D, NaCl free buffer Kd=150nM
2z58  1.88  2008  Kd=16nM       // 2z56.pdf (A|B) ligand is S324A-subtilisin, Kd=16+/-0.8nM
2k6d   NMR  2008  Kd=171uM      // 2k6d.pdf (A|B) CIN85 SH3-C-ubiquitin complex, Kd=171+/-7uM
2otk   NMR  2008  Kd=17nM       // 2otk.pdf (C|F) ligand is Amyloid beta A4 protein(1-40), Kd=17+/-2nM
2w2m  2.40  2008  Kd=196nM      // 2w2m.pdf (A|E) WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR, nuetral PH Kd=196nM
3d5r  2.10  2008  Kd=19nM       // 3d5r.pdf (B|D) 3D5R(N138A/Complement C3d), ITC Kd=19+/-4nM, SPR Kd=19.8+/-6.0nM
2voh  1.90  2008  Kd=1nM        // 2vof.pdf (A|B) ligand is Bak BH3-domain, Bak Kd=1-20nM, not listed. but Bad Kd=1700nM
3dgc  2.50  2008  Kd=1nM        // 3dgc.pdf (M|S) Interleukin-22/Interleukin-22 receptor subunit alpha-1 DDQ mutant
3eba  1.85  2008  Kd=2.36nM     // 3eba.pdf (A|B) CAbHul6 FGLW mutant (humanized) in complex with human lysozyme
3e2u  2.60  2008  Kd=2.3uM      // 3e2u.pdf (A|E) ligand is CAP-Gly domain of human dynactin-1 (p150-GLUED), Kd=2.3+/-0.4uM
2qj9  2.44  2008  Kd=2.4nM      // 2qj9.pdf (B|D) ligand is Bone morphogenetic protein 2, BMP2, Kd=2.4nM
2k3s   NMR  2008  Kd=2.7uM      // 2k3s.pdf (A|B) CH-domain of the smoothelin-like 1 complexed with the C-domain of apo calmodulin, Kd=2.7 X 10-6M
3eoy  3.40  2008  Kd=2.8nM      // 3eoy.pdf (B|H) Reovirus sigma1 with Junctional Adhesion Molecule-A, in ref27 Kd=2.8nM
2oqj  2.80  2008  Kd=200uM      // 2oqj.pdf (KJ|L) Biacore Kd=200uM
2p44  1.80  2008  Kd=20nM       // 2p42.pdf (A|B) cAb-RN05 VHH complexes with RNase A, SE5a-Mono-1(clone 7) form, Kd=20+/-11nM
3bpo  3.00  2008  Kd=20nM       // 3bpl.pdf (AC|B) IL13-IL4R-IL13Ra ternary complex, Kd of IL13-IL13Ra for Interleukin-4 receptor alpha chain is 20nM
2jy6   NMR  2008  Kd=20uM       // 2jy6.pdf (A|B) UQ1-UBA/Ubiquitin protein complex, Kd=20uM
3bn3  2.10  2008  Kd=20uM       // 3bn3.pdf (A|B) ICAM-5 in complex with F265S, F292G double mutant Integrin alpha-L, I domain, Kd around 20uM
2vog  1.90  2008  Kd=210nM      // 2vof.pdf (A|B) ligand is Bmf BH3-domain, Kd=210nM
2vlq  1.60  2008  Kd=22.8pM     // 2vln.pdf (A|B) F86A MUTANT OF E9 DNASE DOMAIN IN COMPLEX WITH IM9, Kd=22.8+/-3.7pM
3bk3  2.70  2008  Kd=22nM       // 3bk3.pdf (B|D) CV-2 VWC1 and BMP-2, Kd=22nM
2p43  1.65  2008  Kd=23nM       // 2p42.pdf (A|B) cAb-RN05 VHH complexes with RNase A, native SE3-Mono-1 form
2p42  1.80  2008  Kd=23nM       // 2p42.pdf (C|D) cAb-RN05 VHH complexes with RNase A, native SE3-Mono-2 form
3b9f  1.60  2008  Kd=24uM       // 3b9f.pdf (I|H) ligand is protein C inhibitor(PCI); Kd=24+/-8uM(positivepH 7.0)
3eo1  3.10  2008  Kd=250pM      // 3eo0.pdf (BA|C) Fab Fragment of GC-1008 Complex with Transforming Growth Factor-Beta 3, Kd=250pM, IC50=7+/-2nM
3be1  2.90  2008  Kd=26nM       // 3bdy.pdf (HL|A) Dual specific bH1 Fab in complex with the extracellular domain of HER2/ErbB-2
3bgf  3.00  2008  Kd=26nM       // 3bgf.pdf (BC|A) SARS coronavirus spike receptor binding domain in complex with F26G19 Fab
3d5s  2.30  2008  Kd=26nM       // 3d5r.pdf (A|C) 3D5S (R131A/Complement C3d), ITC Kd=26+/-6nM, SPR Kd=62.1+/-32.4nM
3b2v  3.30  2008  Kd=3.3nM      // 3b2u.pdf (HL|A) ligand is Fab fragment of IMC-11F8, Kd=3.3+/-0.5nM
3bdy  2.60  2008  Kd=300nM      // 3bdy.pdf (HL|V) Dual specific bH1 Fab in complex with VEGF
3blh  2.48  2008  Kd=300nM      // 3blh.pdf (A|B) CDK9/CycT1, Kd=300nM, unpublished data
3ech  1.80  2008  Kd=300nM      // 3ech.pdf (B|C) Kd=300+/-70nM
3bky  2.61  2008  Kd=30nM       // 3bky.pdf (HL|P) Fab fragment of the antibody C2H7 complex with CD20 epitope peptide, Kd=3 X 10-8M
3d7u  4.11  2008  Kd=30uM       // 3d7t.pdf (A|B) ligand is Proto-oncogene tyrosine-protein kinase Src, Kd~30uM
3cx8  2.00  2008  Kd=340nM      // 3cx6.pdf (A|B) RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to GTP gamma S
2k42   NMR  2008  Kd=35nM       // 2k42.pdf (A|B) GTPase Binding Domain of WASP in Complex with EspFU, Kd=35+/-4.9nM
2vsm  1.80  2008  Kd=35nM       // 2vsk.pdf (A|B) NIPAH VIRUS ATTACHMENT GLYCOPROTEIN WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
2k2u   NMR  2008  Kd=360nM      // 2k2u.pdf (A|B) Tfb1 subunit of TFIIH and the activation domain of VP16, Kd=360+/-40nM
2efh  2.10  2008  Kd=36nM       // 2efc.pdf (A|B) ARA7-GDP / VPS9a-D185N mutant complex, Kd=3.6x10-8M with Mg2+
2rgn  3.50  2008  Kd=36nM       // 2rgn.pdf (A|B) ligand is p63 (149-502), Kd=36+/-3nM, Ki=29+/-4nM
3c66  2.60  2008  Kd=3uM        // 3c66.pdf (B|D) ligand is Fip1 residues 80-105 (Fippbd)
3d2u  2.21  2008  Kd=4.0nM      // 3d2u.pdf (BD|A) UL18 protein
3bp8  2.85  2008  Kd=4.14nM     // 3bp8.pdf (B|D) Putative NAGC-like transcriptional regulator, Mlc/EIIB complex, Kd=4.14+/-1.22nM
3dvm  2.60  2008  Kd=4.32nM     // 3dve.pdf (A|B) Ca2+/CaM-CaV2.1 IQ domain complex, N-lobe Kd=51+/-20nM, C-lobe Kd=4.32+/-0.39nM
3c4p  1.75  2008  Kd=4.4nM      // 3c4o.pdf (A|B) SHV-1 complex with Beta-lactamase inhibitory protein, BLIP (E73M) mutant, Kd=4.4+/-0.6nM
3cqx  2.30  2008  Kd=4.5uM      // 3cqx.pdf (B|C) Hsc70-NBD complex with BAG family molecular chaperone regulator 2, Kd=4.5+/-2uM for Bag2-BNB dimer, not for the Hsc70-NBD-Bag2-BNB complex
3c4o  1.70  2008  Kd=4.6nM      // 3c4o.pdf (A|B) SHV-1 complex with Beta-lactamase inhibitory protein, BLIP (E73M, S130K, S146M) mutant, Kd=4.6+/-0.2nM
3e2h  3.80  2008  Kd=4.6uM      // 3e2h.pdf (AQ|BC) m67 high-affinity mutant of the 2C TCR in complex with Ld/QL9
3cx6  2.50  2008  Kd=4.8uM      // 3cx6.pdf (A|B) RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to GDP
2qjb  2.50  2008  Kd=4.9nM      // 2qj9.pdf (B|D) ligand is Bone morphogenetic protein 2, BMP2, Kd=4.9nM
2jtt   NMR  2008  Kd=4.9uM      // 2jtt.pdf (AB|D) ligand is C-terminal Siah-1 interacting protein (189-219), ITC Kd=4.9+/-0.6uM
2vlr  2.30  2008  Kd=4.9uM      // 2vlj.pdf (DE|ABC) TCR-pMHC complex
3c09  3.20  2008  Kd=43nM       // 3c08.pdf (CB|A) Fab fragment of matuzumab (Fab72000) complex with sEGFR domain 3, Kd=43.0+/-12.9nM
2vyr  2.00  2008  Kd=44nM       // 2vyr.pdf (C|G) VH9 and Humain MDM4 N-terminal domain, Kd=44nM
3ejj  2.40  2008  Kd=455nM      // 3ejj.pdf (A|X) ligand is domains (D1-D3) of FMS; (D1-D3) of FMS Kd=455nM, (D1-D5) of FMS Kd=9.0nM
3bpn  3.02  2008  Kd=487nM      // 3bpl.pdf (AB|C) ternary complex of IL-4Ra/IL-4 complex and Interleukin-13 receptor alpha-1 chain, Kd=487nM
3cqc  2.53  2008  Kd=4nM        // 3cqc.pdf (A|B) ligand is human Nucleoporin Nup133; His-tagged hNup107 658-925, Kd=4+/-2nM
3cqg  3.00  2008  Kd=4nM        // 3cqg.pdf (A|B) ligand is human Nucleoporin His-tagged hNup133 (934-1156), Kd=4+/-2nM
2k5b   NMR  2008  Kd=4uM        // 2k5b.pdf (A|B) Human CDC37M-HSP90N complex, Kd=4uM
2ve7  2.88  2008  Kd=4uM        // 2ve7.pdf (B|D) ligand is Nuf2(1-169)-Spc24(122-197); Kd=4~5uM
2vlj  2.40  2008  Kd=5.2uM      // 2vlj.pdf (DE|ABC) TCR-pMHC complex
3beg  2.90  2008  Kd=50nM       // 3beg.pdf (A|B) ASF/SF2, Kd~50nM
3cx7  2.25  2008  Kd=520nM      // 3cx6.pdf (A|B) RhoGEF-RGS (rgRGS) Domain Complex with Galpha-13 Bound to ALF and GDP
3bpl  2.93  2008  Kd=559nM      // 3bpl.pdf (AB|C) ternary complex of IL-4Ra/IL-4 complex and Cytokine receptor common gamma chain, Kd=559nM
3chw  2.30  2008  Kd=57nM       // 3chw.pdf (A|P) Profilin
2efd  3.00  2008  Kd=7.3nM      // 2efc.pdf (A|B) GDP Nucleotide-free ARA7 / VPS9a complex, with Mg2+, Kd=7.3nM
3c9a  1.60  2008  Kd=7.7nM      // 3c9a.pdf (B|D) ligand is Spitz EGF-domain(SpitzEGF: residues 48-99), for full length Argos419, Kd=20nM
2vay  1.94  2008  Kd=7.9nM      // 2vay.pdf (A|B) ligand is  CAV1.1 IQ PEPTIDE
3d7t  2.90  2008  Kd=70uM       // 3d7t.pdf (A|B) ligand is Proto-oncogene tyrosine-protein kinase Src, Kd~70uM
2v5q  2.30  2008  Kd=71nM       // 2v5q.pdf (A|D) DESIGN ANKYRIN REPEAT PROTEIN VARIANT 3H10, rough estimated Kd=71nM
3crk  2.30  2008  Kd=8.3uM      // 3crk.pdf (A|C) PDHK2 complex with inner lipoyl-bearing domain of dihydrolipoamide transacetylase (L2), Potassium phosphate buffer, Kd=8.3+/-0.3uM
3dbl  2.90  2008  Kd=8.75uM     // 3dbh.pdf (HG|L) APPBP1-UBA3Arg190 (wt) complex with NEDD8 Ala72Gln mutant, Kd=8750+/-70nM
3dvg  2.60  2008  Kd=8.7nM      // 3dvg.pdf (BA|YX) Apu3.A8-K63-linked diubiquitin
2qna  2.84  2008  Kd=83nM       // 2qna.pdf (A|B) ligand is IBB domain of Snurportin-1 (1-65); for full length Imp beta Kd=79nM, for 127-876, Kd=83nM
3bik  2.65  2008  Kd=8uM        // 3bik.pdf (A|B) murine PD-1 and Programmed cell death 1 ligand 1 (human PD-L1), Kd=8uM
3bs5  2.00  2008  Kd=92.5nM     // 3bs5.pdf (A|B) ligand is SAM domain of HYP; SAM domain dimer complex
3dvn  2.70  2008  Kd=92nM       // 3dvg.pdf (HL|VU) Apu2.16-K63-linked diubiquitin
3bh6  2.60  2008  Kd=95nM       // 3bh6.pdf (A|B) ligand is wild type RP2, Kd=95+/-2nm
3bx1  1.85  2008  Kd~1.3uM      // 3bx1.pdf (A|C) Alpha-amylase/subtilisin inhibitor, BASI in complex with the B. lentus subtilisin Savinase
3d1m  1.70  2008  Kd~1.3uM      // 3d1m.pdf (B|C) wt Sonic hedgehog protein complex with third FNIII domain of CDO
3b4v  2.48  2008  Kd~30pM       // 3b4v.pdf (F|G) Activin in complex with FSTL3, Kd~30pM
3fju  1.60  2008  Ki=1.6nM      // 3fju.pdf (A|B) metallocarboxypeptidase (MCP) inhibitor, ACI, Ki=1.6+/-0.2nM
2oul  2.20  2008  Ki=1.7nM      // 2oul.pdf (A|B) chagasin, in complex with a cysteine protease Falcipain 2, Ki=1.7+/-0.53nM
2ody  2.35  2008  Ki=1.8nM      // 2ody.pdf (B|E) bovine a-thrombin  boophilin complex, Ki=1.8nM
3bg4  2.50  2008  Ki=34.33nM    // 3bg4.pdf (BC|D) Guamerin, ki=34.33+/-4.76nM
3ixe  1.90  2009  IC50=2.3uM    // 3ixe.pdf (A|B) PINCH2 LIM1 domain in complex with ILK ARD
3gjn  2.48  2009  Kd<1pM        // 3gjn.pdf (D|C) ColE7-R12-13 complex, Kd<1x10-12M
2w84   NMR  2009  Kd=0.07uM     // 2w84.pdf (A|B) protein 2 is Pex5(108-127), not Pex5(116-124)
3a6b  1.80  2009  Kd=0.108uM    // 3a67.pdf (HL|Y) ligand is hen egg white lysozyme; Ka=0.93x10^7M-1, Kd=1.08x10-7M
2vxq  1.90  2009  Kd=0.11nM     // 2vxq.pdf (HL|A) huMab2 and POLLEN ALLERGEN PHL P 2, KD=1.1x10-10M
3da7  2.25  2009  Kd=0.13uM     // 3da7.pdf (B|C) Circular Permutant of Barnase and Barstar, 20C Kd=0.13uM, 30C Kd=1.9uM, 37C Kd=60uM
3k2u  2.35  2009  Kd=0.16nM     // 3k2u.pdf (HL|A) HGFA/Fab40 complex, KD=0.16+/-0.01nM
2w9e  2.90  2009  Kd=0.1nM      // 2w9d.pdf (HL|A) ICSM-18 with HUMAN PRP FRAGMENT 119-231
3fp6  1.49  2009  Kd=0.1pM      // 3fp6.pdf (E|I) Kd=0.1pM for bovine trypsin with pancreatic trypsin inhibitor; not for rattus norvegicus
2wjv  2.85  2009  Kd=0.2uM      // 2wjv.pdf (B|E) UPF1(115-914) and UPF2(1105-1198), Kd is for UPF2(1105-1207) and UPF1(115-287)
3huj  2.50  2009  Kd=0.2uM      // 3he6.pdf (AB|GH) human CD1d-alpha-Galactosylceramide with semi-invariant NKT cell receptor
3inb  3.10  2009  Kd=0.2uM      // 3inb.pdf (A|D) MV-H-CD46 complex
2kbw   NMR  2009  Kd=0.32uM     // 2kbw.pdf (A|B)
2khs   NMR  2009  Kd=0.36uM     // 2khs.pdf (A|B) SNase121:SNase-(111-143) complex, Kd=0.36+/-0.09uM
2wel  1.90  2009  Kd=0.3uM      // 2vn9.pdf (A|D) Kd=0.3-0.6uM; protein Fragment: KINASE DOMAIN, RESIDUES 11-335 ;
3dxa  3.50  2009  Kd=0.3uM      // 3dx6.pdf (ABC|DE) DM1 TCR and HLA-B4405 EENL complex, Kd=0.3+/-0.1uM
2w83  1.93  2009  Kd=0.42uM     // 2w83.pdf (B|C) JIP4-LZII (fused to GST) and Delta 12-ARF6GTP-Q67L, Kd=0.42+/-0.05uM
3g3a  2.20  2009  Kd=0.43uM     // 3g3a.pdf (C|D) lamprey variable lymphocyte receptor in complex with a protein antigen
3d3v  2.80  2009  Kd=0.46uM     // 3d39.pdf (ABC|DE) A6 TCR binding affinities for modified Tax Y5F-34F peptides presented by HLA-A2, ligand is a complex
3gty  3.40  2009  Kd=0.47nM     // 3gty.pdf (X|S) ligand is 30S ribosomal protein S7; overall dissociation constant of K(AABB) is 4.7x10-10M
2zvk  2.70  2009  Kd=0.4uM      // 2zvk.pdf (A|U) ligand is DNA polymerase eta fragment
3d39  2.81  2009  Kd=0.64uM     // 3d39.pdf (ABC|DE) A6 TCR binding affinities for modified Tax Y5F4F peptides presented by HLA-A2, ligand is a complex
2k79   NMR  2009  Kd=0.67mM     // 2k79.pdf (A|B) average-minimized structure ensemble of interleukin-2 tyrosine kinase SH3 and SH2 domain
2k7a   NMR  2009  Kd=0.67mM     // 2k7a.pdf (A|B) the 20 lowest-energy structure ensemble of interleukin-2 tyrosine kinase SH3 and SH2 domain
3idc  2.70  2009  Kd=0.6nM      // 3idb.pdf (A|B) RII beta(102-265):C in the presence of AMP-PNP and 2Mn2+ ions
2wp0  2.67  2009  Kd=0.93uM     // 2wp0.pdf (A|C) the HobA/DnaAI-II structure
3knb  1.40  2009  Kd=0.94uM     // 3knb.pdf (A|B) ligand is obscurin-like protein 1, Kd=0.94+/-0.08uM
3gd1  3.50  2009  Kd=0.98uM     // 3gc3.pdf (EC|I) ligand is Clathrin-(1-363), Kd=0.98+/-0.01uM
3h3g  1.94  2009  Kd=0.99uM     // 3h3g.pdf (A|B) ligand is 24-mer parathyroid hormone-related protein (PTHrP)
3ew3  3.80  2009  Kd=1.2nM      // 3ew3.pdf (A|B) 1:2 complex between prolactin and prolactin receptor, site 1 Kd=1.2nM, site 2+3 Kd=312nM
2wy2   NMR  2009  Kd=1.3mM      // 2wy2.pdf (C|D) ligand is C10S mutant IIB COMPONENT of N, N-diacetylchitobiose (Chb) transporter of E.coli
3hcu  2.60  2009  Kd=1.48uM     // 3hct.pdf (C|D) TRAF6 in complex with Ubc13 in the C2 space group, Kd=1.48+/-0.02uM for TRAF6 RZ123
3hct  2.10  2009  Kd=1.48uM     // 3hct.pdf (A|B) TRAF6 in complex with Ubc13 in the P1 space group, Kd=1.48+/-0.02uM for TRAF6 RZ123(Supplementary data)
3kpr  2.60  2009  Kd=1.5uM      // 3kpl.pdf (ED|ABC) LC13 TCR in complex with HLA B*4405 bound to EEYLKAWTF
2zvo  2.90  2009  Kd=1.6uM      // 2zvn.pdf (A|D) NEMO CoZi domain incomplex with diubiquitin in C2 space group
2zvn  3.00  2009  Kd=1.6uM      // 2zvn.pdf (A|D) NEMO CoZi domain incomplex with diubiquitin in P212121 space group
2k8c   NMR  2009  Kd=1.8mM      // 2k8b.pdf (A|B) ligand is Ubiquitin; Kd=1.8+/-0.6mM
2k8b   NMR  2009  Kd=1.8mM      // 2k8b.pdf (A|B) ligand is Ubiquitin; Kd=1.8+/-0.6mM
3htu  2.00  2009  Kd=1.8uM      // 3htu.pdf (A|B) human VPS25c-VPS20 alpha1-3 complex; Kd=1.8+/-0.2uM for helix 1-3, structure is helix 1 only
3g6j  3.10  2009  Kd=1.9nM      // 3g6j.pdf (FE|BA) C3b in complex with a C3b specific Fab antibody, S77 IgG
2wo2  2.45  2009  Kd=10.8uM     // 2wo2.pdf (A|B) EphA4-ephrinB2 complex
3k8p  2.60  2009  Kd=10nM       // 3k8p.pdf (C|D) Dsl1Clactis-Sec39 complex, ref Kd data not shown
3hi1  2.90  2009  Kd=11.2nM     // 3hi1.pdf (BA|J) YU2 HIV-1 gp120 (core with V3) complex CD4-Binding-Site Antibody F105(supplementary data)
3idb  1.62  2009  Kd=11.3nM     // 3idb.pdf (A|B) RII beta(108-268):C in the presence of AMP-PNP and 2Mn2+ ions
3dco 11.00  2009  Kd=11.6uM     // 3dc4.pdf (AN|B) Kd1=11.6uM in the presence of excess ADP(1mM), NOD bound to Bovine Alpha Tubulin
3eiq  3.50  2009  Kd=110nM      // 3eiq.pdf (A|C) Programmed cell death protein 4, mPdcd4 DeltaN-eIF4A complex
3ifq  2.80  2009  Kd=116nM      // 3ifq.pdf (A|C) ligand is pE--cadherin-CBD, Kd=116+/-31nM
2knb   NMR  2009  Kd=11uM       // 2knb.pdf (A|B) Parkin Ubl-Endophilin-A1 SH3(as ligand) Complex, Kd=11+/-4uM
2wii  2.70  2009  Kd=11uM       // 2wii.pdf (AB|C) COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4, Kd=11+/-2uM
3hh2  2.15  2009  Kd=12.3nM     // 3hh2.pdf (B|C) myostatin in complex with Fst288, Kd for Fst317=12.3nM, not Fst288
3h2u  2.75  2009  Kd=12.6uM     // 3h2u.pdf (A|B) Human raver1 RRM1, RRM2, and RRM3 domains with human vinculin tail domain Vt
3f1p  1.17  2009  Kd=120uM      // 3f1n.pdf (A|B) human HIF2alpha-ARNT PAS-B heterodimer
3gni  2.35  2009  Kd=12nM       // 3gni.pdf (A|B) STRAD alpha binds MO25 alpha, in present of ATP, two sites Kd1=2.5uM, Kd2=12nM
3fku  3.20  2009  Kd=130pM      // 3fku.pdf (AB|Y) H5-VN04 and Neutralizing antibody F10 complex, Kd=130+/-28pM in sup.info
3ff8  2.00  2009  Kd=130uM      // 3ff7.pdf (B|D) mKLRG1-hEC1, Kd=1.3x10-4M
3jsv  2.70  2009  Kd=131uM      // 3jsv.pdf (CD|A) mouse NEMO CC2-LZ in complex with K63-Ub2
2wqz  3.90  2009  Kd=132nM      // 2vh8.pdf (B|C) ligand is Neuroligin4, X-Linked; 2VH8 (Nrxb1-NL4 complex)
3hpw  1.45  2009  Kd=13uM       // 3g7z.pdf (B|C) CcdB dimer in complex with two C-terminal CcdA domains, low Kd=13uM, high=20pM
2w19  2.15  2009  Kd=140nM      // 2vkl.pdf (A|C) COMPLEX BETWEEN DAHP SYNTHASE AND CHORISMATE MUTASE, Kd=140+/-30nM
2wfx  3.20  2009  Kd=14nM       // 2wfx.pdf (A|B) ShhN-eHHIP Delta N with Ca2+, Kd=14+/-1.6nM
2wub  2.90  2009  Kd=150nM      // 2wub.pdf (HL|A) HGFA complex with Fab40.DeltaTrp, Kd=150+/-9.1nM
3g6d  3.20  2009  Kd=15pM       // 3g6a.pdf (HL|A) anti-IL-13 antibody fab CNTO607/IL-13 complex
2wuc  2.70  2009  Kd=161nM      // 2wuc.pdf (HL|A) Kd=161+/-7.6nM, Antibody FAB40.DELTA TRP Binding to HGFA, not ligand
3hg0  2.10  2009  Kd=16nM       // 3hg0.pdf (A|D) Kd=16nM for BppL alone, Kd=22nM for BppU/BppL complex
3di2  2.70  2009  Kd=18uM       // 3di2.pdf (A|B) E106A mutant human IL-7 with unglycosylated IL-7R alpha(EC), Kd=18uM; IC50=3.0uM
3g9v  2.76  2009  Kd=1pM        // 3g9v.pdf (C|D) receptor IL-22BP bound to interleukin-22
3kv4  2.19  2009  Kd=1uM        // 3kv4.pdf (A|B) ligand is 24-mer Histone H3 peptide
2vxs  2.63  2009  Kd=2.1nM      // 2vxs.pdf (IM|A) IL-17A IN COMPLEX WITH ANTIBODY CAT-2200
3gc3  2.20  2009  Kd=2.1uM      // 3gc3.pdf (A|B) ligand is Clathrin-(1-363), Kd=2.1+/-0.4uM
3eoa  2.80  2009  Kd=2.2nM      // 3eo9.pdf (BA|J) Efalizumab Fab and LFA-1 alpha L I domain, Form I, Kd=2.2+/-0.5nM
3eob  3.60  2009  Kd=2.2nM      // 3eo9.pdf (BA|J) Efalizumab Fab and LFA-1 alpha L I domain, Form II, Kd=2.2+/-0.5nM
2wo3  2.35  2009  Kd=2.3uM      // 2wo2.pdf (A|B) EphA4-ephrinA2 complex
2k8f   NMR  2009  Kd=2.7uM      // 2k8f.pdf (A|B) Taz2/p53 1-39 complex, Kd=2.7+/-0.5uM
2kc8   NMR  2009  Kd=200nM      // 2kc8.pdf (A|B) ligand is antitoxin RelBc (K47-L79) peptide; Kd=200+/-24nM
3ff7  1.80  2009  Kd=200uM      // 3ff7.pdf (B|D) hKLRG1-hEC1, Kd=2x10-4M
3gxu  2.50  2009  Kd=203nM      // 3gxu.pdf (A|B) ligand is Ephrin-B2
2wby  2.60  2009  Kd=20nM       // 2wby.pdf (A|CD) insulin, Kd1=20nM(insulin-binding site 1); Kd2 =280nM(insulin-binding site 2), IC50=180nM
3doe  2.25  2009  Kd=20nM       // 3doe.pdf (A|B) ligand is ARL2 binding protein, BART; Crystal Form 1
3g7z  2.35  2009  Kd=20pM       // 3g7z.pdf (B|D) CcdB dimer in complex with two C-terminal CcdA domains, low Kd=13uM, high=20pM
3fhc  2.80  2009  Kd=21.6nM     // 3fhc.pdf (A|B) human DBP5(1-405), Kd=21.6+/-1.7nM
2w2x  2.30  2009  Kd=21.9uM     // 2w2t.pdf (A|D) RAS-Related C3 Botulinum Toxin Substrate 2
3di3  2.90  2009  Kd=21nM       // 3di2.pdf (A|B) E106A mutant human IL-7 with glycosylated IL-7R alpha(S2), Kd=21nM
3h8k  1.80  2009  Kd=21nM       // 3h8k.pdf (A|B) Ube2g2:G2BR complex, Kd=21+/-4nM
3h2v  2.90  2009  Kd=22.1uM     // 3h2v.pdf (D|H) ligand is Human raver1 RRM1 domain; Kd=22.1uM; for RRM1-3, Kd=12.6uM
3ho5  3.01  2009  Kd=220nM      // 3ho5.pdf (B|H) ligand is Sonic hedgehog (SHH) ; Kd=220nM, IC50=53nM
3gsn  2.80  2009  Kd=27.7uM     // 3gsn.pdf (HLP|AB) RA14 TCR and HLA-A*0201 loaded with a NLV peptide(NLVPMVATV); Kd=27.7+/2.3uM, ligand is a complex
3jvf  3.30  2009  Kd=292nM      // 3jvf.pdf (B|C) Interleukin-17 receptor A and Interleukin-17F complex, Kd=292+/-19nM
3he7  2.80  2009  Kd=296nM      // 3he6.pdf (AB|ED) mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta7 NKT TCR
3etb  3.80  2009  Kd=29pM       // 3etb.pdf (G|K) antibody M18 complex PAD4, KD=2.9x10-11
3gqi  2.50  2009  Kd=33nM       // 3gqi.pdf (A|B) The Secondary Binding Site on the N-SH2 Domain of Phospholipase C-gamma-1
3g3b  2.40  2009  Kd=34nM       // 3g3a.pdf (A|B) lamprey variable lymphocyte receptor mut13 complex with a protein antigen
3g9w  2.17  2009  Kd=36uM       // 3g9w.pdf (A|D) talin2/Integrin beta-1D complex, Kd=36+/-2uM
2w8b  1.86  2009  Kd=38nM       // 2w8b.pdf (A|H) PROCESSED TOLB IN COMPLEX WITH PAL, Kd=38+/-3nM
3gj8  1.82  2009  Kd=3uM        // 3gj0.pdf (C|D) human RanGDP-Nup153 ZnF34 complex
3idx  2.50  2009  Kd=4.04nM     // 3hi1.pdf (HL|G) HXBc2 HIV-1 gp120 complex CD4-Binding-Site antibody b13, space group C222(supplementary data)
3idy  3.20  2009  Kd=4.04nM     // 3hi1.pdf (HL|G) HXBc2 HIV-1 gp120 complex CD4-Binding-Site antibody b13, space group C2221(supplementary data)
2zxx  2.80  2009  Kd=4.4nM      // 2zxx.pdf (E|F) mouse tGeminin (residues 79-157) and tCdt1 (residues 172-368), Kd=4.4+/-2.2nM
3hi6  2.30  2009  Kd=4.7uM      // 3hi5.pdf (XY|B) Fab fragment of AL-57 in complex with IA
3it8  2.80  2009  Kd=43pM       // 3it8.pdf (G|J) TNF alpha complexed with a poxvirus MHC-related TNF binding protein
3hae  2.90  2009  Kd=46nM       // 3gje.pdf (TS|PR) HLA-A2-NYESO-1-3M4E5, in reference 3gje and 3gjg exchange
3gj5  1.79  2009  Kd=47uM       // 3gj0.pdf (C|D) human RanGDP-Nup153 ZnF4 complex
3f7p  2.75  2009  Kd=49uM       // 3f7p.pdf (B|D) integrin beta4(1126-1370) and plectin(1-293), Kd=49+/-7uM
3gj3  1.79  2009  Kd=49uM       // 3gj0.pdf (A|B) human RanGDP-Nup153 ZnF2 complex
3kps  2.70  2009  Kd=49uM       // 3kpl.pdf (AB|DE) Kd=49uM, LC13 TCR in complex with HLA B*4405 bound to EEYLQAFTY, ligand is a complex
2w81  2.35  2009  Kd=4nM        // 2w80.pdf (E|F) FACTOR H BINDING PROTEIN AND CCPS 6-7, Space Group C2, Kd=4+/-1nM
2w80  2.35  2009  Kd=4nM        // 2w80.pdf (E|F) FACTOR H BINDING PROTEIN AND CCPS 6-7, Space Group P1, Kd=4+/-1nM
3h42  2.30  2009  Kd=4pM        // 3h42.pdf (HL|BA) PCSK9 in complex with Fab from LDLR competitive antibody
3gj7  1.93  2009  Kd=4uM        // 3gj0.pdf (A|B) human RanGDP-Nup153 ZnF12 complex
3kls  3.60  2009  Kd=5.5nM      // 3kls.pdf (B|Y) ligand is SSL7 protein from Staphylococcus aureus; ITC test
3a67  1.80  2009  Kd=5.62nM     // 3a67.pdf (HL|Y) ligand is hen egg white lysozyme; Ka=17.8x10^7M-1, Kd=5.62x10-9M
2ka6   NMR  2009  Kd=52nM       // 2ka4.pdf (A|B) CBP-TAZ2/STAT1-TAD complex, Kd=52+/-31nM
2k2s   NMR  2009  Kd=53nM       // 2k2s.pdf (A|B) the TgMIC1-GLD  CTgMIC6-EGF2 complex, Kd=53+/-13nM
2wbj  3.00  2009  Kd=565uM      // 2wbj.pdf (CD|AB)
2ka4   NMR  2009  Kd=58nM       // 2ka4.pdf (A|B) CBP-TAZ1/STAT2-TAD complex, Kd=58+/-3nM
3ejh  2.10  2009  Kd=5uM        // 3ejh.pdf (B|F) Fibronectin 8-9FnI Domain Pair complex a Type-I Collagen Peptide, Kd=5+/-1uM
3gb8  2.90  2009  Kd=6.5uM      // 3gb8.pdf (A|B) CRM1/Snurportin-1 complex, Kd=1.4uM at temp 15, Kd=6.5uM at temp 23
3gj6  2.70  2009  Kd=6.5uM      // 3gj0.pdf (A|B) human RanGDP-Nup153 ZnF1 complex
3gj4  2.15  2009  Kd=6.6uM      // 3gj0.pdf (C|D) human RanGDP-Nup153 ZnF3 complex
3gjf  1.90  2009  Kd=63nM       // 3gje.pdf (MK|DF) HLA-A2-NYESO-1-3M4F4, T-cell receptor-like antibody
2kj4   NMR  2009  Kd=65nM       // 2kj4.pdf (A|B) VEK-30/K2Pg complex
3he6  2.90  2009  Kd=69.1nM     // 3he6.pdf (AB|CD) mouse CD1d-alpha-galactosylceramide with mouse Valpha14-Vbeta8.2 NKT TCR
3a6c  1.80  2009  Kd=7.14nM     // 3a67.pdf (HL|Y) ligand is hen egg white lysozyme; Ka=14x10^7M-1, Kd=7.14x10-9M
2wg3  2.60  2009  Kd=73.6nM     // 2wfx.pdf (A|C) DHHN-eHHIP Delta N without Ca2+, Kd=73.6+/-12.9nM
2wg4  3.15  2009  Kd=73.9nM     // 2wfx.pdf (A|B) ShhN-eHHIP Delta N without Ca2+, Kd=73.9+/-12.3nM
2wwx  1.50  2009  Kd=79nM       // 2wwx.pdf (A|B) SIDM/DRRA(GEF/GDF DOMAIN)-RAB1 (GTPASE DOMAIN) COMPLEX
3dmm  2.60  2009  Kd=8.2uM      // 3dmm.pdf (A|BCD) ligand is murine MHCI molecule H-2Dd
2k3u   NMR  2009  Kd=8.4nM      // 2k3u.pdf (A|B) ligand is C5aR(P7-28S) peptide; Kd=8.4+/-1.1nM
2kde   NMR  2009  Kd=8.9uM      // 2kde.pdf (A|C) major S5a (196-306):K48 linked diubiquitin species, Kd=8.9+/-0.6uM
3ffc  2.80  2009  Kd=8.9uM      // 3ffc.pdf (ABC|DE) CF34 TCR in complex with HLA-B8/FLRGRAYGL, Kd=8.89+/-1.31uM
2wx0  2.40  2009  Kd=8uM        // 2wx0.pdf (A|C) TAB2 NZF 663-693 and K63 U2. Kd=8+/-1.7uM
3ia3  3.20  2009  Kd=93nM       // 3ia3.pdf (C|B) ligand is wild-type bishis-Hemoglobin subunit alpha, Kd=93+/-5nM
3bzd  2.30  2009  Kd=96uM       // 3bzd.pdf (A|B) ligand is Enterotoxin type C-3; Kd=9.6x10-8M, SEC3-1A4 and mVBeta8.2; SEC3-wt and mVBeta8.2, Kd=12uM
2kgx   NMR  2009  Kd=9uM        // 2kgx.pdf (A|B) Talin 1655-1822 Interacts with the Talin F3 Domain, Kd=9+/-0.8uM
3gmw  2.10  2009  Kd~0.05nM     // 3gmv.pdf (C|D) BLIP-I and TEM-1 complex, BLIP and BLIP-I share Ki=0.1-0.6nM, Kd~0.05nM
2vxt  1.49  2009  Kd~0.2nM      // 2vxt.pdf (HL|I) ligand is HUMAN INTERLEUKIN-18  cysteine mutant
3fxd  2.10  2009  Kd~20nM       // 3fxd.pdf (A|B) ligand is Protein IcmR; Kd~20nM, actual Kd may be lower
3fsh  2.76  2009  Kd~5nM        // 3fsh.pdf (B|C) the binding affinity is for Ube2ge bound GST-gp78C.
3h8d  2.20  2009  Kd~80nM       // 3h8d.pdf (A|E) myosin VI CBD in complex with the Dab2 MIR residues 675-713
3f4y  2.00  2009  Ki<0.2nM      // 3f4y.pdf (C|F) HIV gp41 NHR domain complex HIV gp41 CHR domain mutant 3, Ki<0.2nM
3e1z  1.86  2009  Ki=0.036nM    // 3e1z.pdf (A|B) chagasin, a protein inhibitor from Trypanosoma cruzi
3h6s  2.22  2009  Ki=0.08nM     // 3h6s.pdf (B|F) ligand is clitocypin, Ki=0.08+/-0.03nM
3fii  2.17  2009  Ki=1.9nM      // 3fie.pdf (A|B) BoNT F-inh2 complex
3fie  2.10  2009  Ki=1nM        // 3fie.pdf (A|C) BoNT F-inh1 complex
3k9m  2.61  2009  Ki=2nM        // 3k9m.pdf (A|C) affinity data is not for human source stefin A and cathepsin B, Ki=2+/-0.42nM
3e2l  1.87  2009  Ki=69pM       // 3e2k.pdf (A|C) KPC-2 Beta-lactamase G175S mutant and BLIP, space group C2, Ki=69+/-6pM
3e2k  2.10  2009  Ki=69pM       // 3e2k.pdf (A|D) KPC-2 Beta-lactamase G175S mutant and BLIP, space group P212121, Ki=69+/-6pM
3g7a  2.80  2009  Ki=9nM        // 3f4y.pdf (A|B) HIV gp41 NHR domain complex HIV gp41 CHR domain mutant 10, Ki=9nM
3f50  2.80  2009  Ki=9nM        // 3f50.pdf (A|B) Oligomer 10. The binding affinity is for gp41-5. IC50=5+/-2nM.
3n00  2.60  2010  IC50=0.22uM   // 3n00.pdf (A|B) ligand is Nuclear receptor corepressor 1 peptide, affinity may for non-truncated
3ma9  2.05  2010  Kd<10nM       // 3ma9.pdf (HL|A) gp41 derived protein complexed with fab 8066, Kd<<10nM
3ixt  2.75  2010  Kd=0.035nM    // 3ixt.pdf (AB|C) ligand is Peptide Epitope
3mc0  2.00  2010  Kd=0.125uM    // 3mc0.pdf (C|D) Kd=0.125uM by ITC; Kd=0.270uM by SPR
3fpu  1.76  2010  Kd=0.12nM     // 3fpu.pdf (A|B) ligand is C-C motif chemokine 3
3iu3  2.90  2010  Kd=0.14nM     // 3iu3.pdf (CD|J) ligand is IL-2Ra (CD25) ectodomain
3laq  3.20  2010  Kd=0.17nM     // 3laq.pdf (B|V) ligand is murine Urokinase-type plasminogen activator
2wpt  1.78  2010  Kd=0.1uM      // 2wpt.pdf (A|B) ligand is COLICIN-E2 IMMUNITY PROTEIN
3lk2  2.20  2010  Kd=0.1uM      // 3lk2.pdf (AB|T) ligand is CARMIL, capping protein interacting motif, CBR52; Kd=0.1~0.2uM
3nfp  2.86  2010  Kd=0.27nM     // 3nfp.pdf (AB|K) ligand is Interleukin-2 receptor subunit alpha (CD25) ectodomain; SPR Kd=0.27nM
3ogo  2.80  2010  Kd=0.32nM     // 3ogo.pdf (B|G) ligand is GFP-nanobody; ITC Kd<1nM, in reference SPR Kd=0.32nM
3l9j  2.10  2010  Kd=0.34nM     // 3l9j.pdf (C|T) trimeric TN-2-B1-C31, Biacore Kd=3.4 x 10-10M
3mca  2.74  2010  Kd=0.39uM     // 3mca.pdf (A|B) ligand is Protein dom34; Kd=0.39+/-0.02uM, in support info
3kuc  1.92  2010  Kd=0.442uM    // 3kuc.pdf (A|B) ligand is RafRBD(A85K/N71R)
3o6q  2.50  2010  Kd=0.46nM     // 3o6q.pdf (C|D) ligand is Stage II sporulation protein SB; a Toxin-Antitoxin System, Kd=4.6x10-10M
2kwj   NMR  2010  Kd=0.5uM      // 2kwj.pdf (B|A) ligand is  Histone H3K14ac peptide; Kd1=0.5+/-0.1uM(ITC); Kd2=1.2+/-0.2uM(Fluorescent Polarization Assay ); IC50=0.5+/-0.1uM
3lev  2.50  2010  Kd=0.600nM    // 3lev.pdf (HL|A) epitope scaffold ES2, Kd=0.600+/-0.004nM
2wp3  1.48  2010  Kd=0.794uM    // 2wp3.pdf (O|T) ligand is OBSCURIN LIKE 1 IG, Form I, trigonal, Ka=12.6+/-1.5 x10^5M-1
3n85  3.20  2010  Kd=0.79nM     // 3n85.pdf (HL|A) ligand is ryptophan-rich antibody fragment fab37; Kd=0.79+/-0.33nM
3mxw  1.83  2010  Kd=0.7nM      // 3mxv.pdf (HL|A) ITC in solution, Kd=0.7nM
2wwk  1.70  2010  Kd=1.28uM     // 2wp3.pdf (O|T) ligand is OBSCURIN LIKE 1 IG F17R MUTANT, Ka=7.8+/-1.3 x10^5M-1
2ki4   NMR  2010  Kd=1.34uM     // 2ki4.pdf (A|B)
3oky  2.19  2010  Kd=1.3uM      // 3okw.pdf (A|B) mouse Sema6A-PlxnA2(1-4); Kd for monomerized Sema
3ma2  2.05  2010  Kd=1.53uM     // 3ma2.pdf (D|C) ligand is Metalloproteinase inhibitor 1
3lk4  1.99  2010  Kd=1.5nM      // 3lk4.pdf (AB|C) ligand is CARMIL, capping protein interacting motif, CBR115
3lqa  3.40  2010  Kd=1.6uM      // 3lmj.pdf (HL|GC) CAP210 plus sCD4 interaction with human anti HIV 21c Fab
3kud  2.15  2010  Kd=1.7uM      // 3kuc.pdf (A|B) ligand is RafRBD(A85K) mutant
3m0a  2.61  2010  Kd=1.7uM      // 3m0a.pdf (C|D)
3osl  6.00  2010  Kd=1.8nM      // 3osl.pdf (C|D)
3k75  2.95  2010  Kd=110nM      // 3k75.pdf (B|D) ligand is DNA polymerase beta catalytic domain; Kd=110+/-10nM
3kz1  2.70  2010  Kd=110nM      // 3kz1.pdf (A|F) Fragment:residues 710-1085; Kd= 110+/-15nM
2xb6  2.60  2010  Kd=115nM      // 2xb6.pdf (A|C) ligand is NEUREXIN-1-BETA LNS DOMAIN; Kd=115nM, in reference similar Kd=132nM
3pl6  2.55  2010  Kd=14.3uM     // 3pl6.pdf (CD|AB) Autoimmune TCR Hy.1B11 in complex with HLA-DQ1 and MBP 85-99, Kd=14.3+/-1.5uM
3k3q  2.60  2010  Kd=147pM      // 3k3q.pdf (BC|A) ligand is llama Aa1 VHH domain, Kd=1.47x10-10M, IC50=4.7x10-10M
3h3p  2.70  2010  Kd=14nM       // 3h3p.pdf (HL|S) ligand is epitope peptide; Kd=14nM by SPR, ITC data is not successful
2kxh   NMR  2010  Kd=14uM       // 2kxh.pdf (A|B) ligand is peptide of Far upstream element-binding protein 1(FBP Nbox); Kd=14+/-8uM
3k6g  1.95  2010  Kd=16.5nM     // 3k6g.pdf (C|F) ligand is Telomeric repeat-binding factor 2 (275-316)
3oak  2.15  2010  Kd=169nM      // 3oak.pdf (B|C) Spn1 (Iws1)-Spt6 complex
2x1w  2.70  2010  Kd=16nM       // 2x1w.pdf (A|M) ligand is VASCULAR ENDOTHELIAL GROWTH FACTOR C(VEGF-C); Kd=16+/-6.7nM(measured  by ITC) , Kd=18.2+/-5.3nM(measured  by SPR)
2x1x  3.10  2010  Kd=16nM       // 2x1x.pdf (E|R) ligand is VEGF-C(VASCULAR ENDOTHELIAL GROWTH FACTOR C); Kd=16+/-6.7nM(ITC); Kd=18.2+/-5.3nM(SPR)
2l0f   NMR  2010  Kd=172uM      // 2ktf.pdf (A|B) ligand is ubiquitin; Kd=172+/-21uM
3m63  2.40  2010  Kd=175nM      // 3m63.pdf (A|B)
3l5n  7.54  2010  Kd=180nM      // 3l3o.pdf (AB|M) ligand is Staphylococcal Complement Inhibitor (SCIN), SCIN binds directly to activated C3b in near-physiological buffers
3m18  1.95  2010  Kd=180pM      // 3m18.pdf (A|B) ligand is hen egg lysozyme C; code 3m19 is pure VLRA.R5.1, complex Kd=120pM
2kwi   NMR  2010  Kd=184nM      // 2kwi.pdf (A|B) ligand is RalA-binding protein 1 C411S mutant
2wh6  1.50  2010  Kd=18nM       // 2v6q.pdf (A|B) ligand is THE BIM BH3 DOMAIN, Kd=18+/-2nM
2rr3   NMR  2010  Kd=2.1uM      // 2rr3.pdf (A|B) wildtype ITC Kd=2.1+/-0.1uM
3mv7  2.00  2010  Kd=2.2uM      // 3mv7.pdf (A|E) with Beta-2-microglobulin and HPVG peptide, Kd= 2.2+/-0.2uM, WT TK3 TCR with two chain
3o4o  3.30  2010  Kd=2.36uM     // 3o4o.pdf (BC|A) ligand is Interleukin-1 beta; Interleukin-1 beta with IL1-RI, Kd=6.38nM, type II Kd=2.36uM
3onw  2.38  2010  Kd=2.3nM      // 3onw.pdf (A|C) G-alpha-i1 mutation: Q147L; Kd=1.9-2.6nM with GDP
2kwk   NMR  2010  Kd=2.3uM      // 2kwk.pdf (B|A)
3mjh  2.03  2010  Kd=2.4uM      // 3mjh.pdf (C|D) 34-mer C2H2 Zinc Finger of EEA1
3l95  2.19  2010  Kd=2.5nM      // 3l95.pdf (HL|Y) ligand is human Notch1 Negative Regulatory Region (NRR); Kd=2.5x10-9M
3mhp  1.70  2010  Kd=2.75uM     // 3mhp.pdf (A|C) FNR:Tic62 peptide, Kd=2.75+/-0.33uM
3a4s  2.70  2010  Kd=2.81uM     // 3a4s.pdf (B|C) Kd=2.81+/-0.81um
3hug  2.35  2010  Kd=20nM       // 3hug.pdf (I|J) ligand is RNA polymerase sigma factor of SigL; Zn2+ containing;  Kd=150nM(Zn2+ free Mycobacterium tuberculosis RslA to sigma SigL)
3nh7  2.70  2010  Kd=20nM       // 3nh7.pdf (IM|B) ligand is Bone morphogenetic protein receptor type-1A extracellular domain
3ncc  2.50  2010  Kd=3.6uM      // 3mzg.pdf (A|B) KD=3.6x10-6M, PH=7.0, Kd=0.212M ???
3kyi  2.80  2010  Kd=218uM      // 3kyi.pdf (A|B) ligand is CheY6 from R. sphaeroides; Kd=218+/-8uM
3aaa  2.20  2010  Kd=21nM       // 3aa0.pdf (A|B) Actin capping protein in complex with V-1 Myotrophin
2xdf   NMR  2010  Kd=21uM       // 2xdf.pdf (A|C) ligand is PHOSPHOCARRIER PROTEIN HPR; Kd=21+/-1.1uM
3o6b  3.10  2010  Kd=227nM      // 3o6b.pdf (G|H) ligand is Cell division control protein 53, WHB Subdomain; Kd=227+/-37nM
2wd5  2.70  2010  Kd=22nM       // 2wd5.pdf (A|B) SMC hinge heterodimer (Mouse)
3mzw  2.90  2010  Kd=22pM       // 3mzw.pdf (A|B) ligand is ZHER2 affibody molecule
3ouw  2.91  2010  Kd=23nM       // 3ouw.pdf (A|B) ligand is nonphosphorylated  Lymphoid enhancer-binding factor 1; Kd=23+/-3nM
2ktf   NMR  2010  Kd=23uM       // 2ktf.pdf (A|B) ligand is ubiquitin; Kd=23+/-0.9uM, ITC temperature is 10 degree
3aa6  1.90  2010  Kd=260nM      // 3aa0.pdf (AB|C) CP/CD23, Cp-binding motif derived from CD2AP
3l5x  1.90  2010  Kd=269pM      // 3l5w.pdf (HL|A) complex between IL-13 and H2L6 FAB, Kd=269+/-24pM
3kxf  3.10  2010  Kd=27uM       // 3kww.pdf (DE|ABQ) ligand is HLA-B*3508 (Q65A, T69A, Q155A); Kd=27uM for AAA mutant
3l89  3.50  2010  Kd=284nM      // 3l89.pdf (I|U) ligand is domains SCR1 and SCR2 of CD46 (membrane cofactor protein, MCP)
3nvq  2.40  2010  Kd=287nM      // 3nvn.pdf (A|B) ligand is Semaphorin-binding module of PlexinC1
3lhp  2.70  2010  Kd=28pM       // 3lh2.pdf (IM|T) ligand is HIV epitope-scaffold 4E10_D0_1ISEA_004_N (T93); SPR, mAb 4E10 fv in solution, Kd=28pM and Epitope-scaffold in solution Kd=7.5pM
3kj2  2.35  2010  Kd=2nM        // 3kj0.pdf (A|B) ligand is Bim BH3 mutant F4aE, Kd<2nM
3kj1  1.95  2010  Kd=2nM        // 3kj0.pdf (A|B) ligand is Bim BH3 mutant I2dA, Kd<2nM
3kj0  1.70  2010  Kd=2nM        // 3kj0.pdf (A|B) ligand is Bim BH3 mutant I2dY, Kd<2nM
2wvw  9.00  2010  Kd=2uM        // 2wvw.pdf (B|Q) ligand is RbcL
3npz  3.35  2010  Kd=3.15uM     // 3npz.pdf (A|B) ligand is Natural Hormone (PRL), wild type Kd=3.15+/-0.16uM, unit should beuM
3n06  2.00  2010  Kd=29nM       // 3mzg.pdf (A|B) KD=2.9+/-2x10-8M, PH=7.0, Kd=0.0031M ???
2l14   NMR  2010  Kd=3.1uM      // 2l14.pdf (A|B) N-terminally truncated peptides p53(13-61), Kd=3.1+/-0.2uM
2xra  2.30  2010  Kd=3.3nM      // 2xra.pdf (HL|A) ligand is TRANSMEMBRANE PROTEIN GP41 MIMETIC 5-HELIX; SPR Kd=3.3nM
3m9d  4.50  2010  Kd=3.4uM      // 3m91.pdf (K|P) Kd=3.4~4.2uM; Pup and Mpa 1-234 complex
3oiq  2.40  2010  Kd=3.8uM      // 3oiq.pdf (A|B) ligand is catalytic subunit of DNA polymerase alpha Pol1
2xgy  1.80  2010  Kd=30uM       // 2xgy.pdf (A|B) ligand is PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A, CYCLOPHILIN A
2xqr  2.58  2010  Kd=31nM       // 2xqr.pdf (E|F) ligand is protein inhibitor (CIF, or cellwall inhibitor of beta-fructosidase) from tobacco; Kd=31+/-10nM at PH4.5
3mv8  2.10  2010  Kd=34.66uM    // 3mv7.pdf (A|E) TK3 TCR with two chain, mutation at chain B Gln55His; with Beta-2-microglobulin and HPVG peptide, Kd= 34.66+/-1.66uM
2xa0  2.70  2010  Kd=35.3nM     // 2xa0.pdf (B|D) BCL-2 IN COMPLEX WITH A 31-mer BAX BH3 PEPTIDE, Kd=35.3+/-2.42nM
3oux  2.40  2010  Kd=35nM       // 3oux.pdf (A|B) ligand is Casein kinase II phosphorylated Lymphoid enhancer-binding factor 1; Kd=35+/-12nM
2wy8  1.70  2010  Kd=360nM      // 2wy7.pdf (A|Q) ligand is STAPHYLOCOCCUS AUREUS COMPLEMENT SUBVERSION PROTEIN SBI-IV; ITC Kd=360nM, IC50=10uM
3kw5  2.83  2010  Kd=385nM      // 3ifw.pdf (A|B) ligand is ubiquitin vinylmethylester
3jza  1.80  2010  Kd=3pM        // 3jza.pdf (A|B) ligand is GEF domain of DrrA/SidM from Legionella pneumophila(DrrA(340-533)), Kd=3pM(without GDP or GTP) , Kd=7uM(with GDP)
2xtj  2.70  2010  Kd=4.4nM      // 2xtj.pdf (DB|A) apparent equilibrium affinity constant KD=4.4+/-1.4nM
2x9a  2.47  2010  Kd=4.4uM      // 2x9a.pdf (C|D) ligand is C-TERMINAL DOMAIN OF TOLA; Kd=4.4uM for isolated N1, Kd=7.1uM for N1 within G3P
3lb6  3.05  2010  Kd=4.7pM      // 3lb6.pdf (A|C) ligand is Interleukin-13; Kd=4.7pM(measured by ITC); IL-13R alpha2 has sub-100fM affinity for IL-13 by SPR,
3mzg  2.10  2010  Kd=33nM       // 3mzg.pdf (A|B) KD=3.3+/-2x10-8M, PH=7.0, Kd=0.00497M ???
3ajb  2.50  2010  Kd=40.8nM     // 3ajb.pdf (A|B) ligand is Peroxisomal biogenesis factor 19 N-terminal peptide; Kd=40.8+/-1.6nM for pex19p N-terminal, full length pex19p is 3.4nM
3lbx  2.80  2010  Kd=400nM      // 3lbx.pdf (A|B) The overall structure of the alpha 0-1/beta 16-17 complex, Kd=400+/-100nM
3h7b  1.88  2010  Kd=41uM       // 3h7b.pdf (A|B) TCR-pMHC complex
2kwo   NMR  2010  Kd=46.9uM     // 2kwo.pdf (B|A) Supplementary information; ligand is Histone H4K16ac peptide; Kd=46.9+/-10.0uM; IC50=36.5+/-1.1uM.
2kri   NMR  2010  Kd=46uM       // 2kri.pdf (A|B) complex b2GPI-DV/LA4
3lh2  2.65  2010  Kd=47pM       // 3lh2.pdf (HL|S) ligand is HIV epitope-scaffold 4E10_1VI7A_S0_002_N (T88); SPR, mAb 4E10 fv in solution, Kd=47pM and Epitope-scaffold in solution Kd=5.6nM
3im4  2.29  2010  Kd=48nM       // 3im4.pdf (A|C)
3kr3  2.20  2010  Kd=49pM       // 3kr3.pdf (HL|D)
3aa0  1.70  2010  Kd=4uM        // 3aa0.pdf (AB|C) ligand is  peptide from Leucine-rich repeat-containing protein 16A(CA21), Kd=4000nM
3n0p  2.10  2010  Kd=53nM       // 3mzg.pdf (A|B) KD=5.3+/-2x10-8M, PH=7.0, Kd=0.0051M ???
3h9h  2.00  2010  Kd=5.4uM      // 3h9h.pdf (B|A) TCR-pMHC complex; Kd=5.4+/-0.1uM
3ol2  2.99  2010  Kd=5.5uM      // 3okw.pdf (A|B) human Sema4D-PlxnB1(1-2); Kd for monomerized Sema
3mv9  2.70  2010  Kd=5.76uM     // 3mv7.pdf (A|E) TK3 TCR with two chain, mutation at chain B Gln55Ala; with Beta-2-microglobulin and HPVG peptide, Kd= 5.76+/-0.07uM
2kvq   NMR  2010  Kd=50uM       // 2kvq.pdf (E|G) affinity for NusB:NusE:NusG-CTD
2kwu   NMR  2010  Kd=51uM       // 2kwu.pdf (A|B) Kd=51+/-13uM
2xqb  2.60  2010  Kd=52pM       // 2xqb.pdf (HL|A) ligand is human INTERLEUKIN 15
3l5w  2.00  2010  Kd=52pM       // 3l5w.pdf (HL|I) complex between IL-13 and C836 FAB, Kd=52+/-10pM
2kqs   NMR  2010  Kd=55.3uM     // 2kqs.pdf (A|B) Kd=55.3+/-14.2uM
3mj7  2.80  2010  Kd=5uM        // 3mj7.pdf (A|B) ligand is Coxsackie and Adenovirus receptor, CAR
2x2d  1.90  2010  Kd=6.1uM      // 2x2d.pdf (C|D) Kd=6.1+/-0.9uM; ligand is HIV-1 N-TERM CAPSID DOMAIN
3o9w  2.80  2010  Kd=6.2uM      // 3o8x.pdf (CD|A) with BbGL-2c ligand.TCR(Valpha14 chimera:Mouse variable domain, Human T-cell receptor alpha chain C region constant domain; Vbeta8.2 chimera:Mouse variable domain, Human T-cell receptor beta-2 chain C region constant domain )
2l0t   NMR  2010  Kd=64uM       // 2l0t.pdf (A|B) Kd=64+/-8uM(VHS/Ub, 0mM NaCl);Kd=54+/-6uM(Ub/VHS, 0mM NaCl);Kd=156+/-14uM(VHS/Ub, 100mM NaCl);Kd=166+/-12uM(Ub/VHS, 100mM NaCl);
2wy3  1.80  2010  Kd=66nM       // 2wy3.pdf (A|B) ligand is UNCHARACTERIZED PROTEIN UL16; MICBpf Kd=66nM, complete ectodomain Kd=67nM
3lb8  2.60  2010  Kd=66uM       // 3lb8.pdf (B|D) covalent putidaredoxin reductase-putidaredoxin complex, Determined by cyclic voltammetry
2kyg   NMR  2010  Kd=67nM       // 2kyg.pdf (B|C) ligand is cAMP-dependent protein kinase type II-alpha regulatory subunit
3me2  2.80  2010  Kd=68pM       // 3me2.pdf (A|R) ligand is Tumor necrosis factor ligand superfamily member 1; Kd=6.8x10-11M
3o8x  2.74  2010  Kd=690nM      // 3o8x.pdf (CD|A) with GalA-GSL ligand.TCR(Valpha14 chimera:Mouse variable domain, Human T-cell receptor alpha chain C region constant domain; Vbeta8.2 chimera:Mouse variable domain, Human T-cell receptor beta-2 chain C region constant domain )
3lk3  2.68  2010  Kd=6nM        // 3lk3.pdf (AB|T) ligand is CD2AP peptide
3ngb  2.68  2010  Kd=7.7nM      // 3ngb.pdf (HL|G) ligand is HIV-1 gp120; non-CD4-bound conformations Kd=7.7nM, CD4-bound Kd=0.617nM, see support info
3k2m  1.75  2010  Kd=7nM        // 3k2m.pdf (A|D) ligand is Monobody HA4, Kd for HA4 and Abl2 SH2 is 18nM
3egg  1.85  2010  Kd=8.7nM      // 3egg.pdf (B|D) ligand is PP1 binding and PDZ domains of Spinophilin
3o34  1.90  2010  Kd=8.8uM      // 3o34.pdf (A|B) ligand:H3(13-32)K23ac peptide; Kd=8.8+/-0.1uM; incomplete ligand structure
3kbt  2.75  2010  Kd=9.29nM     // 3kbt.pdf (A|D) wild type Kd=9.29nM
3gs2  1.70  2010  Kd=9.2nM      // 3gs2.pdf (A|B) ligand is Chromobox protein homolog 7, Cbox domain
3nvn  2.26  2010  Kd=9.4nM      // 3nvn.pdf (A|B) ligand is Semaphorin-binding module of PlexinC1
3orv  1.91  2010  Kd=9.4uM      // 3orv.pdf (A|CD) ligand is Methylamine utilization protein mauG Y294H mutant; Kd=9.4+/-0.1uM for quinone MADH and diferrous Y294H MauG
3ixa  2.10  2010  Kd=9.8uM      // 3ixa.pdf (A|B) TCR-pMHC complex; Kd=9.8+/-0.1uM
3ixs  1.70  2010  Kd=90nM       // 3gs2.pdf (C|D) ligand is RING1 and YY1-binding protein C-terminal domain
2kwv   NMR  2010  Kd=90uM       // 2kwu.pdf (A|B) Kd=90+/-14uM
3ncb  2.10  2010  Kd=1.36uM     // 3mzg.pdf (A|B) KD=1.36x10-6M, PH=7.0, Kd=0.093M ???
3k1r  2.30  2010  Kd~1nM        // 3k1r.pdf (A|B) ligand is SAM-PBM of Sans, for only SAM Kd=40uM, for only PBM Kd~1uM
3mac  2.50  2010  Kd~200nM      // 3ma9.pdf (HL|A) GP41-derived protein complexed with fab 8062, Kd~200nM
2wus  2.90  2010  Kd~5uM        // 2wus.pdf (B|S) Kd~5-10uM, temperature is 10 C
3lms  2.50  2010  Ki=1.2nM      // 3lms.pdf (A|B) ligand is tick-derived carboxypeptidase inhibitor(TCI), Ki=1.2nM
3l33  2.48  2010  Ki=136nM      // 3l33.pdf (C|G) Ki=1.36+/-0.19x10-7M, so Ki is 136nM, not 19nM
2xtt  0.93  2010  Ki=20pM       // 2xtt.pdf (A|B) liand is PROTEASE INHIBITOR SGPI-1; SGPI with bovine trypsin Ki in micromolar range, SGPI-1-P02 Ki is inpM range; binding data found in ref.20
3kz0  2.35  2010  Ki=273nM      // 3kz0.pdf (B|D) ligand is Mcl-1 specific peptide MB7; Ki=273+/-37nM
3ssb  1.80  2011  IC50=0.6nM    // 3ssb.pdf (A|CI)
2yj1  2.24  2011  IC50=26nM     // 2yj1.pdf (A|B) IC50=26+/-2nM
3qbr  2.60  2011  IC50=68nM     // 3qbr.pdf (A|B) ligand is Bcl-2 homologous antagonist/killer from Homo sapiens;  solution competition assays
3p8m  2.90  2011  Kd<0.007uM    // 2xqq.pdf (A|D)
3tnf  2.50  2011  Kd<0.01nM     // 3tnf.pdf (A|B) mGppNHp form
3zrz  1.70  2011  Kd=0.030nM    // 3zrz.pdf (B|D) complex Fn and SfbI-5; Kd=0.030+/-0.001nM
2xqw  2.30  2011  Kd=0.18uM     // 2xqw.pdf (A|C)
2ybr  2.55  2011  Kd=0.21nM     // 2ybr.pdf (GH|I) crystal space group P212121
3p71  2.70  2011  Kd=0.38uM     // 3p71.pdf (T|C) Ka=2.62+/-0.77uM-1; LCMT-1: Mutation: C19M, A21E, D22N, P115S; PP2A: Fragment: CATALYTIC SUBUNIT ALPHA ISOFORM;
3p11  3.70  2011  Kd=0.39nM     // 3p11.pdf (HL|A) see support information table S1, Kd=0.39+/-0.03nM for DL11f and HER3 ECD domain I-IV
3alz  4.51  2011  Kd=0.52uM     // 3alz.pdf (A|B) Kd=0.52+/-0.21uM
3au4  1.90  2011  Kd=0.53uM     // 3au4.pdf (A|B) Kd=0.53+/-0.06uM
3tac  2.20  2011  Kd=0.55uM     // 3tac.pdf (A|B) Kd=0.55+/-0.03uM by ITC
3ry6  3.80  2011  Kd=0.5mM      // 3ry6.pdf (B|C) Kd=0.5+/-0.02mM
3oed  3.16  2011  Kd=0.5uM      // 3oed.pdf (A|C) Kd=0.5+/-0.05uM, asymmetric unit
3ona  2.60  2011  Kd=0.68uM     // 3ona.pdf (A|B) Kd is the mean value of two measurements
3syn  3.06  2011  Kd=0.6uM      // 3syn.pdf (D|H)
2y8s  2.55  2011  Kd=0.989nM    // 2y8s.pdf (A|B) Kd=9.89x10-10M
3qbt  2.00  2011  Kd=0.9uM      // 3qbt.pdf (A|B) Kd=1.1uM (from kinetics), OCRL1 (539-901) was used to determine the kinetics, crystal is OCRL1 (540-678)
3n4i  1.56  2011  Kd=1.1nM      // 3n4i.pdf (A|B) Kd=1.1+/-0.2nM
3qhy  2.06  2011  Kd=1.1pM      // 3qhy.pdf (A|B) Stopped-flow Tryptophan Fluorescence Spectrometric Measurements
3rt0  2.11  2011  Kd=1.2uM      // 3rt0.pdf (A|C) in the absence of ABA
3r1g  2.80  2011  Kd=1.3nM      // 3r1g.pdf (HL|B)
3uc0  2.71  2011  Kd=1.3nM      // 3uaj.pdf (HL|A) Indirect ELISAs, PH=7.0, Kd=1.3nM
3noc  2.70  2011  Kd=1.5nM      // 3noc.pdf (B|D)
3o5t  2.09  2011  Kd=1.5uM      // 3o5t.pdf (A|B) Kd=1.5+/-0.1uM
3qq8  2.00  2011  Kd=1.5uM      // 3qq8.pdf (A|B) Kd=1.5+/-0.42uM by ITC
3p0y  1.80  2011  Kd=1.92nM     // 3p0y.pdf (HL|A) binding data found in Table S1, Kd=1.92+/-0.32nM for DL11f and EGFR ECD domain I-IV
3p6z  1.70  2011  Kd=1.95uM     // 3p6z.pdf (B|C) Kd1=1.95+/-0.05uM(SA-FPR-alpha-thrombin); Kd2=2.06+/-0.05uM(CM5-FPR-alpha-thrombin)
3sdc  3.10  2011  Kd=10.69uM    // 3scm.pdf (CD|A) ligand is Gb3; Kd=10.69+/-0.62uM
2kxw   NMR  2011  Kd=10nM       // 2kxw.pdf (A|B) fluorescence anisotropy, Kd<10nM
3qc8  2.20  2011  Kd=11.2uM     // 3qc8.pdf (A|B)
2xze  1.75  2011  Kd=113nM      // 2xze.pdf (B|R)
3qlu  2.91  2011  Kd=11nM       // 3qlu.pdf (A|C) GluR6 Delta 1/KA2 heterodimer, affinity is for GluR6 Delta 2/KA2
2xbb  2.68  2011  Kd=11uM       // 2xbb.pdf (B|D)
3rbb  2.35  2011  Kd=12.3nM     // 3rbb.pdf (C|D) Kd=12.3+/-2nM
2l2l   NMR  2011  Kd=12.4nM     // 2l2l.pdf (A|B)
3onl  2.20  2011  Kd=12uM       // 3onl.pdf (A|C)
3qib  2.70  2011  Kd=13.7uM     // 3qib.pdf (CD|ABP)
3oj2  2.20  2011  Kd=130nM      // 3oj2.pdf (B|D) Kd(FGFR2b WT), X-ray(FGFR2b A172F)
3ojm  2.10  2011  Kd=130nM      // 3oj2.pdf (A|B) Kd(FGFR2b WT), X-ray(FGFR2b P253R)
3qml  2.31  2011  Kd=13nM       // 3qfu.pdf (A|C)
2y8t  1.95  2011  Kd=14.2nM     // 2y8s.pdf (D|E) wild type, Kd=1.42x10-8M
2xpx  2.05  2011  Kd=150nM      // 2xpx.pdf (A|B) Kd=150+/-69nM
3zs9  2.10  2011  Kd=150nM      // 3zs8.pdf (B|C) Kd=150+/-20nM
3rgv  2.90  2011  Kd=15uM       // 3rgv.pdf (AB|CE) YAe62 recognized pWM presented by Kb
3t4a  3.40  2011  Kd=16.9uM     // 3t4a.pdf (AB|G)
3zwl  2.20  2011  Kd=160nM      // 3zwl.pdf (D|F)
3b08  1.70  2011  Kd=17.2uM     // 3b08.pdf (G|H) Kd=17.2+/-0.1uM
3qeq  2.59  2011  Kd=170uM      // 3qdg.pdf (DE|AC) for DMF4-nonamer/HLA-A2 complex, Kd=170+/-11uM
3rea  2.00  2011  Kd=179nM      // 3rea.pdf (A|B) Kd=179+/-29nM
3q9n  2.00  2011  Kd=17nM       // 3q9n.pdf (A|C) measured by yeast display in 10mM phosphate + 150mM NaCl +0.1% BSA
3sja  3.00  2011  Kd=17nM       // 3sja.pdf (B|D) Kd=17+/-2nM
3vh8  1.80  2011  Kd=17uM       // 3vh8.pdf (A|G) Kd=16.63+/-1.52uM
3sua  4.39  2011  Kd=18.9uM     // 3su8.pdf (A|D) Kd=18.9+/-0.8uM
3quy  2.25  2011  Kd=187nM      // 3qux.pdf (CD|A) ligand is BnNH-GSL-1', modify the complex type
3sdy  2.85  2011  Kd=1nM        // 3sdy.pdf (HL|AB)
3sip  3.50  2011  Kd=1uM        // 3sip.pdf (CD|E) drICE inhibition by BIR1, Three weak interfaces between BIR1 and drICE cooperate to yield a stable hetero-tetramer with a KD of approximately 1~2uM
3tn0  3.20  2011  Kd=2.20uM     // 3tn0.pdf (CD|A) ligand is Alpha-C-GalCer; Kd=2.20+/-0.73uM
2l9s   NMR  2011  Kd=2.2uM      // 2l9s.pdf (A|B)
3owt  2.00  2011  Kd=2.49uM     // 3owt.pdf (A|C) Kd=2.49+/-0.38uM by ITC
3sf4  2.60  2011  Kd=2.4nM      // 3sf4.pdf (A|D)
3rdz  2.26  2011  Kd=2.69nM     // 3rdz.pdf (A|C)
3sgk  2.40  2011  Kd=2.9nM      // 3sgj.pdf (A|C)
3uaj  3.23  2011  Kd=2.9nM      // 3uaj.pdf (HL|A) Indirect ELISAs, PH=5.5, Kd=2.9nM
3r4d  3.10  2011  Kd=21.4nM     // 3r4d.pdf (C|D)
3nog  3.34  2011  Kd=22.4nM     // 3noc.pdf (B|D)
3qbq  2.50  2011  Kd=230nM      // 3nzy.pdf (C|D) extracellular domains of mouse RANK-RANKL complex
3qux  2.91  2011  Kd=247nM      // 3qux.pdf (CD|A) ligand is alpha-C-GalCer, modify the complex type
2kt5   NMR  2011  Kd=28uM       // 2kt5.pdf (A|B) Kd=28+/-8.7uM
3r2x  3.10  2011  Kd=29nM       // 3r2x.pdf (AB|C)
3qdm  2.80  2011  Kd=29uM       // 3qdg.pdf (DE|AC) for DMF4-decamer/HLA-A2 complex, Kd=29+/-4uM
2y9m  2.60  2011  Kd=2nM        // 2y9m.pdf (A|B) Kd=2+/-0.08nM
3scm  2.50  2011  Kd=3.03uM     // 3scm.pdf (CD|A) ligand is iGb3; Kd=3.03+/-0.24uM
3aon  2.00  2011  Kd=3.2nM      // 3aon.pdf (A|B) structure is Eh-D and Eh-F; binding data is for Eh-A3B3D and Eh-F
3r9a  2.35  2011  Kd=3.5uM      // 3r9a.pdf (C|D) Kd=3.5uM for protein cargo
2xhe  2.80  2011  Kd=3.9nM      // 2xhe.pdf (A|B)
3t6g  2.50  2011  Kd=30nM       // 3t6a.pdf (A|B) support information figure S5-d, ITC Kd=30nM
3sjd  4.60  2011  Kd=31nM       // 3sjd.pdf (C|D) ADP state, bioassay use Get1-CD
3qiu  2.70  2011  Kd=321nM      // 3qib.pdf (CD|ABE)
3ru8  2.07  2011  Kd=33.5nM     // 3ru8.pdf (HL|X)
3oxu  2.10  2011  Kd=34uM       // 3oxu.pdf (A|D) Kd=34+/-1uM by SPR
3quz  2.30  2011  Kd=39.6nM     // 3qux.pdf (CD|A) ligand is NU-alpha-GalCer, modify the complex type
3t2n  2.55  2011  Kd=39.8nM     // 3t2n.pdf (IM|B) 
3q4f  5.50  2011  Kd=4.1uM      // 3q4f.pdf (B|H) Kd=4.1+/-0.2uM(Xrcc4 1-157);Kd=3.9+/-0.2uM(Xrcc4 1-203);
3rug  2.20  2011  Kd=4.4uM      // 3axl.pdf (GH|C) not a very strict binary complex, ternary complex
3r0l  1.35  2011  Kd=4.5nM      // 3r0l.pdf (AB|D) the more toxic class I isoforms are more stable (Kd=4.5nM)
3sdd  3.00  2011  Kd=4.84uM     // 3scm.pdf (CD|A) ligand is beta-LacCer; Kd=4.84+/-0.53uM
3q3g  2.70  2011  Kd=4.97nM     // 3q3g.pdf (BA|E) Fab 107 did not bind to low-affinity rWT, but for human hWT Kd=4.97+/-0.24nM
3qs7  4.30  2011  Kd=40nM       // 3qs7.pdf (D|H)
3qdj  2.30  2011  Kd=40uM       // 3qdg.pdf (DE|AC) for DMF5-nonamer/HLA-A2 complex, Kd=40+/-2uM
3r85  1.95  2011  Kd=41.3uM     // 3r85.pdf (C|G)
3pvm  4.30  2011  Kd=42nM       // 3prx.pdf (C|D)
2x89  2.16  2011  Kd=44nM       // 2x89.pdf (A|D)
3uai  3.06  2011  Kd=45nM       // 3uai.pdf (A|D) Gar1 and Nhp2 did not affect the binding affinity within experimental error, Kd=45+/-27nM
3sda  2.80  2011  Kd=5.24uM     // 3scm.pdf (CD|A) ligand is beta-GalCer; Kd=5.24+/-0.58uM
3q9u  2.30  2011  Kd=5.2nM      // 3q9n.pdf (A|C) measured by yeast display in 10mM phosphate + 150mM NaCl +0.1% BSA
3s5l  2.10  2011  Kd=5.3uM      // 3s4s.pdf (AB|G)
3o6f  2.80  2011  Kd=5.5uM      // 3o6f.pdf (CD|AB)
3qdg  2.69  2011  Kd=5.6uM      // 3qdg.pdf (DE|AC) for DMF5-decamer/HLA-A2 complex, Kd=5.6+/-1.5uM
3rkd  1.90  2011  Kd=5.89nM     // 3rkd.pdf (HL|A) Biacore ITC assay
3pbp  2.60  2011  Kd=50nM       // 3pbp.pdf (A|B) yeast heterotrimeric Nup82-Nup159-Nup116 nucleoporin complex, Kd=50+/-30nM in the presence of Nup159T
3s8v  3.10  2011  Kd=50nM       // 3s8v.pdf (A|X) Alpha Technology binding assay
3to4  3.10  2011  Kd=50nM       // 3to4.pdf (CD|A) Kd=50+/-10nM
3zs8  3.00  2011  Kd=51nM       // 3zs8.pdf (B|D) Kd=51+/-3nM
3rpg  2.65  2011  Kd=5uM        // 3rpg.pdf (BC|A) Kd=5+/-1uM
3t1q  2.70  2011  Kd=5uM        // 3t12.pdf (A|B) Kd=5+/-0.8uM
3uyo  1.83  2011  Kd=6.8uM      // 3uyo.pdf (A|D) Kd=6800+/-200nM
3rzw  2.15  2011  Kd=68nM       // 3rzw.pdf (B|C)
2y0b  2.10  2011  Kd=6nM        // 2xzd.pdf (AB|G)
3rdt  2.70  2011  Kd=6uM        // 3rdt.pdf (AB|CD)
3rgf  2.20  2011  Kd=7.05nM     // 3rgf.pdf (A|B) Kd=7.05+/-0.85nM
3zyi  2.60  2011  Kd=7.3nM      // 3zyi.pdf (A|B)
3zyj  3.25  2011  Kd=7.9nM      // 3zyi.pdf (A|B)
3sku  4.00  2011  Kd=70nM       // 3sku.pdf (A|D)
3s2k  2.80  2011  Kd=71.5nM     // 3s2k.pdf (B|C) Kd=71.5+/-12nM
3rzc  2.80  2011  Kd=718nM      // 3rzc.pdf (CD|A) Kd=718+/-14nM
3q1s  2.15  2011  Kd=73nM       // 3q1s.pdf (HL|I) Kd=73+/-8nM
2l1l   NMR  2011  Kd=7nM        // 2l1l.pdf (A|B) Phi0 PKI NES Peptide in Complex with CRM1-RanGTP, Kd=10uM with -RanGTP, and Kd=7nM with +RanGTP
3pp4  1.60  2011  Kd=7uM        // 3pp3.pdf (HL|P)
3s4s  2.40  2011  Kd=8.8uM      // 3s4s.pdf (AB|G)
2xns  3.41  2011  Kd=810nM      // 2xns.pdf (B|D) protein Fragment: RESIDUES 30-354 ; peptide Fragment:RESIDUES 497-517; GDP-containing; ternary complexes;
3skj  2.50  2011  Kd=810pM      // 3skj.pdf (IM|F) assay by ProteOn XPR36 instrument (Bio-Rad, Hercules, CA), Kd=810+/-296pM
3pmh  3.20  2011  Kd=81nM       // 3pmh.pdf (AB|G) Tyr276, 278, 279 to modified Tys; Kd=81+/-20nM; Fragment: unp residues 17-306; Mutation: C65A;
3qht  2.40  2011  Kd=82nM       // 3qht.pdf (A|C)
3qwo  1.90  2011  Kd=87nM       // 3qwo.pdf (AB|C)
3mj9  2.95  2011  Kd=8nM        // 3mj9.pdf (HL|A)
2ld7   NMR  2011  Kd=9.2nM      // 2ld7.pdf (A|B)
2xzd  2.10  2011  Kd=9.6nM      // 2xzd.pdf (AB|G)
3olm  2.50  2011  Kd=90.6uM     // 3olm.pdf (A|D) Kd=90.6+/-6.4uM by fluorescence anisotropy
3qsk  1.75  2011  Kd=91nM       // 3qsk.pdf (A|B)
3reb  3.45  2011  Kd=96nM       // 3reb.pdf (A|B) Kd=96+/-15nM
3opz  3.40  2011  Kd~0.72nM     // 3opz.pdf (JN|C) Kd~7.2x10-10M
2ygg  2.23  2011  Kd~20nM       // 2ygg.pdf (A|B) Kd~20nM(residue637-657);Kd~350nM(residue 657-700)
3t04  2.10  2011  Kd~52nM       // 3t04.pdf (A|D)
3ay4  2.20  2011  Kd~60nM       // 3ay4.pdf (A|C) Kd=6x10-8M by SPR; estimated Kd value
2y6t  2.74  2011  Ki<0.002nM    // 2y6t.pdf (C|G) binding data found in ref. 23
3u1j  1.80  2011  Ki=0.026uM    // 3u1i.pdf (B|E) Dengue virus protease covalently bound to aprotinin, a 58-amino-acid polypeptide
2y48  3.00  2011  Ki=0.21mM     // 2y48.pdf (AB|C) using a monomethyl-Lys4 H3-peptide as substrate, Ki=0.21+/-0.07mM, using a dimethylated substrate, Ki=0.22+/-0.09mM
3b23  2.40  2011  Ki=0.318nM    // 3b23.pdf (AB|C) Ki=0.318+/-0.02nM; IC50=8.25+/-0.45nM
4a1u  1.54  2011  Ki=0.54uM     // 4a1u.pdf (A|B) ligand is ALPHA-BETA-FOLDAMER 2C
3qtl  2.60  2011  Ki=1.43nM     // 3qtl.pdf (C|D)
3o40  2.10  2011  Ki=1.4nM      // 3o40.pdf (A|B) binding data by FP assay
3p95  1.30  2011  Ki=1.5uM      // 3p92.pdf (A|E) Ki=1.50+/-0.09uM
3pnr  2.60  2011  Ki=11.9nM     // 3pnr.pdf (A|B) Ki=11.9+/-4.7nM by fluorimetric protease assay
3zv0  2.80  2011  Ki=110uM      // 3zv0.pdf (A|C) Kd of hTERC-3'sl for SHQ1 is 75uM, and NAP57 competitive inhibition of SHQ1 with hTERC-3'sl is Ki=110uM
4a94  1.70  2011  Ki=4.9pM      // 4a94.pdf (B|C) Ki=4.9+/-0.6pM
3p92  1.60  2011  Ki=5.9nM      // 3p92.pdf (A|E) Ki=5.9+/-1.7nM
3nps  1.50  2011  Ki=70.4pM     // 3nps.pdf (BC|A) Apparent Ki values derived from IC50 value
3o43  2.80  2011  Ki=9nM        // 3o40.pdf (A|B) binding data by fluorescence polarization assay
4eah  3.40  2012  IC50=1.7nM    // 4eah.pdf (G|E)
3ujg  2.60  2012  IC50=1.7uM    // 3ujg.pdf (A|B) IC50=1.7+/-0.4uM; Inhibition of the interaction between H6GST-SnRK2.6 and biotin-HAB1 by SnRK2.6
4ers  2.64  2012  IC50=1.9nM    // 4ers.pdf (HL|A)
3v6o  1.95  2012  IC50=1nM      // 3v6o.pdf (DF|B) LBD-9F8 Fab complex
3v1c  1.13  2012  Kd<30nM       // 3v1c.pdf (A|B) symmetric homodimer in presence of Zinc; Kd<30nM(with zinc); Kd=4uM(with out zinc)
3ukx  2.20  2012  Kd=0.03nM     // 3ukw.pdf (B|C)
3ro2  2.30  2012  Kd=0.046uM    // 3ro2.pdf (A|B)
2lnh   NMR  2012  Kd=0.04uM     // 2lnh.pdf (AC|B)
4di3  3.05  2012  Kd=0.06uM     // 4di3.pdf (E|C) 2:1 complex of Treponema pallidum TatP(T) (Tp0957) bound to TatT (Tp0956)
3uzq  1.60  2012  Kd=0.082nM    // 3uyp.pdf (A|B)
2lxm   NMR  2012  Kd=0.08nM     // 2lxm.pdf (A|B)
4dke  3.00  2012  Kd=0.12nM     // 4dkd.pdf (HL|A) method:biolayer interferometry
4dck  2.20  2012  Kd=0.12uM     // 4dck.pdf (BC|A) binding data is for NaV1.5WT and FGF12B WT
4etq  2.10  2012  Kd=0.18nM     // 4ebq.pdf (AB|X)
3v6b  3.21  2012  Kd=0.28uM     // 3v6b.pdf (A|R) Kd=0.28uM for VEGF-A/VEGFR-2 D23 complex, not Kd=5.99uM for VEGF-A/VEGFR-2 ECD
4g6m  1.81  2012  Kd=0.29nM     // 4g5z.pdf (HL|A)
3tsr  2.20  2012  Kd=0.2fM      // 3tsr.pdf (D|H) Kd=2x10-16M
4eee  2.71  2012  Kd=0.2nM      // 4eee.pdf (C|D)
4b1v  1.75  2012  Kd=0.32uM     // 4b1v.pdf (B|N) G-actin in complex with RPEL-N; Kd=0.32+/-0.05uM
3thm  2.10  2012  Kd=0.35nM     // 3thm.pdf (HL|F)
4hkx  2.50  2012  Kd=0.36uM     // 4hk0.pdf (AB|E)
4etp  2.30  2012  Kd=0.37uM     // 4etp.pdf (A|B) Kd=0.37+/-0.07uM for ADP
4am0  3.02  2012  Kd=0.42nM     // 4al8.pdf (AB|S)
4g59  2.44  2012  Kd=0.42uM     // 4g59.pdf (A|C)
3uzv  2.10  2012  Kd=0.43nM     // 3uyp.pdf (A|B)
3tkl  2.18  2012  Kd=0.43uM     // 3sfv.pdf (A|B) GTP-bound
4al8  1.66  2012  Kd=0.45nM     // 4al8.pdf (HL|C)
4dgi  2.40  2012  Kd=0.45uM     // 4dgi.pdf (HL|A)
4ala  1.84  2012  Kd=0.47nM     // 4al8.pdf (HL|C)
4auo  3.00  2012  Kd=0.4uM      // 4auo.pdf (B|F) full length MMP-1 with collagen
4dbg  2.71  2012  Kd=0.52uM     // 4dbg.pdf (A|B) Kd=5.2x10-7M
3uz0  2.82  2012  Kd=0.56uM     // 3uz0.pdf (A|B) Ka=1.8x10-6M-1, that is, Kd=0.56uM
4dt1  1.90  2012  Kd=0.56uM     // 4dt1.pdf (A|B) Kd=0.56+/-0.04uM
3tei  2.40  2012  Kd=0.5uM      // 2xrw.pdf (A|B) ligand is pepRSK1; incomplete ligand
3u9d  2.50  2012  Kd=0.5uM      // 3sjh.pdf (A|B) Mg2+ and ATP containing
4ft4  2.70  2012  Kd=0.5uM      // 4fsx.pdf (A|P) Intermolecular interaction between the BAH domain of ZMET2 and H3(1 C32)K9me2 peptide
4apf  3.10  2012  Kd=0.65uM     // 4ap2.pdf (A|B)
4eef  2.70  2012  Kd=0.6nM      // 4eef.pdf (AB|G) ligand is F-HB80.4 (G12K, L17l, L21l, A35K, S42K mutants)
3twi  2.55  2012  Kd=0.6uM      // 3twi.pdf (C|F) binding data by biolayer interferometry
4f3f  2.65  2012  Kd=0.72nM     // 4f33.pdf (BA|C)
3ux9  2.80  2012  Kd=0.747nM    // 3ux9.pdf (C|D)
3vwj  3.09  2012  Kd=0.74uM     // 3vwj.pdf (CD|A) Kd=0.74+/-0.07uM
2luh   NMR  2012  Kd=0.7uM      // 2luh.pdf (A|B)
3vwk  2.94  2012  Kd=0.83uM     // 3vwj.pdf (CD|A) Kd=0.83+/-0.03uM
4aei  2.30  2012  Kd=0.8nM      // 4aeh.pdf (JN|C)
4afz  2.25  2012  Kd=0.9nM      // 4afq.pdf (A|C)
4fqi  1.71  2012  Kd=0.9nM      // 4fqh.pdf (HL|AB)
4fqj  2.50  2012  Kd=0.9nM      // 4fqh.pdf (HL|A)
4dra  2.41  2012  Kd=1.17uM     // 4dra.pdf (C|G)
4fqv  5.75  2012  Kd=1.1nM      // 4fqh.pdf (JN|D)
4ehq  1.90  2012  Kd=1.3uM      // 4ehq.pdf (A|G) Ca-containing; one CaM molecule binds two Orai1-CMBDs
3u9z  2.09  2012  Kd=1.54uM     // 3sjh.pdf (A|C) Mg2+ and ADP containing
3tq7  2.30  2012  Kd=1.5uM      // 3tq7.pdf (B|P)
4dm6  1.90  2012  Kd=1.5uM      // 4dm6.pdf (A|E) The SRC-1 NR2 peptide binds to RAR-beta LBD with a stoichiometry of 2 (2 NR2 peptides per homodimer) and a mean Kd of 1.5uM.Kd=1.5+/-0.1uM
4dm8  2.30  2012  Kd=1.5uM      // 4dm6.pdf (A|C) The SRC-1 NR2 peptide binds to RAR-beta LBD with a stoichiometry of 2 (2 NR2 peptides per homodimer) and a mean Kd of 1.5uM.Kd=1.5+/-0.1uM
4dxa  1.95  2012  Kd=1.8uM      // 4dxa.pdf (A|B) Kd measured in Pulldown Assay
3ve0  3.35  2012  Kd=1.94uM     // 3ve0.pdf (AB|IJ)
3qt2  2.55  2012  Kd=1.9nM      // 3qt2.pdf (A|C)
3vys  2.35  2012  Kd=1.9uM      // 3vyr.pdf (AB|C) HypC-HypD-HypE complex (form I); Kd=1.9+/-0.2uM
2lpb   NMR  2012  Kd=10.1uM     // 2ko4.pdf (A|B) Kd=10.1+/-1.4uM
4hcn  2.60  2012  Kd=106.7uM    // 4hcn.pdf (A|B)
3ul4  1.95  2012  Kd=11.4nM     // 3ul4.pdf (A|B) Ka=8.77E7+/-1.31E7M-1
4gg6  3.20  2012  Kd=11.4uM     // 4gg6.pdf (GH|ABJ) Kd=11.4+/-0.6uM
3zuv  2.72  2012  Kd=117nM      // 3zu7.pdf (C|D)
3vfr  1.85  2012  Kd=119.0uM    // 3vfm.pdf (AC|B) Kd=119.0+/-1.0uM
2lvo   NMR  2012  Kd=12.8uM     // 2lvo.pdf (A|C)
2lkm   NMR  2012  Kd=12nM       // 2lkm.pdf (A|B)
4fzv  2.00  2012  Kd=13.3nM     // 4fzv.pdf (A|B) Kd=13.3+/-0.4nM
2lvp   NMR  2012  Kd=13.4uM     // 2lvo.pdf (A|C)
4auq  2.18  2012  Kd=136uM      // 4auq.pdf (AB|C)
3vyr  2.55  2012  Kd=140nM      // 3vyr.pdf (A|B) HypC-HypD complex; Kd=140+/-20nM
2l29   NMR  2012  Kd=15.3nM     // 2l29.pdf (A|B)
3rtq  2.80  2012  Kd=150nM      // 3rtq.pdf (CD|A)
3zwh  1.94  2012  Kd=1540nM     // 3zwh.pdf (A|Q)
4drx  2.22  2012  Kd=155nM      // 4drx.pdf (B|F) Kd=155+/-10nM, Mg-containing
4f9p  3.52  2012  Kd=15nM       // 4f9l.pdf (B|D)
3vhx  2.81  2012  Kd=15uM       // 3vhx.pdf (C|D) complex Arf6-MKLP1
3sri  1.60  2012  Kd=165nM      // 3sri.pdf (A|B)
3p9w  2.41  2012  Kd=16nM       // 3p9w.pdf (E|F)
3u82  3.16  2012  Kd=17.1nM     // 3u82.pdf (A|B)
4ei5  3.10  2012  Kd=17.6uM     // 4ei5.pdf (CD|A) Kd=17.6+/-0.7uM, incomplete ligand structure
3v4y  2.10  2012  Kd=17.8nM     // 3v4y.pdf (A|B) structure is NIPP1(158-216):PP1a(7-307); binding data is for NIPP1(1-225) and PP1a(7-330)
4g6u  2.35  2012  Kd=17.8nM     // 4g6u.pdf (A|B)
3tje  1.93  2012  Kd=17nM       // 3thm.pdf (HL|F)
4g6f  2.10  2012  Kd=17nM       // 4g6f.pdf (BD|F)
4g8a  2.40  2012  Kd=186pM      // 4g8a.pdf (B|D) X-ray(human TLR4(Asp299Gly/Thr399Ile)/MD-2/LPS), Kd(TLR4(D229G/T399I)/MD-2/endotoxin-CD14 comlpex)
3vfn  1.50  2012  Kd=188uM      // 3vfm.pdf (AC|B) Kd=188+/-11.0uM
4ffy  2.50  2012  Kd=18nM       // 4ffy.pdf (HL|A)
2lox   NMR  2012  Kd=190nM      // 2lox.pdf (A|B)
4h6j  1.52  2012  Kd=190nM      // 4h6j.pdf (A|B) Kd=190nM(temperature is 20 degree);Kd=125nM(10 degrees centigrade)
3t0y  2.10  2012  Kd=193nM      // 3t0y.pdf (C|D)
3u43  1.72  2012  Kd=1fM        // 3u43.pdf (A|B)
4f6r  2.64  2012  Kd=1nM        // 4f61.pdf (AB|C) Mg-containing
3tjz  2.90  2012  Kd=1uM        // 3tjz.pdf (A|B) Kd(H. sapiens Arf1), X-ray(Saccharomyces cerevisiae S288c)
4eoz  2.40  2012  Kd=1uM        // 4eoz.pdf (C|D)
4giq  2.70  2012  Kd=2.09uM     // 4giq.pdf (A|R) Scatchard analysis
4fqy  5.25  2012  Kd=2.2nM      // 4fqh.pdf (HL|AB)
3ul0  2.00  2012  Kd=2.3nM      // 3ukw.pdf (B|C)
4b93  2.00  2012  Kd=2.3uM      // 4b93.pdf (A|B)
4eo5  2.35  2012  Kd=2.42nM     // 4eo5.pdf (BC|A) fluorescence quenching
4eqa  1.60  2012  Kd=2.42nM     // 4eqa.pdf (A|C)
4b0m  1.80  2012  Kd=2.42uM     // 4ayf.pdf (BM|A)
3ukz  2.30  2012  Kd=2.4nM      // 3ukw.pdf (B|C)
4afq  1.51  2012  Kd=2.4nM      // 4afq.pdf (A|C)
4aqe  2.27  2012  Kd=2.4uM      // 4apx.pdf (A|B)
3uez  3.41  2012  Kd=2.5pM      // 3uez.pdf (B|G) Using displacement ITC, titrate BARF1 into an established hCSF-1 RD1-D5 and hCSF-1 complex
4en3  2.57  2012  Kd=2.5uM      // 4en3.pdf (AB|C)
3vpj  2.50  2012  Kd=2.77nM     // 3vpj.pdf (A|E)
3ul1  1.90  2012  Kd=2.7nM      // 3ukw.pdf (B|A)
3ula  3.60  2012  Kd=2.84nM     // 3ul7.pdf (A|D) complex of MD2 and F63W; Kd=2.84+/-1.66nM
4f38  2.80  2012  Kd=2.9nM      // 4f38.pdf (A|B) Kd=2.9+/-0.65nM
2lqc   NMR  2012  Kd=2.9uM      // 2lqc.pdf (A|B)
4apx  1.65  2012  Kd=2.9uM      // 4apx.pdf (A|B)
3zwz  2.10  2012  Kd=20.3nM     // 3sri.pdf (A|B)
3vfv  1.55  2012  Kd=20.9uM     // 3vfm.pdf (AC|B) Kd=20.9+/-0.4uM
4ap2  2.80  2012  Kd=20nM       // 4ap2.pdf (A|B)
4gms  2.95  2012  Kd=20nM       // 4gms.pdf (HL|A) Kd value measured by bio-layer interferometry
4g6v  2.64  2012  Kd=21.1nM     // 4g6u.pdf (A|B)
4fao  3.36  2012  Kd=21.64pM    // 4fao.pdf (B|F) ALK1-ECD/BMP9/ActRIIB-ECD ternary structure, BMP9 binds to both ALK1-ECD and ActRIIB-ECD, Kd=45.22pM for ALK1
2lp0   NMR  2012  Kd=22.2uM     // 2lp0.pdf (A|B)
2lvq   NMR  2012  Kd=22.6uM     // 2lvo.pdf (B|D)
4dn4  2.80  2012  Kd=22pM       // 4dn3.pdf (HL|M)
3uts  2.71  2012  Kd=278uM      // 3utp.pdf (DE|AC) complex 1E6-ALW; monoclinic crystal; Kd=278+/-7.6uM(25 degree); Kd=274.5+/-14uM(5 degree); Kd=335+/-44uM(37 degree)
3qwr  3.25  2012  Kd=2nM        // 3qwq.pdf (AB|D)
3qwq  2.75  2012  Kd=2nM        // 3qwq.pdf (A|B)
4ayi  2.31  2012  Kd=2nM        // 4ayd.pdf (A|D)
2ypl  2.40  2012  Kd=3.0uM      // 2ypk.pdf (DE|A)
4dkf  2.61  2012  Kd=3.1nM      // 4dkd.pdf (IM|B) binding data by biolayer interferometry
4etw  2.05  2012  Kd=3.1uM      // 4etw.pdf (C|D)
4f48  3.00  2012  Kd=3.2uM      // 4f48.pdf (A|B) 
2leh   NMR  2012  Kd=3.3nM      // 2leh.pdf (A|B) Kd value measured in PBS
3u8x  2.00  2012  Kd=3.4uM      // 3sjh.pdf (C|D) Mg2+ and ATP containing
3sjh  1.75  2012  Kd=3.4uM      // 3sjh.pdf (A|B) Mg2+, ATP and Lat.A containing
3tl8  2.50  2012  Kd=3.5uM      // 3tl8.pdf (D|F)
4e05  2.30  2012  Kd=3.65nM     // 4e05.pdf (HL|I) code 4e05 is high-resolution dataset, 4e06 is low-resolution dataset
4d9q  2.28  2012  Kd=30pM       // 4d9q.pdf (HL|A) Kd(cynomolgus)=30pM;Kd(human)=4.0pM
3sjv  3.10  2012  Kd=31uM       // 3sjv.pdf (DE|AC)
4dh2  1.75  2012  Kd=32.6nM     // 3ul4.pdf (A|B) Ka=3.07E7+/-3.57E6
4aye  2.80  2012  Kd=3330nM     // 4ayd.pdf (A|D)
2ly4   NMR  2012  Kd=346nM      // 2ly4.pdf (A|B)
4h1l  3.30  2012  Kd=38.3uM     // 4h1l.pdf (ABC|IJ) Kd=38.3uM+/-2.9uM; ANI2.3 TCR with DR52c-pHIR
4dge  2.20  2012  Kd=38.5uM     // 4dgb.pdf (B|D) Kd=38.5uM in the presence of DTT, Kd=47.8uM in the absence of DTT
4d9r  2.42  2012  Kd=4.0pM      // 4d9q.pdf (ED|B) Kd(cynomolgus)=30pM; Kd(human)=4.0pM
4g6j  2.03  2012  Kd=4.1nM      // 4g5z.pdf (HL|A)
3uyp  2.00  2012  Kd=4.1uM      // 3uyp.pdf (A|B)
2y5b  2.70  2012  Kd=4.2uM      // 2y5b.pdf (E|F)
3vg9  2.70  2012  Kd=4.4nM      // 3vg9.pdf (CB|A) complex A2AAR and Fab 2838(resolution=2.7)
4day  3.30  2012  Kd=4.5nM      // 4day.pdf (AB|C)
4ffz  3.80  2012  Kd=416nM      // 4ffy.pdf (HL|A)
4a49  2.21  2012  Kd=42uM       // 2y1n.pdf (A|B) Kd=42+/-2uM
3vfw  2.30  2012  Kd=44.5uM     // 3vfm.pdf (AC|B) Kd=44.5+/-1.5uM
3qi2  2.80  2012  Kd=45nM       // 3qe0.pdf (A|C) ligand is Regulator of G-protein signaling 14; GDP containing; Kd=45+/-7nM
3qbv  2.65  2012  Kd=478nM      // 3qbv.pdf (C|D) Kd=478+/-22nM
4hkj  3.00  2012  Kd=480nM      // 4hkj.pdf (AB|D)
2lp4   NMR  2012  Kd=4mM        // 2lp4.pdf (A|Y) cheY-P2 Kd=2uM, cheA P1-cheY Kd=5mM, cheA P1-cheY/P2 Kd=4mM
2lnk   NMR  2012  Kd=4nM        // 2lnk.pdf (C|B)
2lfw   NMR  2012  Kd=5.6nM      // 2lfw.pdf (A|B)
4gh7  2.60  2012  Kd=5.77nM     // 4gh7.pdf (A|B)
4elm  3.48  2012  Kd=5.98uM     // 4elk.pdf (GH|A) Kd=5.98+/-4.73uM
4exp  2.80  2012  Kd=500nM      // 4exp.pdf (A|X) Kd for (D1-D5) domains is 1.3nM
3tvm  2.80  2012  Kd=51.9nM     // 3tvm.pdf (GH|E) Kd=51.9+/-6.6nM
3tu3  1.92  2012  Kd=57nM       // 3tu3.pdf (A|B) ExoU was titrated with SpcU
3oun  2.71  2012  Kd=58nM       // 3oun.pdf (A|B) Kd=58+/-2nM
4a1s  2.10  2012  Kd=5nM        // 4a1s.pdf (A|C)
3sqo  2.70  2012  Kd=5pM        // 3sqo.pdf (HL|A)
4ag2  1.80  2012  Kd=6.2nM      // 4afq.pdf (B|D)
4gxu  3.29  2012  Kd=6.2nM      // 4gxu.pdf (OP|C) Kd value measured using anti-Penta-HIS tips
3zu7  1.97  2012  Kd=6.6nM      // 3zu7.pdf (A|B)
4f9l  3.14  2012  Kd=66nM       // 4f9l.pdf (A|D)
4doh  2.80  2012  Kd=687nM      // 4doh.pdf (BR|A)
4did  2.35  2012  Kd=6uM        // 4did.pdf (A|B) Protein 2 Source: Salmonella enterica subsp. enterica serovar Typhimurium; Kd=6+/-2uM; Mg-containing
4ds8  2.21  2012  Kd=7.7uM      // 3oji.pdf (A|B) in the presence of (+)-ABA
4dtg  1.80  2012  Kd=73pM       // 4dtg.pdf (HL|K) Kd=73+/-13pM
3v62  2.90  2012  Kd=79nM       // 3v62.pdf (AB|C) Kd=79+/-18nM for SUMO-K164-PCNA-mono, Kd=26.3+/-3.1nM for SUMO-K164-PCNA-tri, Kd=25.1+/-4.9nM for SUMO-K127-PCNA-tri
3vfp  1.85  2012  Kd=81.7uM     // 3vfm.pdf (AC|B) Kd=81.7+/-3.0uM
4ayd  2.40  2012  Kd=820nM      // 4ayd.pdf (A|D)
2lqh   NMR  2012  Kd=85uM       // 2lqh.pdf (A|B)
3vfm  1.90  2012  Kd=89.8uM     // 3vfm.pdf (AC|B) Kd=89.8+/-5.3uM
3uze  2.04  2012  Kd=8nM        // 3uyp.pdf (A|C)
4hcp  2.52  2012  Kd=9.4uM      // 4hcp.pdf (A|B)
4dkd  3.00  2012  Kd=94nM       // 4dkd.pdf (A|C) Kd=120nM by BLI assay
4dj9  2.25  2012  Kd=98nM       // 4dj9.pdf (A|B) Kd is the mean value of two independent measurements
3ukw  2.10  2012  Kd~0.11nM     // 3ukw.pdf (B|C) estimated Kd value
4f0a  3.25  2012  Kd~2.4uM      // 4f0a.pdf (A|B)
4dcn  3.01  2012  Kd~3.3uM      // 4dcn.pdf (A|C) Mg-containing
4dvg  2.60  2012  Kd~3uM        // 4dvg.pdf (A|B) Mg-containing
4dzu  2.10  2012  Ki<0.2nM      // 4dzu.pdf (A|B) Ki<0.2nM by FP binding assay
3uir  2.78  2012  Ki=0.436nM    // 3uir.pdf (B|D)
4gi3  1.75  2012  Ki=0.68nM     // 4gi3.pdf (A|C) 
3tg1  2.71  2012  Ki=1.01uM     // 3tg1.pdf (A|B) Ki=1.01+/-0.01uM
3v96  1.90  2012  Ki=1.1nM      // 3v96.pdf (A|B)
4dzv  2.10  2012  Ki=11nM       // 4dzu.pdf (A|B) binding data by FP assay
4dg4  1.40  2012  Ki=2.7uM      // 4dg4.pdf (B|C) equilibrium inhibition constants (Ki) using classic competitive inhibition experiments
4an7  2.23  2012  Ki=3.2nM      // 4an7.pdf (A|B)
2yq7  1.90  2012  Ki=35nM       // 2yq6.pdf (A|B) ligand is BimLOCK; Ki=35+/-3.7nM
3so3  2.10  2012  Ki=392pM      // 3so3.pdf (CB|A) KI is calculated from the IC50 value
4g35  2.00  2012  Ki=54nM       // 4g35.pdf (A|B) Ki=54+/-14nM
3tvj  1.28  2012  Ki=6nM        // 3tvj.pdf (AB|I)
4hx3  2.70  2012  Ki=6nM        // 4hx3.pdf (G|H)
4djz  3.20  2012  Ki=7nM        // 3tvj.pdf (B|H) Protease inhibitor SGPI-2 in PDB structure, while Protease inhibitor SGPI-1 is refered in paper
3w9e  2.30  2013  IC50=3.6nM    // 3w9e.pdf (AB|C)
4kvn  3.10  2013  IC50=3nM      // 4kvn.pdf (HL|A)
4ksd  4.10  2013  IC50=520nM    // 4ksd.pdf (A|B) Nb592 is a strong inhibitor of ATP hydrolysis for P-glycoprotein
4i77  1.90  2013  Kd<0.01nM     // 4i77.pdf (HL|Z) Biacore-derived Kd for IL-13 binding to wt lebrikizumab is lower than the detection limit, 10pM
4k2u  2.45  2013  Kd=0.0153nM   // 4k2u.pdf (HL|A)
2ypv  1.80  2013  Kd=0.03nM     // 2ypv.pdf (HL|A)
3wd5  3.10  2013  Kd=0.115nM    // 3wd5.pdf (HL|A) Kd=1.152+/-0.172x10-10M
3v6z  3.34  2013  Kd=0.12uM     // 3v6f.pdf (AB|F) PDB code of HBeAg-e6 Fab complex in paper should be 3V6Z.
3tz1  1.80  2013  Kd=0.141uM    // 3tz1.pdf (A|B) ITC Ka=7.1x10 E6 M-1, Kd=0.141uM, TnI L was titrated by asTnC C
3w8h  2.43  2013  Kd=0.164uM    // 3w8h.pdf (A|B)
4k0a  2.13  2013  Kd=0.18nM     // 4jzw.pdf (A|R) Kd=0.18+/-0.03nM
4kbb  2.30  2013  Kd=0.18uM     // 4kbb.pdf (B|D) Kd=0.14+/-0.05uM(without GD1a),Kd=0.18+/-0.06uM(with GD1a)
4hgk  3.04  2013  Kd=0.19nM     // 4hgk.pdf (B|C)
4gn4  1.86  2013  Kd=0.253uM    // 4gla.pdf (B|A)
4bpx  3.40  2013  Kd=0.25uM     // 4bpu.pdf (C|D)
4c4p  2.00  2013  Kd=0.25uM     // 4c4p.pdf (A|B) Kd=0.25+/-0.05uM
4hff  2.40  2013  Kd=0.269nM    // 4hff.pdf (A|B) The crystal structure is Tae4-Tai4 complexes from Salmonella Typhimurium
4hfk  2.10  2013  Kd=0.269nM    // 4hff.pdf (A|B) The crystal structure is Tae4-Tai4 complexes from Enterobacter cloacae
4kt3  1.44  2013  Kd=0.26nM     // 4kt3.pdf (A|B)
4b1y  1.29  2013  Kd=0.27uM     // 4b1u.pdf (B|M) this is a prot-prot complex, ligand is not ATP
3zet  2.31  2013  Kd=0.29uM     // 3zet.pdf (A|B) Kd=0.29+/-0.1uM
3zeu  1.65  2013  Kd=0.29uM     // 3zet.pdf (D|E) bound to ATPgammaS;Kd=0.29+/-0.1uM
4l67  2.80  2013  Kd=0.32uM     // 4l67.pdf (A|B)
4hdo  1.67  2013  Kd=0.36uM     // 4hdo.pdf (A|B) Kd=0.36+/-0.11uM
4iyp  2.80  2013  Kd=0.3uM      // 4iyp.pdf (A|C)
4kp3  2.40  2013  Kd=0.3uM      // 4kp3.pdf (A|C) MLPH-GTBD and RILP2-RH1 bind to MyoVa-GTD with different interaction modes
4ic7  2.60  2013  Kd=0.43uM     // 4ic7.pdf (A|B) Kd=0.43+/-0.06uM
3w2d  3.10  2013  Kd=0.5787nM   // 3w2d.pdf (HL|A)
4bqd  2.45  2013  Kd=0.5nM      // 4bqd.pdf (A|C)
4leo  2.64  2013  Kd=0.5nM      // 4leo.pdf (AB|C)
4awx  2.30  2013  Kd=0.5uM      // 4awx.pdf (A|B)
4k94  2.40  2013  Kd=0.63nM     // 4k94.pdf (HL|C)
4iop  3.20  2013  Kd=0.67nM     // 4iop.pdf (A|B)
4gur  2.51  2013  Kd=0.68uM     // 4gur.pdf (AB|C) Kd=0.68+/-0.07uM(H3K4M bind to LSD2 and WT NPAC);Kd=0.92+/-0.08uM(WT NPAC bind to LSD2,Supplementary Table S3.)
4bfi  3.22  2013  Kd=0.6uM      // 4bfe.pdf (A|B)
4gu0  3.10  2013  Kd=0.741uM    // 4gu0.pdf (A|E)
4fq0  2.82  2013  Kd=0.87uM     // 4fq0.pdf (A|D)
4lmq  2.77  2013  Kd=0.923nM    // 4lmq.pdf (HL|D) chains for antibody FAB on RCSB website should be wrong, assay by Biolayer Interferometry
4hdq  1.95  2013  Kd=0.96uM     // 4hdo.pdf (AB|C) Kd=0.96+/-0.14uM
4mhh  3.56  2013  Kd=0.9nM      // 4mhh.pdf (JK|A) determined by biolayer interferometry
4c5g  2.10  2013  Kd=1.03uM     // 4c5e.pdf (A|B) P6122 space group
4g9f  1.90  2013  Kd=1.10uM     // 4g8g.pdf (DE|A) Kd=1.10+/-0.05uM
4kt5  2.70  2013  Kd=1.1uM      // 4kt5.pdf (A|C)
2ma9   NMR  2013  Kd=1.225uM    // 2ma9.pdf (BC|A)
4dx8  2.54  2013  Kd=1.24uM     // 4dx8.pdf (E|K) Kd=1.24+/-0.03uM
4j32  1.80  2013  Kd=1.28nM     // 4j30.pdf (A|B) Kd=1.28+/-3.29nM
3zkq  1.51  2013  Kd=1.2nM      // 3zkg.pdf (A|D)
4k3j  2.80  2013  Kd=1.2nM      // 4k3j.pdf (HL|B)
4i2x  2.48  2013  Kd=1.2uM      // 4i2x.pdf (BA|E) equilibrium ultracentrifugation, Kd=1.2+/-0.3uM
4hh3  1.75  2013  Kd=1.3uM      // 4hh3.pdf (A|C) microscale thermophoresis, MST assay
4jeu  3.20  2013  Kd=1.4nM      // 4jeh.pdf (A|B)
4jo6  1.75  2013  Kd=1.53nM     // 4jo6.pdf (B|Z)
4gko  3.30  2013  Kd=1.5mM      // 4gko.pdf (A|G)
3vxu  2.70  2013  Kd=1.6uM      // 3vxm.pdf (DE|AC) Kd=1.6+/-0.3uM
4h2w  1.95  2013  Kd=1.73uM     // 4h2s.pdf (A|D)
4idj  3.36  2013  Kd=1.7pM      // 4idj.pdf (HL|A) determined via the kinetic exclusion assay (KinExA)
4gaf  2.15  2013  Kd=1.8pM      // 4gaf.pdf (A|B) indirect SPR combined with competition assay
4hsa  3.15  2013  Kd=1.9nM      // 4hsa.pdf (B|C)
3vep  2.50  2013  Kd=10.3uM     // 3vep.pdf (J|H)
4asw   NMR  2013  Kd=100nM      // 4asw.pdf (B|C) One Get5_UBL interacts with each Sgt2_NT dimer.
2m04   NMR  2013  Kd=10nM       // 2m04.pdf (A|B) Results of analytical ultracentrifugation equilibrium experiment, Kd=10-30nM
4hem  1.65  2013  Kd=10nM       // 4hem.pdf (B|E)
4imy  2.94  2013  Kd=10nM       // 4imy.pdf (B|G) Kd=10+/-1nM
2m49   NMR  2013  Kd=10uM       // 2m49.pdf (C|D)
4geh  1.95  2013  Kd=11.7nM     // 4geh.pdf (C|D)
4i3r  3.00  2013  Kd=11.9nM     // 4i3r.pdf (HL|G) Kd=11.9+/-0.1nM(SPR);Kd=36.8nM(biolayer interferometry) space group P3221
4c99  2.80  2013  Kd=114nM      // 4c99.pdf (A|B) crystal form I
4h5s  1.70  2013  Kd=12.5uM     // 4h5s.pdf (A|B)
4may  2.20  2013  Kd=124uM      // 4grl.pdf (CD|AB)
2m0j   NMR  2013  Kd=12nM       // 2m0j.pdf (A|B) Kd=12+/-4nM
4jeg  2.30  2013  Kd=12nM       // 4je4.pdf (A|B)
2lz6   NMR  2013  Kd=12uM       // 2lz6.pdf (A|B)
4llo  2.00  2013  Kd=13.2uM     // 4llo.pdf (E|F) 
4jw3  2.60  2013  Kd=1450nM     // 4jw2.pdf (B|D)
4je4  2.31  2013  Kd=14nM       // 4je4.pdf (A|B)
4jzw  1.78  2013  Kd=15.4pM     // 4jzw.pdf (G|M) Kd=15.4+/-0.8pM; in P212121 space group
4hix  2.20  2013  Kd=151nM      // 4hix.pdf (HL|A) Microscale Thermophoresis (MST) to measure the affinity
4kgg  2.78  2013  Kd=153nM      // 4j6g.pdf (D|A) Kd=153+/-54nM by SPR
4grl  2.86  2013  Kd=154uM      // 4grl.pdf (CD|AB)
4j6g  2.40  2013  Kd=16.3nM     // 4j6g.pdf (B|D) Kd=16.3+/-0.3nM by SPR
4kr0  2.70  2013  Kd=16.7nM     // 4kr0.pdf (A|B) complex of RBD-CD26
4hjj  2.10  2013  Kd=160pM      // 4hjj.pdf (HL|A)
4krp  2.82  2013  Kd=166nM      // 4krl.pdf (DC|A) ternary complex of 9G8:FabC225:sEGFR, affinity is for 9G8:sEGFR complex
4hgm  2.34  2013  Kd=16nM       // 4hgk.pdf (A|B)
3znz  1.90  2013  Kd=196nM      // 3znz.pdf (A|B)
4ios  2.40  2013  Kd=19nM       // 4hem.pdf (C|F)
4eig  2.50  2013  Kd=1nM        // 4eig.pdf (A|B)
4hrl  2.55  2013  Kd=1nM        // 4hrl.pdf (C|A)
4mhj  6.98  2013  Kd=1nM        // 4mhh.pdf (TX|M) binding data determined by biolayer interferometry
3w8i  2.40  2013  Kd=2.15nM     // 3w8h.pdf (A|B)
4nm8  4.00  2013  Kd=2.5nM      // 4nm4.pdf (NJ|F) binding data determined by biolayer interferometry
2m86   NMR  2013  Kd=2.6nM      // 2m86.pdf (A|B)
4glv  2.57  2013  Kd=2.92nM     // 4gla.pdf (A|B)
4h88  1.90  2013  Kd=2.9nM      // 4h88.pdf (HL|A)
4iu3  1.97  2013  Kd=20.83nM    // 4iu2.pdf (A|B) SeMet derivative of the type IIIe RfCohE-XDoc complex
4bru  3.24  2013  Kd=200nM      // 4bru.pdf (A|B)
4aoq  2.00  2013  Kd=201.8nM    // 4aoq.pdf (C|F) Kd=60.9+/-8.4nM(for SOTI-III);Kd=201.8+/-27.7nM(for F14A variant)
4i6l  2.49  2013  Kd=20nM       // 4i6l.pdf (A|B) Kd=20nM, not 20pM
4jan  3.15  2013  Kd=20nM       // 4jam.pdf (HL|G)
4hmy  7.00  2013  Kd=20uM       // 4hmy.pdf (B|C) Kd=20+/-0.6uM
4h2s  2.15  2013  Kd=21.5uM     // 4h2s.pdf (B|D)
4ekc  7.40  2013  Kd=22nM       // 4ekc.pdf (C|D) Kd=22+/-9nM, IC50=0.27+/-0.06uM
4ekd  2.71  2013  Kd=22nM       // 4ekc.pdf (A|B) Kd=22+/-9nM, IC50=0.27+/-0.06uM
4hj0  3.00  2013  Kd=23nM       // 4hj0.pdf (PQ|A)
4jry  2.80  2013  Kd=25uM       // 4jrx.pdf (ABC|DE) SB47 TCR with the HLA-B*35:08LPEP
4kro  3.05  2013  Kd=276nM      // 4krl.pdf (DC|A) ternary complex of EgA1:FabC225:sEGFR, affinity is for EgA1:sEGFR complex
4bq6  2.30  2013  Kd=27nM       // 4bq6.pdf (A|D) Kd=27+/-2nM; crystal form I
3wa5  1.90  2013  Kd=28.1nM     // 3wa5.pdf (A|B)
4jgh  3.00  2013  Kd=28.1nM     // 4jgh.pdf (AC|D)
4c9b  2.00  2013  Kd=28.4nM     // 4c9b.pdf (A|B)
4jra  2.30  2013  Kd=28nM       // 4jra.pdf (A|D)
4bsr  3.20  2013  Kd=2nM        // 4bsr.pdf (B|D) in P22121 crystal form, Kd=2~3uM found in reference
4hlz  2.90  2013  Kd=2nM        // 4hlz.pdf (IJ|D) binding data by biolayer interferometry (BLI)
4h3p  2.30  2013  Kd=2uM        // 4h3p.pdf (D|E)
3zjy  3.60  2013  Kd=3.0uM      // 3zjy.pdf (AB|C) Kd=3.0+/-0.4uM by differential scanning fluorimetry (DSF)
4ng2  2.41  2013  Kd=3.2uM      // 4ng2.pdf (D|L)
4g01  2.20  2013  Kd=3.4uM      // 4g01.pdf (A|B) Ca-containing
4geq  2.01  2013  Kd=3.5uM      // 4geq.pdf (AB|F)
4k81  2.40  2013  Kd=3.6uM      // 4k81.pdf (C|D) Kd=3.6+/-0.6uM
4jrx  2.30  2013  Kd=3.75uM     // 4jrx.pdf (ABC|DE) CA5 TCR with the HLA-B*35:08LPEP
4jw2  1.90  2013  Kd=3.7nM      // 4jw2.pdf (A|B)
4hep  1.75  2013  Kd=300nM      // 4hem.pdf (A|G)
4ftg  2.51  2013  Kd=30nM       // 4ftg.pdf (ABCD|E)
4bj5  3.29  2013  Kd=30uM       // 4bj5.pdf (C|B) Kd=30+/-10uM
4gn5  1.86  2013  Kd=31.1nM     // 4gla.pdf (B|C)
4iiq  2.86  2013  Kd=31uM       // 4iiq.pdf (AB|C) human MAIT TCR (type F7)
4ihl  2.20  2013  Kd=346nM      // 4iea.pdf (A|P)
4gla  2.75  2013  Kd=35.3uM     // 4gla.pdf (A|D)
2m55   NMR  2013  Kd=35uM       // 2m55.pdf (A|B) ligand is N-terminally acetylated peptide containing the rst 19 residues (AcN19);Kd=35+/-10uM
4kgq  2.27  2013  Kd=36nM       // 4j6g.pdf (B|C) Kd=36+/-1.8nM by SPR
3v3k  3.49  2013  Kd=38.7nM     // 3v3k.pdf (K|L) binding data by surface acoustic wave; mean Kd value of five assays is showed in Table S1
4lad  2.30  2013  Kd=38nM       // 2lxp.pdf (A|B) crystal structure, redundant to 2lxp
2lxp   NMR  2013  Kd=38nM       // 2lxp.pdf (BC|A) NMR structure, redundant to 4lad
4hnj  2.90  2013  Kd=3nM        // 2m04.pdf (A|C) BCL-xL domain-swapped dimer in complex with PUMA BH3 peptide
4eiz  2.20  2013  Kd=3nM        // 4eig.pdf (A|D)
4euk  1.95  2013  Kd=4.1uM      // 4euk.pdf (A|B)
4b1x  1.80  2013  Kd=4.34uM     // 4b1u.pdf (B|M) 
4g8g  2.40  2013  Kd=4.58uM     // 4g8g.pdf (DE|A) Kd=4.58+/-0.11uM
4gn3  1.95  2013  Kd=4.6uM      // 4gla.pdf (A|B)
4ilg  2.10  2013  Kd=4.9nM      // 4ilg.pdf (BC|A)
4kjy  1.93  2013  Kd=41.3pM     // 4kjy.pdf (C|D)
4naw  2.19  2013  Kd=41nM       // 4naw.pdf (A|D) no direct Kd data for ATG3-RIA12, use Kd=41nM for longer ATG3-FR
3zo0  1.99  2013  Kd=437nM      // 2vol.pdf (A|B) MURINE TRIM21 IN COMPLEX WITH MURINE IGG FC, Kd=4.3 X 10-7M
4jb8  1.70  2013  Kd=44nM       // 4jb8.pdf (AB|P)
4jpk  2.40  2013  Kd=44nM       // 4jpi.pdf (HL|A)
4i0c  1.95  2013  Kd=460nM      // 4i0c.pdf (A|D)
4krl  2.85  2013  Kd=47nM       // 4krl.pdf (B|A) 
3vza  1.90  2013  Kd=481nM      // 3vz9.pdf (BD|F)
2m5a   NMR  2013  Kd=48nM       // 2m5a.pdf (A|B)
4f0z  1.70  2013  Kd=4nM        // 4f0z.pdf (AB|C)
4iof  3.35  2013  Kd=4nM        // 4iof.pdf (CD|A)
4cc4  2.60  2013  Kd=5.4uM      // 4cc2.pdf (C|D) Kd=5.4+/-0.2uM
4f37  2.57  2013  Kd=5.5nM      // 4f37.pdf (FK|B)
4i18  3.24  2013  Kd=5.6nM      // 4i18.pdf (AB|R)
4i9x  2.10  2013  Kd=5.96nM     // 4i9x.pdf (B|C) TRAIL-R2 as Immobilized ligand
4brw  2.80  2013  Kd=50nM       // 4bru.pdf (A|B)
4jkp  2.82  2013  Kd=51nM       // 4jkp.pdf (HL|G)
3vv2  1.83  2013  Kd=52pM       // 3vv2.pdf (A|B) Kd=5.2x10-11M, not Kd=52nM
4kt1  2.50  2013  Kd=56.5nM     // 4kt1.pdf (A|E) STF reporter assays
4ika  2.70  2013  Kd=57.5uM     // 4ika.pdf (A|D)
2lww   NMR  2013  Kd=57nM       // 2lww.pdf (A|B)
4ihh  2.13  2013  Kd=59nM       // 4ihf.pdf (F|K)
4m5z  2.25  2013  Kd=5nM        // 4m4y.pdf (HL|A) assay by biolayer interferometry, Kd=5~50nM in table 2
4bkx  3.00  2013  Kd=5uM        // 4bkx.pdf (A|B) HDAC1 activity was measured with the HDAC Assay Kit (Millipore)
4k9e  2.70  2013  Kd=6.4pM      // 4k94.pdf (HL|C)
4aor  1.70  2013  Kd=60.9nM     // 4aoq.pdf (A|D) Kd=60.9+/-8.4nM(for SOTI-III); Kd=201.8+/-27.7nM(for F14A variant)
4iw4  3.20  2013  Kd=610nM      // 4iw4.pdf (D|F)
3vxs  1.80  2013  Kd=64.8uM     // 3vxm.pdf (DE|A) Kd=64.8+/-3.4uM
3wn7  1.57  2013  Kd=7.31nM     // 3wn7.pdf (A|B) Kd=7.31+/-2.59nM by SPR
4jeh  2.50  2013  Kd=8.1nM      // 4jeh.pdf (A|B)
4ka2  1.79  2013  Kd=8.4pM      // 4ka2.pdf (A|R)
4g3y  2.60  2013  Kd=8.7nM      // 4g3y.pdf (HL|C)
2m0g   NMR  2013  Kd=84nM       // 2m0g.pdf (A|B)
4j2l  3.15  2013  Kd=88.5nM     // 4j2l.pdf (B|D) ITC Kd is for Ataxin-1 and CIC-21 in PDB code 4j2j, CIC-28 has no data
4k71  2.40  2013  Kd=8nM        // 4k71.pdf (BC|A) 
3vxr  2.40  2013  Kd=9.7uM      // 3vxm.pdf (DE|A) Kd=9.7+/-0.7uM
4dpg  2.84  2013  Kd=90nM       // 4dpg.pdf (E|L)
4lqw  1.95  2013  Kd=94uM       // 4lqw.pdf (A|D)
4fza  3.15  2013  Kd=99.1nM     // 4fza.pdf (A|B) Kd1=99.1nM, Kd2=69.5nM, not full-length MST4, Kd1=9.12nM, Kd2=80.0nM
3vux  1.70  2013  Kd=9uM        // 3vuw.pdf (A|G)
2m5b   NMR  2013  Kd~10uM       // 2m5b.pdf (A|B)
3w6j  2.60  2013  Kd~56nM       // 3w6j.pdf (D|F)
4j2y  2.00  2013  Ki=0.88nM     // 4j2y.pdf (A|B)
4ij3  2.70  2013  Ki=0.9nM      // 4ij3.pdf (CB|A)
4doq  2.00  2013  Ki=140nM      // 4doq.pdf (C|D)
4gnk  4.00  2013  Ki=220nM      // 4gnk.pdf (B|A) Ki=220+/-30nM
4bd9  2.20  2013  Ki=31nM       // 4bd9.pdf (A|B)
4ilw  2.10  2013  Ki=5.8nM      // 4ilw.pdf (A|D) competitive inhibition model
4boh  2.60  2013  Ki=55.56nM    // 4boh.pdf (H|M)
4nst  2.20  2014  IC50=1.37uM   // 4nst.pdf (A|B)
4bpk  1.76  2014  IC50=25nM     // 4bpi.pdf (B|D) complex of Bcl-XL and peptide 5
4oqt  3.23  2014  Kd<50pM       // 4oqt.pdf (HL|A) Kd<=50pM by SPR for the binding of the Li81 Fab to the LINGO-1 ectodomain
4plo  2.90  2014  Kd=0.038uM    // 4pln.pdf (B|A) binding data by biolayer interferometry (BLI)
4pbz  2.15  2014  Kd=0.05uM     // 4pbz.pdf (A|B)
4u6h  3.10  2014  Kd=0.091nM    // 4u6h.pdf (CD|J) binding data by biolayer interferometry (BLI)
4lgr  1.65  2014  Kd=0.11nM     // 4lgp.pdf (A|B)
4mit  2.35  2014  Kd=0.178uM    // 4mit.pdf (C|G) Kd=178+/-30nM
4m1l  2.10  2014  Kd=0.18uM     // 4m1l.pdf (A|B) Kd=5.07nM by SPR for Ca2+-free CaM, PDB code 4lzx
3wkt  4.30  2014  Kd=0.1uM      // 3wkt.pdf (A|C) Kd=0.1~0.2uM by SPR for heme-rHO-1 binding to Delta TGEE
4pz6  2.41  2014  Kd=0.21uM     // 4pz6.pdf (B|P) Pol2-CDT; Kd=0.21+/-0.03uM
4lgp  2.40  2014  Kd=0.23nM     // 4lgp.pdf (C|D)
4bkl  3.25  2014  Kd=0.274uM    // 4bkl.pdf (AB|EGF) Kd=2.74 x 10-7M by SPR
4ml7  1.80  2014  Kd=0.27nM     // 4ml7.pdf (A|B)
4qt8  3.00  2014  Kd=0.28uM     // 4qt8.pdf (A|C)
4jmf  2.10  2014  Kd=0.298uM    // 4jmf.pdf (A|B) Kd=0.298+/-0.06uM by SPR
4mqw  2.90  2014  Kd=0.29nM     // 4mqw.pdf (AB|X) FSH binding to FSHR in the absence of Compound 5
4peq  2.21  2014  Kd=0.2fM      // 3tsr.pdf (C|D) Kd=2x10-16M
4cmh  1.53  2014  Kd=0.2nM      // 4cmh.pdf (BC|A)
4liq  2.60  2014  Kd=0.2nM      // 4liq.pdf (HL|E)
4pc0  2.50  2014  Kd=0.2uM      // 4pbz.pdf (A|C)
3wry  2.30  2014  Kd=0.31uM     // 3wry.pdf (B|D) 
4pl8  2.00  2014  Kd=0.32uM     // 4pl7.pdf (A|H) T-belta4N full length; Kd=0.32+/-0.02uM
4qxa  2.30  2014  Kd=0.32uM     // 4qxa.pdf (A|B) Kd=0.32+/-0.08uM(Rab-9A Q66L mutant(WT));Kd=2.60+/-0.60uM(Rab-9A Q66L mutant(R68A)); Kd=45.0+/-13.0uM((Rab-9A Q66L mutant(L256AWT));Kd=1.41+/-0.30uM((Rab-9A Q66L mutant(Q361AWT))
4p1n  2.20  2014  Kd=0.36uM     // 4p1n.pdf (B|D) Kd=0.36+/-0.03uM; Atg13 MIM(N+C) wild-type
4nqw  2.40  2014  Kd=0.42uM     // 4nqw.pdf (A|B) Oxidized sigma condition, Kd on reduced sigma condition is 1.15uM
4r8g  3.50  2014  Kd=0.49uM     // 4r8g.pdf (E|H) Kd=0.49uM for IQ2 binding motifs, Kd=3.14uM for IQ3 motif, not the whole tail
4n8c  1.60  2014  Kd=0.4nM      // 4n8c.pdf (IM|Y) 
4k24  4.50  2014  Kd=0.54uM     // 4k23.pdf (HL|U) measured by direct binding assays
4pwx  5.40  2014  Kd=0.54uM     // 4pwx.pdf (A|C) Get4-5 prefers ATP bound state of Get3; Kd= 0.54+/-0.08uM
4lrz  2.32  2014  Kd=0.5uM      // 4lrx.pdf (D|E)
4ofy  3.30  2014  Kd=0.602uM    // 4ofy.pdf (C|F) ITC assay is Protein SYG-1 D1, protein in crystal structure is Protein SYG-1 D1-D2
4kdi  1.86  2014  Kd=0.71uM     // 4kdi.pdf (B|D)
4kvg  1.65  2014  Kd=0.7uM      // 4kvg.pdf (A|B)
4cmm  1.92  2014  Kd=0.8uM      // 4cmm.pdf (A|B)
4od2  3.20  2014  Kd=0.92nM     // 4od2.pdf (BA|S) Kd=0.92+/-0.01nM
4mrt  2.00  2014  Kd=0.92uM     // 4mrt.pdf (C|A) binding data measured in presence of coenzyme A
4nso  2.40  2014  Kd=0.98nM     // 4nso.pdf (A|B)
4byf  2.74  2014  Kd=0.9uM      // 4byf.pdf (C|D) calmodulin in the pre-power stroke state
4pj8  3.30  2014  Kd=1.0uM      // 4pj5.pdf (CD|A) Kd=1.0+/-0.3uM; C-F7 (TRBV20) TCR
4ne9  2.60  2014  Kd=1.17uM     // 4ne9.pdf (B|D)
3wdg  2.20  2014  Kd=1.198nM    // 3wdg.pdf (A|B) Kd=1.198+/-0.029nM by SPR
4pqt  2.05  2014  Kd=1.1uM      // 4k1r.pdf (A|B)
4u0q  3.10  2014  Kd=1.1uM      // 4u0q.pdf (A|B) in paper, the protein is PfRH5 Delta NL, Kd=1.3uM, length does not match that in RCSB PDB
4cu4  2.30  2014  Kd=1.2uM      // 4cu4.pdf (A|B) FhuA-MccJ25
4re1  2.20  2014  Kd=1.2uM      // 4re1.pdf (B|C)
4mi8  2.10  2014  Kd=1.38uM     // 4mi8.pdf (B|D)
4w4l  2.45  2014  Kd=1.3nM      // 4w4k.pdf (AB|C) binding data by biolayer interferometry (BLI)
4wfd  2.40  2014  Kd=1.3uM      // 4wfc.pdf (AB|C)
4ov6  2.69  2014  Kd=1.58nM     // 4ov6.pdf (AB|F) Kd=1.58+/-0.18nM by SPR for Form of Adnectin: 1459D05 (progenitor)
4w6y  1.57  2014  Kd=1.58nM     // 4w6w.pdf (A|B) Microscale thermophoresis (MST), Kd=1.58+/-0.65nM
4nn6  2.54  2014  Kd=1.5nM      // 4nn5.pdf (AC|B) TSLP N123Q and TSLPR N122Q in ternary complex with IL-7R alpha, complex at neutral pH, crystal form 1B
3wkn  2.90  2014  Kd=1.6nM      // 3wkn.pdf (D|H)
3wn5  2.78  2014  Kd=1.6uM      // 3wn5.pdf (AB|C)
4qlb  2.60  2014  Kd=1.6uM      // 4qlb.pdf (C|G) Kd=1.6+/-0.3uM
4kv5  3.00  2014  Kd=1.7nM      // 4kv5.pdf (A|H) Kd=1.7+/-0.6nM by SPR for GC1008 scFv:TGF beta1
4nee  2.88  2014  Kd=1.8uM      // 4nee.pdf (BD|C) Kd=1.8+/-0.4uM by ITC
2mcn   NMR  2014  Kd=1.9uM      // 2mcn.pdf (A|B)
4cdk  2.80  2014  Kd=1.9uM      // 4cdk.pdf (C|G) Kd=1.9+/-0.1uM by SPR
4k1r  1.63  2014  Kd=10.2uM     // 4k1r.pdf (A|B)
4k5a  1.50  2014  Kd=10.3nM     // 4k5a.pdf (A|B)
4cni  2.20  2014  Kd=10pM       // 4cni.pdf (AB|D)
4u6v  2.56  2014  Kd=10pM       // 4u6v.pdf (KM|B) 
4q96  1.85  2014  Kd=114uM      // 4q96.pdf (E|C) Kd=114+/-2uM
4cj2  1.50  2014  Kd=11nM       // 4cj0.pdf (A|D) Kd=11+/-2.8nM by ITC
4pas  1.62  2014  Kd=126.6nM    // 4pas.pdf (A|B)
2ru4   NMR  2014  Kd=126nM      // 2ru4.pdf (A|B) Kd=126+/-5nM by ITC
4m38  2.20  2014  Kd=12uM       // 4m37.pdf (A|E)
4m5f  2.50  2014  Kd=13.5pM     // 4m5f.pdf (A|B) Kd=13.5pM in presence of 0.1mM CaCl2
2mbb   NMR  2014  Kd=130uM      // 2mbb.pdf (A|B)
4m1g  1.60  2014  Kd=14.4nM     // 4lqf.pdf (HL|AB) binding data by BLI
4p3y  2.15  2014  Kd=146nM      // 4p3y.pdf (A|B) Kd=146+/-37nM; oxidized EF-Tu
4ons  2.80  2014  Kd=15.8nM     // 4ons.pdf (A|B) Kd is not for exact the same protein sequence
4ozg  3.00  2014  Kd=15.8uM     // 4ozf.pdf (HG|ABJ)
4pou  1.75  2014  Kd=157nM      // 4pou.pdf (A|B) Kd=157+/-3nM by ITC
3wo4  3.10  2014  Kd=15nM       // 3wo4.pdf (AB|C) IL-18 signaling ternary complex, Kd=1.5+/-0.1x10-8M by SPR
4rdq  2.85  2014  Kd=15nM       // 4rdq.pdf (IH|A) Ca2+ containing
4lrx  3.25  2014  Kd=15uM       // 4lrx.pdf (A|C)
4u3j  2.81  2014  Kd=160nM      // 4u3j.pdf (AB|C)
4n7z  2.85  2014  Kd=177nM      // 4n7v.pdf (A|B) Kd=177+/-23nM for CPB-binding affinity of Cep192-58mer
2mej   NMR  2014  Kd=17uM       // 2mej.pdf (A|B)
4c1n  2.53  2014  Kd=18.1nM     // 4c1n.pdf (CD|J)
4d0n  2.10  2014  Kd=18.1uM     // 4d0n.pdf (A|B) complex of RhoA with GDP; Kd=18.1uM
4v2c  4.00  2014  Kd=18uM       // 4v2c.pdf (C|D)
4myw  3.19  2014  Kd=19.1nM     // 4myw.pdf (A|B)
4bwq  2.10  2014  Kd=19.7uM     // 4bwq.pdf (G|H)
4np4  2.89  2014  Kd=19pM       // 4np4.pdf (IM|A) High affinity binding site Kd=19+/-5pM; low affinity binding site Kd=370+/-310pM
2mre   NMR  2014  Kd=19uM       // 2mre.pdf (A|B) Kd=19+/-1.2uM by NMR
4per  1.92  2014  Kd=1fM        // 3tsr.pdf (A|B) Kd=1x10-15M
4py8  2.91  2014  Kd=1nM        // 4py7.pdf (JI|AB) Kd by biolayer interferometry (BLI)
4u2x  3.15  2014  Kd=1nM        // 4u2x.pdf (B|E) Kd=1.0+/-0.3nM by ITC
4odx  3.10  2014  Kd=2.06nM     // 4m62.pdf (AL|Y)
3wrx  2.50  2014  Kd=2.1uM      // 3wrx.pdf (B|D)
4pjd  2.78  2014  Kd=2.2uM      // 4pj5.pdf (GH|C) Kd=2.2+/-0.3uM; C-C10 TCR
4qrp  2.90  2014  Kd=2.48uM     // 4qrp.pdf (DE|AC) Kd=2.48+/-0.11uM
4pbv  2.50  2014  Kd=2.4uM      // 4pbv.pdf (B|D)
4pj9  2.00  2014  Kd=2.4uM      // 4pj5.pdf (CD|A) Kd=2.4+/-0.4uM; number 4 (TRAJ20) TCR
4m62  1.80  2014  Kd=2.57nM     // 4m62.pdf (HL|S)
4u97  2.65  2014  Kd=2.5uM      // 4u97.pdf (A|B) IRAK4 FL-D311N; Asymmetric Dimerization with Kd=2.5+/-0.4uM
4u5w  1.86  2014  Kd=2.63uM     // 4u5w.pdf (C|D)
3wa0  2.31  2014  Kd=2.64uM     // 3wa0.pdf (A|G) affinity is for C29 DCAF1(1478-1506), crystal is for DCAF1 (1417-1506)
4ra0  3.07  2014  Kd=2.7pM      // 4ra0.pdf (B|D) measured using the kinetic exclusion assay (KinExA)
4c4k  1.95  2014  Kd=2.7uM      // 4c4k.pdf (O|T) M10:O1 (orthorhombic)
4pj7  2.50  2014  Kd=2.7uM      // 4pj5.pdf (HG|A) Kd=2.7+/-0.7uM; number 6 TRBV6-4 TCR
4qd2  2.40  2014  Kd=2.7uM      // 4qd2.pdf (ABD|E)
4mqv  1.95  2014  Kd=2.9uM      // 4mqv.pdf (A|B) Kd=2.9+/-0.1uM
4mjs  2.50  2014  Kd=21.6nM     // 4mjs.pdf (W|X) Kd=21.6+/-2.09nM by ITC
4n8v  2.50  2014  Kd=22.2uM     // 4n8v.pdf (AC|G)
4oyd  1.80  2014  Kd=220pM      // 4oyd.pdf (A|B) binding data by bio-layer interferometry (BLI)
4ojk  2.66  2014  Kd=22uM       // 4ojk.pdf (A|C) Kd=22+/-0.3uM; PKG II LZ (residues 40-83) binds to Rab11b-GDP
2mnu   NMR  2014  Kd=230nM      // 2mnu.pdf (A|B) Kd=230+/-36nM by ITC
2ruk   NMR  2014  Kd=24.21uM    // 2ruk.pdf (A|B) Kd=24.21+/-3uM by ITC
4ozh  2.80  2014  Kd=24.8uM     // 4ozf.pdf (HG|ABJ)
4bxl   NMR  2014  Kd=240nM      // 4bxl.pdf (A|C)
4nl9  1.50  2014  Kd=249nM      // 4nl9.pdf (B|C) Kd=249+/-8nM by SPR
2mp0   NMR  2014  Kd=25mM       // 2mp0.pdf (A|B)
4nzl  1.85  2014  Kd=25nM       // 4nzl.pdf (A|B)
4o27  3.19  2014  Kd=25nM       // 4nzw.pdf (A|B) between WT MO25-alpha and WT MST3
4ct0  2.45  2014  Kd=28nM       // 4ct0.pdf (A|B)
4x7f  1.70  2014  Kd=28nM       // 4x7c.pdf (A|C)
4jlr  2.71  2014  Kd=29.9pM     // 4jlr.pdf (AB|C)
4p6i  2.30  2014  Kd=290nM      // 4p6i.pdf (A|D)
4w6w  2.51  2014  Kd=3.57nM     // 4w6w.pdf (A|B) Microscale thermophoresis (MST), Kd=3.57+/-2.59nM
4x7d  2.15  2014  Kd=3.5nM      // 4x7c.pdf (B|C)
4p2c  2.82  2014  Kd=3.95nM     // 4p2c.pdf (HC|A)
4m8q  2.89  2014  Kd=3.96nM     // 4m62.pdf (HL|C)
4u4c  2.40  2014  Kd=310nM      // 4u4c.pdf (A|B)
2mak   NMR  2014  Kd=310uM      // 2mak.pdf (C|B) NMR Kd values of 310, 160, 90uM for A277, A280 and E272 curves, respectively
4lyl  1.93  2014  Kd=31nM       // 4lyl.pdf (E|F)
4n9g  2.50  2014  Kd=326pM      // 4jlr.pdf (HL|Y)
4n7v  2.76  2014  Kd=32nM       // 4n7v.pdf (A|C) CPB-binding affinity of Cep152-60mer is Kd= 32+/-4nM
4p59  3.40  2014  Kd=32pM       // 4p59.pdf (HL|A) solution equilibrium titration
4p46  2.85  2014  Kd=32uM       // 4p23.pdf (AB|CD)
4p9h  3.00  2014  Kd=33.1nM     // 4p9h.pdf (HL|G) 93TH057 gp120 mutant
4v0m  3.45  2014  Kd=348nM      // 4v0k.pdf (E|F) CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM
4v0o  3.35  2014  Kd=348nM      // 4v0k.pdf (C|D) CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM; lead soak; same as 4v0m
4v0n  3.13  2014  Kd=348nM      // 4v0k.pdf (C|D) CrARL6 delta N-GTP-CrBBS1N; Kd=348+/-45nM; mercury soak; same as 4v0m
4r2g  3.28  2014  Kd=34nM       // 4r26.pdf (QP|E) PGT124 Fab bind to precomplexed HIV-1 JRCSF gp120 core and CD4
4pjf  2.45  2014  Kd=35.4uM     // 4pj5.pdf (GH|A) Kd=35.4+/-3.0uM
4qzv  2.59  2014  Kd=35.7uM     // 4qzv.pdf (C|D)
4kxz  2.83  2014  Kd=3nM        // 4kv5.pdf (HL|A) Kd=3.0+/-1.2nM by SPR for GC1008 FAB:TGF beta2
3wwk  2.98  2014  Kd=3uM        // 3wsr.pdf (A|C) Kd estimated by SPR
4msm  1.74  2014  Kd=3uM        // 4k1r.pdf (C|D)
4khx  2.92  2014  Kd=4.2nM      // 4kht.pdf (HL|A) A+B+B+B interaction, Kd1 based on a global analysis of the ITC, fluorescence and sedimentation data results
4pjc  2.50  2014  Kd=4.2uM      // 4pj5.pdf (GH|C) Kd=4.2+/-0.5uM; C-A11 TCR
4pja  2.68  2014  Kd=4.2uM      // 4pj5.pdf (GH|C) Kd=4.2+/-0.6uM; B-B10 TCR
4kht  2.82  2014  Kd=4.3nM      // 4kht.pdf (HL|A) A+B+B+B interaction, Kd1 based on a global analysis of the ITC, fluorescence and sedimentation data results
2mj5   NMR  2014  Kd=4.3uM      // 2mj5.pdf (A|B) Kd=4.3+/-0.4uM by ITC; Kd=3+/-0.9uM by NMR
4ol0  2.90  2014  Kd=4.7nM      // 4ol0.pdf (A|B) Kd=4.7+/-1.2nM; GTP containing
4noo  2.30  2014  Kd=4.92nM     // 4noo.pdf (C|D) putative catalytic domain (VgrG3CCD) as ligand and TsiV3 as analyte
4j4p  2.91  2014  Kd=40nM       // 4j4p.pdf (CD|B)
4ovn  2.80  2014  Kd=46nM       // 4ovn.pdf (B|G) Temperature is 28C, Kds ranging from 46+/-33nM to 105+/-15nM depending on the buffer conditions
4pp8  1.95  2014  Kd=486nM      // 1jsk.pdf (A|C) RAE-1 BETA IN COMPLEX WITH murine NKG2D, Kd=486nM
4cj1  1.63  2014  Kd=48nM       // 4cj0.pdf (A|B) Kd=48+/-10nM by ITC
4jzj  2.80  2014  Kd=4nM        // 4jzj.pdf (AB|D)
4lzx  1.50  2014  Kd=5.07nM     // 4lzx.pdf (A|B) Kd=0.18uM by SPR for Ca2+-bound CaM, PDB code 4m1l
4w6x  1.88  2014  Kd=5.25nM     // 4w6w.pdf (A|B) Microscale thermophoresis (MST), Kd=5.25+/-3.08nM
2mfq   NMR  2014  Kd=5.2uM      // 2mfq.pdf (A|B)
4ps4  2.80  2014  Kd=5.7pM      // 4ps4.pdf (HL|A) SPR Kd=5.7+/-1.3pM
4lxr  2.20  2014  Kd=5.9nM      // 4lxr.pdf (A|K)
4nzw  3.58  2014  Kd=504nM      // 4nzw.pdf (A|B) between WT MO25-alpha and WT STK25
4pbw  3.05  2014  Kd=551nM      // 4pbv.pdf (B|E)
4q5e  1.87  2014  Kd=580nM      // 4q5e.pdf (BC|A) OspG with UbcH7~Ub; Kd=580+/-20nM
4js0  1.90  2014  Kd=5uM        // 4js0.pdf (A|B) Kd measured by ITC
4p5t  3.26  2014  Kd=5uM        // 4p23.pdf (AB|CD)
2mjw   NMR  2014  Kd=6.2uM      // 2mjw.pdf (A|B)
4o1q  2.59  2014  Kd=6.2uM      // 4o1q.pdf (CD|A) binding data for quinone MADH, not preMADH
3wwn  1.85  2014  Kd=6.62uM     // 3wwn.pdf (A|B) Kd=6.62+/-0.56uM by ITC
4m0w  1.40  2014  Kd=6.7uM      // 4m0w.pdf (A|B)
4ln0  2.90  2014  Kd=6.8nM      // 4ln0.pdf (B|C) binding data by BLI assay
4lqf  2.30  2014  Kd=64.5pM     // 4lqf.pdf (HL|A) binding data by BLI assay
4k5b  1.85  2014  Kd=643pM      // 4k5a.pdf (B|C) The PDB website may label the two protein chains wrong
4lu5  2.90  2014  Kd=65.9pM     // 4lqf.pdf (HL|B) binding data by BLI assay
4wo4  2.50  2014  Kd=66nM       // 4qrr.pdf (CD|A)
3wo3  3.10  2014  Kd=69nM       // 3wo3.pdf (A|B) Kd=6.9+/-0.2 x10-8M by SPR
4p23  2.25  2014  Kd=6uM        // 4p23.pdf (CD|AB)
4m6b  1.78  2014  Kd=7.1nM      // 4m6b.pdf (D|F) Kd is for yeast Swr1 (504-650), length in RCSB PDB is only 55 aa
2mkc   NMR  2014  Kd=7.8nM      // 2mkc.pdf (AC|B) Kd of cPml1p to the cSnu17p-cBud13p dimer was 7.8+/-0.3nM
4ozi  3.20  2014  Kd=70uM       // 4ozf.pdf (HG|ABJ)
4ozf  2.70  2014  Kd=79.4uM     // 4ozf.pdf (HG|ABJ)
4x7e  2.11  2014  Kd=7nM        // 4x7c.pdf (B|D)
4mp0  2.10  2014  Kd=8.7nM      // 4moy.pdf (A|B) Kd=8.7+/-0.8nM
4pjb  2.85  2014  Kd=9.1uM      // 4pj5.pdf (GH|C) Kd=9.1+/-1.0uM; B-F3-C1 TCR
2mur   NMR  2014  Kd=9.26uM     // 2mur.pdf (A|B)
4c2a  2.08  2014  Kd=9.7nM      // 4c2a.pdf (A|B) Kd value determined by radiometric titration
4kfz  2.80  2014  Kd=94nM       // 4kfz.pdf (B|D) Mammalian two-hybrid data, Kd=9.4 x 10-8 M
4cj0  1.10  2014  Kd=98nM       // 4cj0.pdf (A|B) Kd=98+/-36nM by ITC
4c2b  2.80  2014  Kd=9nM        // 4c2a.pdf (G|H) Kd value determined by radiometric titration
4l0p  2.26  2014  Kd=9nM        // 4l0p.pdf (A|B)
4edw  2.48  2014  Kd~10nM       // 4edw.pdf (HL|V)
2mlz   NMR  2014  Kd~14uM       // 2mlx.pdf (A|B)
4c7n  2.10  2014  Kd~1nM        // 4c7n.pdf (A|B)
4q5u  1.95  2014  Kd~1pM        // 4q5u.pdf (A|C)
4p2o  2.60  2014  Kd~1uM        // 4p2o.pdf (CD|ABP)
4p2q  3.30  2014  Kd~1uM        // 4p2o.pdf (DE|ABC)
4p2r  3.30  2014  Kd~1uM        // 4p2o.pdf (DE|ABC)
2mly   NMR  2014  Kd~2uM        // 2mlx.pdf (A|B) characterization showed that TF formed complexes with the three PhoA fragments (PhoAa-c, PhoAd-e, and PhoAf-g) with Kd values of ~2uM, ~4uM, and ~14uM, respectively (Fig. 3A and fig. S14).
4mne  2.85  2014  Kd~43nM       // 4mne.pdf (D|C) exact value in support information is not available
2mlx   NMR  2014  Kd~4uM        // 2mlx.pdf (A|B) seems RCSB confuse the sequence range, should be d-e, not 220-310 as PDB code 2mlz
4niq  2.30  2014  Kd~5uM        // 4niq.pdf (A|C) ITC Kd is for full-length Vfa1 in this paper, Kd~5-10uM in ref 32
4u30  2.50  2014  Ki=138nM      // 4u30.pdf (D|Y)
4u32  1.65  2014  Ki=379nM      // 4u30.pdf (X|A)
4nm3  2.10  2014  Ki=60uM       // 4nm0.pdf (A|B) phosphoylated Ser9 peptide(pS9); Ki= 60+/-11uM
4nu1  2.50  2014  Ki=60uM       // 4nm0.pdf (A|B) phosphoylated Ser9 peptide; AlF3 is a transition state mimicry ;pS9; Ki= 60+/-11uM
4zgm  1.80  2015  IC50=0.38nM   // 4zgm.pdf (A|B) semaglutide;
4ywc  2.40  2015  IC50=0.49uM   // 4ywc.pdf (B|D) Jas motif peptide competitively inhibits the MYC3-MED25 interaction, AlphaScreen interaction assay
5agw  2.70  2015  IC50=10.2nM   // 5agw.pdf (B|C) binding of oligomers to anti-apoptotic proteins determined by competition SPR assays
5agx  2.24  2015  IC50=50.5nM   // 5agw.pdf (A|D) binding of oligomers to anti-apoptotic proteins determined by competition SPR assays
4zii  2.19  2015  IC50=66nM     // 4zie.pdf (A|C)
4rws  3.10  2015  IC50=6nM      // 4rws.pdf (A|C) vMIP-II is a high affinity antagonist of CXCR4 (IC50 6-15nM)
4z5r  3.00  2015  Kd=0.018nM    // 4z5r.pdf (SR|H)
5e4e  3.00  2015  Kd=0.084nM    // 5e4e.pdf (BC|A)
5c6t  3.60  2015  Kd=0.13nM     // 5c6t.pdf (HL|A)
5bnq  2.80  2015  Kd=0.156nM    // 5bnq.pdf (A|R)
4yh7  4.40  2015  Kd=0.15uM     // 4yfc.pdf (A|B)
4r8w  2.79  2015  Kd=0.183nM    // 4r8w.pdf (HL|AB)
4xhj  3.16  2015  Kd=0.194nM    // 4xhj.pdf (HG|EF)
4wen  1.89  2015  Kd=0.1uM      // 4wem.pdf (A|B)
4zkc  3.15  2015  Kd=0.22nM     // 4zk9.pdf (A|B)
4qlp  1.10  2015  Kd=0.23nM     // 4qlp.pdf (A|B) Kd=2.3 x 10E-10M by ITC
4rwt  2.98  2015  Kd=0.23uM     // 4rwt.pdf (B|D) Kd for whole Lmod2 (1-495) (B-GS); also provide Kd for three individual binding sites
4zk9  2.60  2015  Kd=0.24nM     // 4zk9.pdf (A|B)
4uuz  2.90  2015  Kd=0.24uM     // 4uuz.pdf (AB|C)
4x33  1.45  2015  Kd=0.25uM     // 4x33.pdf (A|B) [Nonstandard assay: Temp 10]
4zs6  3.17  2015  Kd=0.312uM    // 4zs6.pdf (HL|A)
4yk4  2.80  2015  Kd=0.364uM    // 4yjz.pdf (ZY|E) binding data by biolayer interferometry
4zi2  2.20  2015  Kd=0.42uM     // 4zi2.pdf (B|D)
4xi5  3.90  2015  Kd=0.49nM     // 4xhj.pdf (CD|AB)
5c7x  2.95  2015  Kd=0.4pM      // 5c7x.pdf (HL|A) MOR04357 in complex with human GM-CSF
5abv  2.13  2015  Kd=0.52nM     // 5abu.pdf (C|D)
5bw8  2.80  2015  Kd=0.54uM     // 5bw8.pdf (B|C)
5cjq  3.60  2015  Kd=0.5nM      // 5cjq.pdf (HL|AB) KD value determined using biolayer interferometry
5dfv  2.80  2015  Kd=0.5nM      // 5dfv.pdf (EF|B)
5dfw  2.33  2015  Kd=0.5nM      // 5dfv.pdf (A|H)
5d3i  3.20  2015  Kd=0.6nM      // 5d3i.pdf (A|B) Kd=0.6+/-0.4nM by AlphaScreen assay
4yoc  2.92  2015  Kd=0.6uM      // 4yoc.pdf (A|C)
5bo1  2.56  2015  Kd=0.79nM     // 5bo1.pdf (HL|B)
4zgy  2.63  2015  Kd=0.7uM      // 4zgy.pdf (A|B)
2mzd   NMR  2015  Kd=0.877uM    // 2mzd.pdf (A|B) Ka=1.14x10E6/M
4wnn  1.80  2015  Kd=0.8uM      // 4wnn.pdf (CD|T)
4v3k  2.04  2015  Kd=0.92uM     // 4v3k.pdf (DE|F)
2n2h   NMR  2015  Kd=0.93uM     // 2n2h.pdf (A|B) [Different protein in assay: the crystal structure is complex of SDS3(202-228) and Sin3A (605-729)]
5cff  2.50  2015  Kd=1.07uM     // 5cff.pdf (B|E) [Different protein in assay: the protein used in binding assay is Trx-Mira (514-595)] [Different ligand in assay: the protein used in binding assay is Trx-Stau (951-1018)]
5bqe  2.30  2015  Kd=1.10uM     // 5bpu.pdf (A|B) Norrin in complex with the cysteine-rich domain of Frizzled 4 -Methylated form
4xxb  2.40  2015  Kd=1.48uM     // 4xxb.pdf (A|B) Microscale thermophoresis (MST) measurements
4r8i  2.05  2015  Kd=1.4nM      // 4r8i.pdf (A|B) [Nonstandard assay: temp=37C]
4xl5  2.00  2015  Kd=1.4nM      // 4xl5.pdf (A|C)
4zlt  3.00  2015  Kd=1.4nM      // 4zlt.pdf (A|L)
4y5o  2.35  2015  Kd=1.4uM      // 4y5o.pdf (A|B)
2mv7   NMR  2015  Kd=1.56nM     // 2mv7.pdf (A|B) [Multiple sites: site 1: Kd> 2uM; site 2: Kd=26.7nM; site 3: Kd=1.56nM] DOT1L has three binding sites
4yc7  2.50  2015  Kd=1.89uM     // 4yc7.pdf (B|A)
3wqb  1.41  2015  Kd=1.8nM      // 3wqb.pdf (A|B)
5e8e  1.90  2015  Kd=1.8nM      // 5e8e.pdf (BA|H)
4d0g  2.50  2015  Kd=1.8uM      // 4d0g.pdf (A|C)
5anm  2.85  2015  Kd=1.95pM     // 5anm.pdf (BA|G) KinExA-determined affinity
4rey  1.96  2015  Kd=108nM      // 4rey.pdf (A|B)
4x7s  1.90  2015  Kd=10nM       // 4x7s.pdf (H|L) P212121 symmetry and resolution of 1.9 A, Kd=1x10-8M, data not shown
4s0s  2.80  2015  Kd=11.4nM     // 4s0s.pdf (B|E)
5brm  2.65  2015  Kd=119nM      // 5brk.pdf (B|H)
5bn5  3.00  2015  Kd=11uM       // 5bn3.pdf (A|B) Kd=11+/-2uM
4ui1  2.35  2015  Kd=124nM      // 4ui0.pdf (A|D) RGMC-ND-BMP2
4z80  1.53  2015  Kd=12nM       // 4z80.pdf (B|D)
4wuu  3.05  2015  Kd=13.2nM     // 4wuu.pdf (DE|AC)
4pw9  2.49  2015  Kd=13.5uM     // 4pw3.pdf (A|B) SorT/SorU complex
5d1l  1.62  2015  Kd=141nM      // 5d1k.pdf (A|B) binding data by MST
2rvb   NMR  2015  Kd=143.3nM    // 2rvb.pdf (A|B)
4uu9  2.12  2015  Kd=14pM       // 4uu9.pdf (AB|C)
4uyq  1.81  2015  Kd=14pM       // 4uyp.pdf (A|B)
4wwi  2.31  2015  Kd=15.2nM     // 4wwi.pdf (B|E) Ka=6.6x107M-1
2mro   NMR  2015  Kd=150uM      // 2mro.pdf (A|B)
5do2  2.41  2015  Kd=162nM      // 5do2.pdf (CD|B)
4zqu  2.09  2015  Kd=16nM       // 4zqu.pdf (A|B) CdiA-CT/CdiIYPIII
4qti  3.00  2015  Kd=17.2nM     // 4qth.pdf (HL|U)
4z8l  2.60  2015  Kd=170nM      // 4z8l.pdf (AB|C)
4yeb  3.19  2015  Kd=17nM       // 4yeb.pdf (A|B)
5d1k  1.78  2015  Kd=180nM      // 5d1k.pdf (A|B) binding data by MST
4ypi  3.71  2015  Kd=19.4nM     // 4ypi.pdf (C|G)
3wih  1.70  2015  Kd=19nM       // 3wih.pdf (IM|B)
2n01   NMR  2015  Kd=1uM        // 2n01.pdf (A|B) [Nonstandard assay: Temp=37C]
4zrk  2.32  2015  Kd=1uM        // 4zri.pdf (C|G)
5dob  2.47  2015  Kd=1uM        // 5dob.pdf (A|B)
4yvq  2.40  2015  Kd=2.03uM     // 4yvq.pdf (A|C)
4ydh  3.80  2015  Kd=2.55uM     // 4yc7.pdf (C|D)
4zgq  3.00  2015  Kd=2.5uM      // 4zgn.pdf (A|B)
4wv1  2.36  2015  Kd=2.6nM      // 4wv1.pdf (ED|F) phage ELISA-binding assay
4zrj  2.30  2015  Kd=2.9uM      // 4zri.pdf (A|B) S518D, A585W mutant Merlin CTD
5d70  2.06  2015  Kd=2000pM     // 5c7x.pdf (HL|A) MOR03929 in complex with human GM-CSF
4uyp  1.49  2015  Kd=20pM       // 4uyp.pdf (A|D)
4zfo  1.90  2015  Kd=21pM       // 4zfo.pdf (AB|F) SPR data under 1.1nM BCMA concentration
4rgm  2.69  2015  Kd=22.9nM     // 4rgm.pdf (CB|A) binding data by BLI assay
5cmn  3.61  2015  Kd=220nM      // 5cmn.pdf (A|E) binding data by BLI assay
4rs1  2.68  2015  Kd=23.9nM     // 4rs1.pdf (B|A) saturation binding assays using radioiodinated GM-CSF and COS cells transiently expressing GMRa alone
4zv4  3.50  2015  Kd=23nM       // 4zv0.pdf (A|C) Tse6265-CT with EF-TuPA/GDP
5di9  2.28  2015  Kd=2400nM     // 5dh9.pdf (C|D)
5cyk  3.00  2015  Kd=249nM      // 5cxb.pdf (A|B) Biolayer Interferometry assay
4rjf  2.01  2015  Kd=250nM      // 4rjf.pdf (A|B)
4xlw  3.39  2015  Kd=262nM      // 4xl1.pdf (E|F)
5ajk  2.55  2015  Kd=2640nM     // 5ajj.pdf (C|D)
4pgj  2.60  2015  Kd=26nM       // 4pgj.pdf (A|B) crystal with well solution (100mM sodium citrate, pH 5.4, supplemented with 28% (w/v) PEG 1500
4xhu  2.09  2015  Kd=26nM       // 4xhu.pdf (A|B)
4pvz  2.50  2015  Kd=27.3nM     // 4pvz.pdf (A|C)
5eiv  2.41  2015  Kd=28.2uM     // 5eiv.pdf (B|E) consensus THP
4yyp  2.60  2015  Kd=280nM      // 4yyp.pdf (A|B)
4qci  2.30  2015  Kd=28pM       // 4qci.pdf (BA|D)
4yiq  1.85  2015  Kd=2uM        // 4yiq.pdf (C|D) heterodimer
5e6p  3.22  2015  Kd=2uM        // 5e6p.pdf (A|B)
5aam  2.49  2015  Kd=3.8nM      // 5aam.pdf (A|C) Entry 5AAM supersedes 4UD3
5bvp  2.20  2015  Kd=30.5pM     // 5bvj.pdf (HL|I)
4xl1  2.30  2015  Kd=304nM      // 4xl1.pdf (A|B)
4cvw  2.67  2015  Kd=30pM       // 4cvw.pdf (A|C) pH=6.5, Temp=25C
5a6w  1.60  2015  Kd=31nM       // 5a6w.pdf (B|C)
4wnd  1.50  2015  Kd=32.9nM     // 4wnd.pdf (A|B) [Different ligand in assay: MBP-Frmpd4 (978-1011)]
5ajj  1.75  2015  Kd=3220nM     // 5ajj.pdf (A|B)
3wwq  1.90  2015  Kd=35.9uM     // 3wwq.pdf (AH|C)
4tq1  1.80  2015  Kd=350uM      // 4tq0.pdf (A|B) [Different ligand in assay: minimal peptide, 36 residue from Thr575 to Val610 of TECPR1]
4y61  3.36  2015  Kd=355.5nM    // 4y61.pdf (A|B) PTPdelta Ig1-Fn1 meA9B+
5a3i  2.89  2015  Kd=36nM       // 5a3i.pdf (CD|A)
5dh9  2.55  2015  Kd=37nM       // 5dh9.pdf (C|D)
4xkl  2.10  2015  Kd=39.1uM     // 4xkl.pdf (C|D)
4uwq  3.28  2015  Kd=3uM        // 4uwq.pdf (KL|J) disulfide-linked complex
5c0n  3.00  2015  Kd=4.13uM     // 5c0n.pdf (HL|A) 
5aoq  2.70  2015  Kd=4.1nM      // 5aoq.pdf (B|L) two sequential binding events
4w4o  1.80  2015  Kd=4.2nM      // 4w4o.pdf (A|C)
4xvp  3.40  2015  Kd=4.2nM      // 4xl5.pdf (C|F)
5aaw  3.27  2015  Kd=4.32nM     // 5aaw.pdf (H|I)
4xwj  2.10  2015  Kd=4.45nM     // 4xwj.pdf (A|B) [Different protein in assay: The Rsd protein is A133S mutant]
5d2n  2.10  2015  Kd=4.7uM      // 5d2n.pdf (FC|HG)
5e3e  1.70  2015  Kd=40.9nM     // 5e3e.pdf (C|D) biolayer interferometry assay
4ypg  3.00  2015  Kd=44pM       // 4ypg.pdf (BA|C) KD was determined using a KinExa instrument
2mws   NMR  2015  Kd=45uM       // 2mro.pdf (A|B)
4pj2  1.24  2015  Kd=47pM       // 4pj2.pdf (B|C) [Different ligand in assay: SPR assay is for  i-type lysozyme from V. philippinarium]
5dwu  3.97  2015  Kd=49nM       // 5dwu.pdf (HL|AB)
5d2l  3.51  2015  Kd=5.1uM      // 5d2l.pdf (IJ|QA)
4yl8  1.50  2015  Kd=5.4uM      // 4yl8.pdf (A|B) [Nonstandard assay: assay in the presence of 400mM NaCl]
4d2g  2.65  2015  Kd=5.56uM     // 4d2g.pdf (B|E) [Different ligand in assay: The protein in crystal structure is P15(51-71),the protein uesd in binding assay is P15(50-77)]
4weu  2.61  2015  Kd=5.7uM      // 4wem.pdf (D|B) PDF is not editable
5bw7  3.00  2015  Kd=52.3nM     // 5bw7.pdf (A|C)
4zak  2.82  2015  Kd=56nM       // 4zak.pdf (CD|A) mCD1d/DB06-1/iNKTCR ternary complex;
4zfg  2.27  2015  Kd=5nM        // 4zff.pdf (HL|A)
4zff  2.75  2015  Kd=5nM        // 4zff.pdf (HL|D)
4s3o  2.00  2015  Kd=6.1uM      // 4s3o.pdf (E|D) assay using bio-layer interferometry (BLI)
5ee4  2.30  2015  Kd=6.1uM      // 5ee4.pdf (CD|A)
4uem  2.82  2015  Kd=6.4nM      // 4uel.pdf (A|B)
5e8d  2.50  2015  Kd=6.5nM      // 5e8d.pdf (HL|A)
4wem  1.55  2015  Kd=6.8uM      // 4wem.pdf (A|B)
4uf1  2.30  2015  Kd=6.98uM     // 4uf1.pdf (A|B)
4tq0  2.70  2015  Kd=6.9uM      // 4tq0.pdf (E|F) [Different ligand in assay: mininal peptide, 36 residues from Phe10 to Lys45 of ATG16L1]
4uwx  1.65  2015  Kd=6.9uM      // 4uwx.pdf (B|D)
2n1d   NMR  2015  Kd=60nM       // 2n1d.pdf (A|B)
5d1m  1.58  2015  Kd=62nM       // 5d1k.pdf (A|B) Binding was assessed by MST
5d71  2.25  2015  Kd=65pM       // 5c7x.pdf (HL|A) MOR04302 in complex with human GM-CSF
5d72  2.60  2015  Kd=6pM        // 5c7x.pdf (HL|A) MOR04252 in complex with human GM-CSF
4xoi  2.09  2015  Kd=7.3uM      // 4xoi.pdf (C|D)
5c0s  4.30  2015  Kd=7.7nM      // 5c0s.pdf (HL|A)
4rgo  1.80  2015  Kd=7.9nM      // 4rgm.pdf (HL|S) BLI assay, data not shown
5dha  2.95  2015  Kd=780nM      // 5dh9.pdf (C|D) competition test
4x4m  3.49  2015  Kd=8.8nM      // 4x4m.pdf (A|F) [Nonstandard assay: NaCl=0.15M]
4yn0  2.20  2015  Kd=85nM       // 4yn0.pdf (A|B) assay by biolayer interferometry
4ui0  2.80  2015  Kd=88nM       // 4ui0.pdf (B|C) crystal form 2
4xnm  2.51  2015  Kd=8nM        // 4xnm.pdf (HL|C) Measured on an Octet interferometry instrument
4yiz  2.20  2015  Kd=8nM        // 4yiz.pdf (E|F)
5cxb  2.10  2015  Kd=9.19nM     // 5cxb.pdf (A|B)
5e7f  2.70  2015  Kd=9.1nM      // 5e7f.pdf (C|I) Biolayer interferometry (BLI)
5cjs  4.30  2015  Kd=9.5nM      // 5cjq.pdf (HL|CD) KD values were determined using biolayer interferometry
4zpt  2.59  2015  Kd=9.93nM     // 4zpt.pdf (AB|R) Crystal Form 1, measured in triplicate by biolayer interferometry
4yj4  2.10  2015  Kd=9.9nM      // 4yj4.pdf (A|B)
4qnp  2.80  2015  Kd=95nM       // 4qnp.pdf (EF|AB) BioLayer Interferometry
5c3f  1.43  2016  IC50=1.6uM    // 5c3f.pdf (A|B) FITC competition assay for inhibition of Mcl-1/NOXA-B interaction
5gpg  1.67  2016  IC50=2.61nM   // 5gpg.pdf (A|B) with rapamycin
5ibk  2.50  2016  IC50=70nM     // 5ibk.pdf (AB|C)
5e94  2.00  2016  IC50~3nM      // 5e94.pdf (DC|H) Fab 3F52 prevented binding of 125I-GLP-1 to human GLP-1R in a concentration-dependent manner
5d1z  3.17  2016  Kd<1pM        // 5d1q.pdf (CD|I)
5j57  1.70  2016  Kd=0.02nM     // 5boz.pdf (A|B)
5hvf  2.85  2016  Kd=0.03nM     // 5hvf.pdf (A|B) 0.3 x 10 -10M is not 3nM
5hgg  1.97  2016  Kd=0.054nM    // 5hgg.pdf (A|T) +/-0.02
5eg3  2.61  2016  Kd=0.135uM    // 5eg3.pdf (A|B) cSH2
5f6k  2.41  2016  Kd=0.13uM     // 5f59.pdf (A|E)
5hpy  2.40  2016  Kd=0.13uM     // 5hpy.pdf (D|F)
5jsb  2.74  2016  Kd=0.15uM     // 5jsb.pdf (G|H) BLI assay
4ybl  3.10  2016  Kd=0.17nM     // 4ybl.pdf (HL|G)
5dcq  1.83  2016  Kd=0.18uM     // 5dcq.pdf (C|F)
5lxm  2.08  2016  Kd=0.18uM     // 5lxm.pdf (A|D) ligand is stapled TPX2 protein 10
5t5f  2.98  2016  Kd=0.19nM     // 5t5f.pdf (HL|A)
5eoa  2.50  2016  Kd=0.1uM      // 5eoa.pdf (A|D) [Different protein in assay: Optineurin, OPTN(26-119) E50K mutant] ITC assay use OPTN(26-119) E50K mutant
5j7c  2.54  2016  Kd=0.209nM    // 5j7c.pdf (B|D) bio-layer interferometry (BLI) assay
5ibw  1.90  2016  Kd=0.25nM     // 5ibw.pdf (A|C) [Multiple sites: Kd1=0.25nM, Kd2=55nM] 2:1 MlcC / M1C-IQ1.2 Complex
5cw7  2.83  2016  Kd=0.28pM     // 5cw7.pdf (I|J) T=300.15K
5ifs  2.46  2016  Kd=0.2nM      // 5ifs.pdf (A|B)
5sx4  2.80  2016  Kd=0.34nM     // 5sx4.pdf (JI|M)
5fo8  2.40  2016  Kd=0.35uM     // 5fo7.pdf (AB|C)
5ies  2.16  2016  Kd=0.368uM    // 5ies.pdf (HL|C)
5eo9  2.30  2016  Kd=0.37uM     // 5eo9.pdf (A|B) Dpr6 D1 / DIP-alpha (CG32791) D1-D2
5czv  3.19  2016  Kd=0.3nM      // 5czv.pdf (HL|A) flow cytometric studies
5mi0  2.35  2016  Kd=0.41uM     // 5mi0.pdf (BC|A) SPR Kd after lyophilizing of PfRH5 Delta NL-HS1 is 0.30uM
4zi3  2.00  2016  Kd=0.42uM     // 4zi3.pdf (B|D) [Nonstandard assay: Temp 20C]
5li1  2.00  2016  Kd=0.47uM     // 5li1.pdf (A|B)
5ays  2.09  2016  Kd=0.508nM    // 5ayr.pdf (B|D)
5cx3  2.30  2016  Kd=0.54uM     // 5cx3.pdf (A|E)
5c0b  2.03  2016  Kd=0.5uM      // 5c07.pdf (DE|AC) complex of 1E6-A2-RQF[I]
5sv3  2.73  2016  Kd=0.627nM    // 5sv3.pdf (C|D)
5hvg  3.05  2016  Kd=0.63nM     // 5hvf.pdf (A|B) 6.3 x 10 -10M is not 63nM
5lxq  3.34  2016  Kd=0.64uM     // 5lxq.pdf (C|H)
5czx  2.10  2016  Kd=0.6nM      // 5czv.pdf (CD|B) flow cytometric studies
5ep6  1.45  2016  Kd=0.72uM     // 5eoa.pdf (A|B)
5boz  3.10  2016  Kd=0.7nM      // 5boz.pdf (E|K)
5d5m  2.20  2016  Kd=0.7uM      // 5d5m.pdf (GH|A)
5eyp  1.90  2016  Kd=0.82nM     // 5eyp.pdf (AB|F) +/-0.18
5bt1  2.62  2016  Kd=0.83uM     // 5bt1.pdf (A|D) ITC Kd1=0.83uM, Kd2=0.22uM; SPR Kd1=0.52uM, Kd2=0.21uM
5ctr  3.01  2016  Kd=0.88uM     // 5ctr.pdf (A|C)
5jsn  2.10  2016  Kd=0.8uM      // 5jsb.pdf (A|B) BLI assay
5dmi  3.69  2016  Kd=0.91nM     // 5dmi.pdf (HL|A)
4xkh  3.00  2016  Kd=0.94uM     // 4xkh.pdf (A|E)
5k8q  1.74  2016  Kd=0.9nM      // 5k8q.pdf (A|B) [Nonstandard assay: assay at temp 37C]
5kho  2.78  2016  Kd=0.9uM      // 5kho.pdf (B|D) Kd=0.9+/-0.2uM, Rasip1 in complex with Rap1B
5sx5  2.50  2016  Kd=1.15nM     // 5sx4.pdf (HL|N)
5l2k  3.20  2016  Kd=1.15uM     // 5l2j.pdf (ED|A)
5c4v  2.60  2016  Kd=1.1uM      // 5c4v.pdf (C|D)
5szk  2.80  2016  Kd=1.1uM      // 5lpn.pdf (A|B)
5hdq  1.83  2016  Kd=1.2nM      // 5hdq.pdf (HL|A)
5j3d  4.08  2016  Kd=1.37nM     // 5itb.pdf (AB|FI) protein 2 in crystal is RSV A2 F, protein name for assay is FFL_001
5fob  2.60  2016  Kd=1.3uM      // 5fo7.pdf (AB|C)
5chv  3.01  2016  Kd=1.49uM     // 5chv.pdf (A|C)
5edv  3.48  2016  Kd=1.6uM      // 5edv.pdf (AE|C)
5jg6  2.00  2016  Kd=1.6uM      // 5jg6.pdf (D|C) measured by BLI
5d8j  3.00  2016  Kd=1.78nM     // 5c0n.pdf (HL|A) biomolecular interaction analysis
5kov  3.25  2016  Kd=1.87nM     // 5kov.pdf (H|K)
5b78  1.40  2016  Kd=1.88uM     // 5b75.pdf (A|B)
4zrp  2.10  2016  Kd=1.8nM      // 4zrp.pdf (B|D) Solid-phase binding assay
5fvk  1.66  2016  Kd=1.8uM      // 5fvk.pdf (A|C)
5ayr  2.40  2016  Kd=1.959nM    // 5ayr.pdf (C|D)
5fo9  3.30  2016  Kd=1.9uM      // 5fo7.pdf (DE|F)
5d7l  3.40  2016  Kd=10.4uM     // 5d5m.pdf (GH|A)
2n8j   NMR  2016  Kd=10.7nM     // 2n8j.pdf (A|B) SPR assay at 225nM free Ca2+
5b77  1.55  2016  Kd=10.8uM     // 5b75.pdf (A|B)
5czf  2.67  2016  Kd=100pM      // 5cw7.pdf (A|D) T=300.15K
5kn5  2.80  2016  Kd=102pM      // 5kn5.pdf (AB|C)
5et1  1.65  2016  Kd=107nM      // 5et1.pdf (B|D)
5b75  1.70  2016  Kd=10uM       // 5b75.pdf (A|B)
5dju  2.10  2016  Kd=11.4nM     // 5djt.pdf (D|C) A radiometric binding assay
5ft8  2.50  2016  Kd=117nM      // 5ft8.pdf (I|Y) (CsdAper-CsdEper)2, interaction between the CsdA homodimer and each CsdE monomer
5g1x  1.72  2016  Kd=12.1uM     // 5g1x.pdf (A|B) [Nonstandard assay: 150mM NaCl] +/-0.6; phosphorylated Aurora-A
5inb  1.30  2016  Kd=123nM      // 5inb.pdf (A|B)
5ius  2.89  2016  Kd=127pM      // 5ius.pdf (A|C) SPR PH=7.4
5e9d  2.51  2016  Kd=129nM      // 5e9d.pdf (DE|AC)
5fhx  2.55  2016  Kd=12pM       // 5fhx.pdf (HL|A) SPR Kd for antigen 1, IL4
4z9v  2.10  2016  Kd=12uM       // 4z9v.pdf (B|D) [Different protein in assay: Bcl-xL]
4rt6  2.80  2016  Kd=13.2nM     // 4rt6.pdf (A|B) SI page of nature is not accessible with internal error 500, please check ITC Kd data later
5ij9  3.70  2016  Kd=13.4uM     // 5ij0.pdf (A|B) Kd=13.4+/-3.7uM
5d1q  3.22  2016  Kd=13pM       // 5d1q.pdf (AB|E) SPR Kd is 13-16pM
5eb1  1.80  2016  Kd=140nM      // 5eb1.pdf (C|D)
5fr2  3.35  2016  Kd=141nM      // 5fr2.pdf (A|B) +/-45
5hk5  2.90  2016  Kd=146nM      // 5hk5.pdf (E|A)
5e95  1.40  2016  Kd=15.7nM     // 5e95.pdf (B|A) +/-2.7
5j8h   NMR  2016  Kd=153nM      // 5j8h.pdf (A|B) average Kd over measurements in triplicate
5f1b  2.30  2016  Kd=158uM      // 5f1b.pdf (AB|C)
5jlv  2.00  2016  Kd=15nM       // 5jlv.pdf (A|C) ITC curve has two binding components
5i5k  4.20  2016  Kd=17.6pM     // 5i5k.pdf (HL|B)
5djt  1.40  2016  Kd=17nM       // 5djt.pdf (A|B) A radiometric binding assay
5j28  2.00  2016  Kd=193nM      // 5inb.pdf (B|D)
5ejc  3.10  2016  Kd=197nM      // 5ejc.pdf (B|D)
5lz3  3.00  2016  Kd=19uM       // 5lz3.pdf (A|B)
4z2m  2.98  2016  Kd=2.01uM     // 4z2m.pdf (GHIJ|B) 1:1 stoichiometry
5jhf  3.21  2016  Kd=2.0uM      // 5jhf.pdf (B|C) Kd=2.0+/-0.2uM
5ksb  2.90  2016  Kd=2.0uM      // 5ks9.pdf (GH|ABJ) Kd=2.0+/-0.1uM
4z9k  1.50  2016  Kd=2.2nM      // 4z9k.pdf (A|B) another PDB code 5E1H for antibody F8 is not in PDBbind
5tar  1.90  2016  Kd=2.3uM      // 5tar.pdf (A|B)
5te6  2.40  2016  Kd=2.59nM     // 5te4.pdf (HL|G)
5j3h  3.27  2016  Kd=2.5nM      // 5j3h.pdf (CD|E) Kd=2.5+/-0.6uM
5k59  2.84  2016  Kd=2.5pM      // 5k59.pdf (HL|A) measured by MSD
5d50  2.49  2016  Kd=2.6uM      // 5d50.pdf (B|F) assay using bio-layer interferometry (BLI)
5jhl  3.00  2016  Kd=2.7nM      // 5jhl.pdf (HL|A)
5te7  2.15  2016  Kd=2.81nM     // 5te4.pdf (HL|G)
5jh5  2.55  2016  Kd=2.8uM      // 5jh5.pdf (CD|A) heterotetramer structure of two dimers
5ks9  2.55  2016  Kd=2.8uM      // 5ks9.pdf (GH|ABJ)
5kw9  2.30  2016  Kd=20.5nM     // 5kw9.pdf (HL|A) biolayer interferometry (BLI)
5glh  2.80  2016  Kd=20.7pM     // 5glh.pdf (A|B)
4zs7  2.93  2016  Kd=21pM       // 4zs7.pdf (HL|A) Kd=13-21pM, Dissociation kinetics outside the detection limit of the Biacore T200
5d1x  3.21  2016  Kd=21pM       // 5d1q.pdf (AB|E) SPR Kd is 21-31pM
4xr8  2.25  2016  Kd=22.1uM     // 4xr8.pdf (BH|D)
5fqd  2.45  2016  Kd=220nM      // 5fqd.pdf (B|A) +/-4; lenalidomide induced, competes with CRL4CRBN
5f5s  2.40  2016  Kd=22nM       // 5f5s.pdf (A|B) [Nonstandard assay: ITC test at 10 centigrade] ITC test at 10 centigrade
5szi  2.85  2016  Kd=253nM      // 5lpn.pdf (A|B)
5k22  3.00  2016  Kd=25nM       // 5k22.pdf (A|B)
5kvd  1.65  2016  Kd=266nM      // 5kvd.pdf (HL|E) KD (equilibrium) determined by BLI
5ee5  2.28  2016  Kd=26uM       // 5ee5.pdf (A|B) [Nonstandard assay: pH 8.0] [Different protein in assay: Protein in binding assay is DCB domain of BIG1] ARL1 with ATP; +/-5
5d28  2.85  2016  Kd=27nM       // 5d28.pdf (D|C) bio-layer interferometry (BLI) assay
5ikc  2.06  2016  Kd=27nM       // 5ikc.pdf (HL|N) [Different protein in assay: assay use length human doublecortin (hDCX)] SPR data is for length human doublecortin (hDCX)
5cd5  3.40  2016  Kd=289nM      // 5cd5.pdf (CD|A) Glycosylated Kd1
5mhs  3.70  2016  Kd=2nM        // 5mhs.pdf (ED|AB)
5l8j  1.68  2016  Kd=2uM        // 5l8j.pdf (A|B) [Different ligand in assay: ligand protein in assay is wildtype vNAR-D01] SPR Kd=2uM for wt vNAR-D01
5f3x  2.65  2016  Kd=3.11nM     // 5f3x.pdf (A|B)
2n13   NMR  2016  Kd=3.1uM      // 2n13.pdf (D|C)
5j56  1.80  2016  Kd=3.2nM      // 5boz.pdf (A|B)
5fr1  2.75  2016  Kd=3.3uM      // 5fr1.pdf (A|B)
5ibl  3.39  2016  Kd=3.6uM      // 5ibl.pdf (HL|B) biolayer interferometry (BLI) assay
5eof  2.05  2016  Kd=3.8uM      // 5eoa.pdf (A|D)
4ww2  2.48  2016  Kd=3.9uM      // 4ww1.pdf (AB|CF)
5sws  2.86  2016  Kd=30uM       // 5sws.pdf (DE|AC) ligand is NP2-B17 TCR
2n73   NMR  2016  Kd=320nM      // 2n73.pdf (A|B) [Different protein in assay: recombinant full length ACBD3] [Different ligand in assay: recombinant full length PI4KB] Kd is for recombinant full length ACBD3 and PI4KB
5hps  2.05  2016  Kd=322.9nM    // 5c7j.pdf (A|B) BLI assay
5kvf  1.40  2016  Kd=32nM       // 5kvd.pdf (HL|E) KD (equilibrium) determined by BLI
5m72  1.60  2016  Kd=33nM       // 5m72.pdf (A|B)
5hxb  3.60  2016  Kd=347nM      // 5hxb.pdf (Y|Z) [Nonstandard assay: 150mM NaCl] CC-885
5men  2.81  2016  Kd=34uM       // 5men.pdf (DE|AC)
5dc4  1.48  2016  Kd=35nM       // 5dc4.pdf (A|B) crystal form A, mean fluorescence intensity (MFI)
5kve  1.70  2016  Kd=35nM       // 5kvd.pdf (E|L) KD (equilibrium) determined by BLI
5imt  2.70  2016  Kd=367nM      // 5imt.pdf (A|D) [Different protein in assay: assay use wildtype ILY (ILY-wt)] assay by microscale thermophoresis
5hys  2.50  2016  Kd=38.9pM     // 5hys.pdf (HL|I)
5jdo  3.20  2016  Kd=3nM        // 5jdo.pdf (CF|B)
5f3b  1.76  2016  Kd=3pM        // 5f3b.pdf (AB|C)
5d7j  1.97  2016  Kd=3uM        // 5d5m.pdf (GH|C)
4wwk  3.10  2016  Kd=4.0uM      // 4ww1.pdf (AB|CD)
5drz  2.54  2016  Kd=4.4nM      // 5drz.pdf (BA|Q) SPR Kd=4.4nM, ITC Kd=34nM
5fug  2.70  2016  Kd=4.4nM      // 5fug.pdf (AB|C)
5ksa  2.00  2016  Kd=4.7uM      // 5ks9.pdf (CD|ABJ)
5eib  2.10  2016  Kd=4.8uM      // 5eib.pdf (CD|F) [Nonstandard assay: Temp 15C, pH 6.8] [Different protein in assay: protein in binding assay is tubulin-PN2-3c without DARPin] DARPin molecule didnot affect binding of PN2-3C to tubulin
4zw2  1.86  2016  Kd=4.9nM      // 4zw2.pdf (A|B)
5elu  2.35  2016  Kd=414nM      // 5elu.pdf (A|B)
5grj  3.21  2016  Kd=42.1pM     // 5grj.pdf (HL|A)
5kwy  2.41  2016  Kd=429nM      // 5kwy.pdf (A|D) [Different protein in assay: Kd for murine NPC1 middle lumenal domain] Microscale thermophoresis; Kd for murine NPC1 middle lumenal domain bound to NPC2; SPR Kd is about 2uM
5c0c  1.97  2016  Kd=44.4uM     // 5c07.pdf (IJ|AC) complex of 1E6-A2-RQF[A]
5ip4  1.81  2016  Kd=451nM      // 5ikc.pdf (B|D) [Different protein in assay: assay use length human doublecortin (hDCX)] SPR data is for length human doublecortin (hDCX)
5f4e  2.40  2016  Kd=48nM       // 5f4e.pdf (A|B)
5fzt  2.10  2016  Kd=48uM       // 5fzt.pdf (A|B)
4udm  2.96  2016  Kd=4nM        // 4udm.pdf (A|B) under 20mM NaCl concentration
4xxw  2.26  2016  Kd=5.12uM     // 4xxw.pdf (A|D)
5szh  2.30  2016  Kd=5.2uM      // 5lpn.pdf (A|B)
5gzn  3.00  2016  Kd=5.39uM     // 5gzn.pdf (HL|AE) apparent KD was calculated by steady-state affinity mode
5dmj  2.79  2016  Kd=5.3nM      // 5dmi.pdf (A|B) CD40/3h-56-5 dAb C2 crystal form
5b76  1.65  2016  Kd=5.8uM      // 5b75.pdf (A|B)
5l6y  1.99  2016  Kd=58pM       // 5l6y.pdf (HL|C) SPR Kd=58pM for Tralokinumab IgG4; Kd=63pM for Tralokinumab IgG1
5hlz  2.85  2016  Kd=5nM        // 5hlz.pdf (E|F) biolayer interferometry (BLI) assay
5jem  2.50  2016  Kd=6.02uM     // 5jek.pdf (B|D) IRF-3/CBP complex
5foa  4.19  2016  Kd=6.1uM      // 5fo7.pdf (AB|E) [Different ligand in assay: The binding data is for C3b and DAF (CCP1-4)] Maybe author made a typo as DAF (CCP1-4)
5eu6  2.02  2016  Kd=6.3uM      // 5eu3.pdf (DE|AC) Kd for PMEL17 TCR and A2-YLE-9V
5eql  2.49  2016  Kd=68nM       // 5elu.pdf (A|B)
5fcu  1.85  2016  Kd=6nM        // 4ybl.pdf (HL|G)
5fv2  3.45  2016  Kd=7.17pM     // 5fv2.pdf (A|X) [Different ligand in assay: ligand in assay is VEGF-A165]
5jze  2.47  2016  Kd=7.48uM     // 5jze.pdf (D|C) Kd=7.48+/-0.26uM
5c07  2.11  2016  Kd=7.4uM      // 5c07.pdf (DE|AC) complex of 1E6-A2-YQF
5c08  2.33  2016  Kd=7.8uM      // 5c07.pdf (DE|AC) complex of 1E6-A2-RQW
5ij0  3.80  2016  Kd=7.9uM      // 5ij0.pdf (A|B) Kd=7.9+/-3.2uM
5ixd  2.85  2016  Kd=70.5nM     // 5ixd.pdf (A|B) Biolayer Interferometry assay
5b64  2.70  2016  Kd=70nM       // 5b64.pdf (A|B)
5igx  3.39  2016  Kd=711nM      // 5f7e.pdf (HL|G)
5j4a  2.00  2016  Kd=72nM       // 5j4a.pdf (A|B) Biolayer interferometry (BLI) assay
5itz  2.20  2016  Kd=75nM       // 5itz.pdf (AB|D) Kd=75+/-12nM
5ioh  2.57  2016  Kd=778nM      // 5inb.pdf (A|B)
5imy  2.40  2016  Kd=779nM      // 5imt.pdf (A|C) [Different protein in assay: assay use wildtype VLY (VLY-wt)] assay by microscale thermophoresis
5szj  2.66  2016  Kd=790uM      // 5lpn.pdf (A|B)
5d3f  2.74  2016  Kd=8.05uM     // 5d3f.pdf (A|C) ligand is CFTR_R6 peptide, in presence of stabilizer FC-A; Kd=24uM when without FC-A
5jyl  2.55  2016  Kd=8.7nM      // 5jyl.pdf (A|B)
5kvg  1.40  2016  Kd=8.8nM      // 5kvd.pdf (HL|E) KD (equilibrium) determined by BLI
5fw5  1.92  2016  Kd=80nM       // 5fw5.pdf (A|C) MST assay in a two-phase binding mode
5d7i  2.00  2016  Kd=81.4uM     // 5d5m.pdf (GH|A)
5lcv  2.64  2016  Kd=840nM      // 5lcv.pdf (HL|AB) Biolayer interferometry experiments
5t1d  3.10  2016  Kd=85.8nM     // 5t1d.pdf (HL|B)
5jmc  2.64  2016  Kd=86nM       // 5jlv.pdf (E|F)
5lz6  2.60  2016  Kd=8uM        // 5lz3.pdf (A|B)
2nbv   NMR  2016  Kd=9.3uM      // 2nbv.pdf (A|B)
5lrw  2.00  2016  Kd=9.3uM      // 5lrv.pdf (C|D)
5ghw  2.40  2016  Kd=9.6nM      // 5ghw.pdf (HL|P)
5hpk  2.43  2016  Kd=9.7nM      // 5c7j.pdf (A|B) BLI assay
5te4  2.75  2016  Kd=9.9nM      // 5te4.pdf (HL|G)
5jke  2.86  2016  Kd=91nM       // 5jkc.pdf (A|B)
5jtl   NMR  2016  Kd~0.5uM      // 5jtl.pdf (B|E)
5jto   NMR  2016  Kd~11uM       // 5jtl.pdf (D|G)
5jtm   NMR  2016  Kd~15uM       // 5jtl.pdf (B|F)
5lqb  1.95  2016  Kd~1nM        // 5lqb.pdf (HL|A) near 1nM SPR data in figure S3A, but SI file is not freely available
5jtr   NMR  2016  Kd~2.5uM      // 5jtl.pdf (A|G)
5c09  2.48  2016  Kd~400uM      // 5c07.pdf (DE|AC) complex of 1E6-A2-YLG
5jtp   NMR  2016  Kd~40uM       // 5jtl.pdf (A|E)
5swz  2.65  2016  Kd~40uM       // 5sws.pdf (DE|AC) ligand is NP1-B17 TCR
5jtq   NMR  2016  Kd~4uM        // 5jtl.pdf (B|E)
5c0a  2.46  2016  Kd~600uM      // 5c07.pdf (DE|AC) complex of 1E6-A2-MVW
5jtn   NMR  2016  Kd~8uM        // 5jtl.pdf (D|E)
5e6j  2.85  2016  Ki=12.07uM    // 5e6j.pdf (A|B)
5d93  2.20  2016  Ki=16nM       // 5d93.pdf (FE|D)
5d96  2.30  2016  Ki=2.2nM      // 5d93.pdf (CB|A)
5c67  1.83  2016  Ki=89pM       // 5c67.pdf (A|E)
5jhw  2.35  2017  IC50=0.3nM    // 5jhw.pdf (B|C) GDF11:FS288
5gy2  2.10  2017  IC50=204pM    // 5gy2.pdf (A|C) competitive binding assay
5v62  1.90  2017  IC50=25nM     // 5v62.pdf (A|I) [Incomplete ligand] [Nonstandard assay: Temp 30] ligand is SBP3, the SBP3 linker is mostly not resolved by electron density!!!
5t0f  2.40  2017  IC50=58nM     // 5t0f.pdf (A|B) CMIDJAZ10 peptide competitively inhibit the MYC3-MED25 interaction
5th9  3.00  2017  Kd<0.008nM    // 5th9.pdf (IM|B) assay using a ProteOn XPR36 biosensor
5wql  2.30  2017  Kd<10nM       // 5wql.pdf (A|C) [Different protein in assay: protein in crystal is K477A] Prc-sNlpI
5nhu  1.45  2017  Kd<1nM        // 5nhu.pdf (H|I) another Kd=0.3nM from displacement titration experiments
5tdy  2.11  2017  Kd<40nM       // 5tdy.pdf (C|D)
5usl  2.90  2017  Kd=0.016nM    // 5ush.pdf (BC|A) biolayer interferometry (BLI) assay
5nwm   NMR  2017  Kd=0.04uM     // 5nwm.pdf (A|B) data from reference
5jw9  2.00  2017  Kd=0.086uM    // 5jw9.pdf (A|B) Fluorescence anisotropy
5mj3  1.74  2017  Kd=0.11nM     // 4oe8.pdf (AB|C) Crystal form 1
5t5b  2.07  2017  Kd=0.123nM    // 5sy8.pdf (HL|E) mutant 5
5gjk  2.05  2017  Kd=0.12uM     // 5gjk.pdf (A|B)
5m2j  1.90  2017  Kd=0.13nM     // 5m2i.pdf (A|D)
5w06  2.60  2017  Kd=0.14nM     // 5w05.pdf (HL|T)
5b71  2.11  2017  Kd=0.152nM    // 5b71.pdf (BA|E) SKY59 bind human C5 at pH 7.4 with KD of 0.152nM, in a pH-dependent manner
5vob  3.02  2017  Kd=0.15nM     // 5vob.pdf (HL|DE) SI file is not available
5gzo  2.76  2017  Kd=0.1636uM   // 5gzo.pdf (HL|A) real-time biophysical binding assays (BIAcore)
5thp  3.01  2017  Kd=0.21nM     // 5thp.pdf (AB|C) binds to close conformation of integrin alpha2-A domain
5o76  2.47  2017  Kd=0.25uM     // 5o76.pdf (C|F) +/-0.04
5h3j  1.33  2017  Kd=0.27uM     // 5h3j.pdf (A|B)
5xot  2.79  2017  Kd=0.27uM     // 5xos.pdf (ED|A) TU55/B35-pol448-9
6b9j  2.90  2017  Kd=0.35nM     // 5ush.pdf (HL|X) biolayer interferometry (BLI) assay
5t29  2.03  2017  Kd=0.379nM    // 5sy8.pdf (HL|O) mutant 3
5u4m  2.50  2017  Kd=0.39nM     // 5u4l.pdf (A|B) crystal under no salt conditions
5nvl  2.30  2017  Kd=0.3nM      // 5nvk.pdf (A|B)
5vey   NMR  2017  Kd=0.3uM      // 5vey.pdf (AB|C)
5vmm  3.60  2017  Kd=0.42nM     // 5vmm.pdf (B|H) previous ITC assay for carboxyhemoglobin
5omb  1.94  2017  Kd=0.43uM     // 5omb.pdf (B|C) [Different ligand in assay: ligand protein in bioassay is ScDdc2N] MST assay
6atk  3.51  2017  Kd=0.43uM     // 6atk.pdf (B|E)
5kxh  1.33  2017  Kd=0.49uM     // 5kxh.pdf (A|B) [Nonstandard assay: 500uM GDP]
5nvk  2.90  2017  Kd=0.4nM      // 5nvk.pdf (G|H)
5vx3  1.95  2017  Kd=0.4nM      // 5vwv.pdf (G|H) Bcl-xL: Bim-h3Pc-RT
5xeq  3.14  2017  Kd=0.4nM      // 5xeq.pdf (A|B) [Multiple sites: site 1: Kd=0.4nM; site 2: Kd=11nM] assay by biolayer light interferometry, dimeric NL2 contains two binding sites for MDGA1
5lp5  2.74  2017  Kd=0.4uM      // 5lp5.pdf (B|D)
5m2i  2.15  2017  Kd=0.54nM     // 5m2i.pdf (A|H)
5wy2  1.90  2017  Kd=0.54uM     // 5wy2.pdf (C|D)
5o2u  2.76  2017  Kd=0.69nM     // 5o2u.pdf (C|D) assay by biolayer Interferometry
5wrv  1.70  2017  Kd=0.73uM     // 5wrv.pdf (A|B) microscale thermophoresis (MST) assay; length of SRP68 is not 103 as described on RCSB
5wb7  2.94  2017  Kd=0.76uM     // 5wb7.pdf (A|E)
5jq6  2.40  2017  Kd=0.79nM     // 5jq6.pdf (HL|A) [Different protein in assay: Clumping factor A, ClfA (229-545)]
5ky5  1.50  2017  Kd=0.79uM     // 5kxh.pdf (A|B) [Nonstandard assay: 500uM GDP]
5wgg  2.04  2017  Kd=0.7uM      // 5wgg.pdf (A|B) [Different ligand in assay: Ligand in binding assay is 5,6-TAMRA label  on the N-terminus] CteB+SAM +CteA-M1-C21
5o05  2.00  2017  Kd=0.81nM     // 5o02.pdf (D|A)
5uk5  2.51  2017  Kd=0.81uM     // 5uk5.pdf (A|B)
5tvq  2.35  2017  Kd=0.88uM     // 5tvp.pdf (A|B)
5tuv  2.90  2017  Kd=0.8uM      // 5tuu.pdf (AB|C)
5npo  1.95  2017  Kd=0.95uM     // 5npo.pdf (A|B)
5tgh  2.80  2017  Kd=0.95uM     // 5tgh.pdf (A|B)
5n88  1.70  2017  Kd=1.013uM    // 5n88.pdf (A|D)
5xov  2.68  2017  Kd=1.06uM     // 5xos.pdf (GH|D) S19-2/A24-nef138-10
5oo6  2.80  2017  Kd=1.0uM      // 5oo6.pdf (AB|C) +/-0.2,  ARS2
5tz2  2.30  2017  Kd=1.12nM     // 5tz2.pdf (HL|C)
5mad  1.53  2017  Kd=1.1nM      // 5ma3.pdf (G|H)
5lgk  3.50  2017  Kd=1.2uM      // 5lgk.pdf (A|E) [Multiple sites: site 1: Kd=1.2uM; site 2: Kd=14.4uM] The two CD23 binding sites on IgE
5vwy  1.56  2017  Kd=1.3uM      // 5vwv.pdf (A|B) Bak Core/Latch Dimer: Bim-h3Pc-RT
5wt9  2.40  2017  Kd=1.45nM     // 5wt9.pdf (HL|G)
5mv8  1.88  2017  Kd=1.4uM      // 5mv8.pdf (A|B) Myo7b MF2
5sxp  1.65  2017  Kd=1.59uM     // 5sxp.pdf (B|F)
5m2m  2.30  2017  Kd=1.5nM      // 5m2i.pdf (G|H)
5ush  2.30  2017  Kd=1.5nM      // 5ush.pdf (HL|X) biolayer interferometry (BLI) assay
5xbf  1.80  2017  Kd=1.7uM      // 5xbf.pdf (A|B) Myo7b CMF/USH1C PDZ3;+/-0.1
5iia  1.70  2017  Kd=1.81nM     // 5iia.pdf (G|H) MST assay
5whk  2.50  2017  Kd=1.81nM     // 5whj.pdf (HL|AB) SPR assay at pH 7.5
5tp6   NMR  2017  Kd=1.9nM      // 5tp6.pdf (A|B)
5omm  1.70  2017  Kd=10.4nM     // 5o02.pdf (A|C)
5tru  3.00  2017  Kd=10.6nM     // 5tru.pdf (hl|c)
5nt7  1.40  2017  Kd=10.6uM     // 5nt7.pdf (D|C)
5upk  2.40  2017  Kd=104uM      // 5upk.pdf (B|C) Kd=104+/-38uM,  complex is PAK4cat-PAK4N45-CDC42
5uzu  2.40  2017  Kd=10nM       // 5uzu.pdf (B|A) SPR Kd=10nM, AlphaScreen Kd=2nM
5vt9  1.85  2017  Kd=10nM       // 5vt9.pdf (A|C)
5ky4  1.47  2017  Kd=10uM       // 5kxh.pdf (A|B) [Nonstandard assay: 500uM GDP]
5lhn  2.55  2017  Kd=11.2nM     // 5lhn.pdf (A|B) [Nonstandard assay: Temp 37] muPA:Nb7
5sy8  1.62  2017  Kd=11.2pM     // 5sy8.pdf (HL|O) mutant 1
5mjy  2.25  2017  Kd=11.3uM     // 5mjy.pdf (B|F) +/-0.3, SARA
5vkl  2.20  2017  Kd=113nM      // 5vkl.pdf (A|B) [Different ligand in assay: ligand in assay is RPB1 (1468-1500) pS1493 peptide]
5nus  2.20  2017  Kd=11nM       // 5nus.pdf (A|B)
5un7  2.10  2017  Kd=120nM      // 5un7.pdf (A|B)
5b3h  2.70  2017  Kd=123.8nM    // 5b3g.pdf (B|C)
5h7y  2.20  2017  Kd=125nM      // 5h7y.pdf (A|B)
6b3s  2.80  2017  Kd=12nM       // 6b3s.pdf (JK|I)
5xfs  2.90  2017  Kd=132.23nM   // 5xfs.pdf (AB|C) MST assay
5vwx  2.49  2017  Kd=14.9nM     // 5vwv.pdf (A|B) Bak core/latch dimer: Bim-h0-h3Glt
5nvm  2.00  2017  Kd=14nM       // 5nvk.pdf (C|D)
5hyc  2.40  2017  Kd=15.2uM     // 5hyc.pdf (A|C) [Different ligand in assay: ITC Kd for MoDyn1I2(122-143) peptide] ITC Kd for MoDyn1I2(122-143) peptide
5uws  2.40  2017  Kd=1500nM     // 5uwh.pdf (C|D) protein2 is X11L2 NES Peptide.
5osh  4.30  2017  Kd=151nM      // 5osh.pdf (AB|C)
5v5h  1.50  2017  Kd=158nM      // 5v5g.pdf (A|B) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.2
5u4k   NMR  2017  Kd=15uM       // 5u4k.pdf (A|B)
5tfw  2.17  2017  Kd=16.4pM     // 5sy8.pdf (HL|O) mutant 2
5f5o  2.20  2017  Kd=162nM      // 5f5o.pdf (E|F)
6ba6   NMR  2017  Kd=162uM      // 6ba6.pdf (A|B) HSQC assay; interaction in a GTP-dependent manner
5o2t  2.19  2017  Kd=167nM      // 5o2s.pdf (A|B) GTPgammaS forms
5nqf  1.90  2017  Kd=169nM      // 5nqf.pdf (A|B)
5tzq  1.65  2017  Kd=16nM       // 5tzp.pdf (B|C)
6b08  2.20  2017  Kd=16nM       // 6azz.pdf (CB|A) biolayer interferometry
5ngv  2.00  2017  Kd=16pM       // 5ngv.pdf (HL|A)
5t5w  2.85  2017  Kd=16uM       // 5t5w.pdf (AC|B)
5nan  3.30  2017  Kd=17.5nM     // 5n92.pdf (AF|B)
5wvo  2.00  2017  Kd=17.8nM     // 5wvo.pdf (ABD|C)
6amb  2.50  2017  Kd=17.8uM     // 6amb.pdf (A|B) AF6-RAS
6b0s  1.95  2017  Kd=178nM      // 6b0s.pdf (HL|C) biolayer interferometry assay
5vpl  1.90  2017  Kd=17nM       // 5vpg.pdf (DC|A) this entry supersedes 3RVV
5uq3  3.60  2017  Kd=180nM      // 5uq1.pdf (AB|C)
5ona  2.70  2017  Kd=183nM      // 5ona.pdf (B|C)
5tl7  2.44  2017  Kd=1870uM     // 5tl6.pdf (A|B) ligand is C-terminal domain of mouse ISG15
5mfc  2.40  2017  Kd=18nM       // 5mfc.pdf (C|D)
5un5  2.99  2017  Kd=18nM       // 5un5.pdf (B|C)
5vpg  1.95  2017  Kd=19nM       // 5vpg.pdf (DC|A) 5VPG supersedes 3RVW
5wko  3.49  2017  Kd=1nM        // 5wko.pdf (AB|NQ) biolayer interferometry (BLI), Kd is 1-10nM, marked as +++ level
5hu3  1.89  2017  Kd=1uM        // 5h9b.pdf (A|B) [Nonstandard assay: MG2+, ADP] Kd=1+/-0.1uM
5mv9  2.60  2017  Kd=1uM        // 5mv8.pdf (A|B) Myo7a MF2
5w6g  2.79  2017  Kd=2.12uM     // 5w6c.pdf (HL|A) measured by BLI assay
5me5  1.90  2017  Kd=2.15uM     // 5me5.pdf (A|B) MBP pull-down assay
5gwp  2.58  2017  Kd=2.1nM      // 5gwo.pdf (B|D)
5gvi  1.87  2017  Kd=2.2uM      // 5gvi.pdf (BC|A) [Different protein in assay: bioassay use catalytically inactive zUSP30 mutant (C73A)] bioassay use catalytically inactive zUSP30 mutant (C73A)
5x4l  2.40  2017  Kd=2.34uM     // 5x4l.pdf (B|D)
5swk  1.92  2017  Kd=2.57uM     // 5swk.pdf (A|C) measured by biolayer interferometry
5vx2  1.85  2017  Kd=2.5nM      // 5vwv.pdf (C|D) Mcl-1/Bim-h3Pc-RT
6bit  2.19  2017  Kd=2.6nM      // 6bit.pdf (IK|H) SPR Kd for prevalent Allele 1 and 2
5mn2  2.35  2017  Kd=2.6uM      // 5ml9.pdf (B|C)
5m36  2.45  2017  Kd=2.75uM     // 5m35.pdf (B|C) [Nonstandard assay: 250uM CLR01] +/-0.57, Cdc25CpS216
5h07  2.59  2017  Kd=2.82uM     // 5h07.pdf (A|D)
5tzt  2.89  2017  Kd=2.87nM     // 5tz2.pdf (AB|D)
5wb8  3.00  2017  Kd=2.8uM      // 5wb7.pdf (A|C)
6b6u  1.35  2017  Kd=20.1uM     // 6b6u.pdf (A|B) monomer/dimer equilibrium;+/- 1.3
5uwq  2.28  2017  Kd=20000nM    // 5uwh.pdf (C|D) protein2 is CDC7 NES Peptide.
5ml9  2.35  2017  Kd=217nM      // 5ml9.pdf (A|B)
5v5v  4.11  2017  Kd=21nM       // 5v5v.pdf (F|J)
5vx0  1.60  2017  Kd=21uM       // 5vwv.pdf (C|D) Bim-h3Glg;+/-3
5mtn  2.85  2017  Kd=23.5nM     // 5mtj.pdf (A|B) +/-7.6, Mb(Lck_1)/Lck SH2
5toj  3.30  2017  Kd=23nM       // 5toj.pdf (B|E) KD of F-VHH-4 for monomeric prefusion F was 23nM, while for tri-meric prefusion F is < 18pM
5odw  2.80  2017  Kd=240pM      // 5odw.pdf (B|D)
5y11  2.10  2017  Kd=25.9nM     // 5y11.pdf (AB|C)
5u4y  2.50  2017  Kd=25nM       // 5u4y.pdf (B|D) Kd=25+/-2nM, complex is Fc/Z-domain
5ua4  2.60  2017  Kd=26nM       // 5ua4.pdf (A|B)
5w8t  2.76  2017  Kd=27.06uM    // 5w8t.pdf (B|A)
5wux  2.90  2017  Kd=27.4pM     // 5wuv.pdf (HL|E)
5tte  3.50  2017  Kd=272nM      // 5tte.pdf (EF|B)
5u52  1.94  2017  Kd=27nM       // 5u4y.pdf (B|Z) Kd=27+/-1.4nM, complex is Fc/Z34C
5t6l  2.10  2017  Kd=28.5pM     // 5sy8.pdf (HL|I) mature wild-type
5y4r  2.30  2017  Kd=28.6nM     // 5y4r.pdf (B|C) CheR1/MapZ/c-di-GMP
5j11  2.56  2017  Kd=29nM       // 5j11.pdf (AC|B) bio-layer interferometry (BLI) assay
5mak  2.50  2017  Kd=29pM       // 5ma3.pdf (B|A)
5ma5  1.85  2017  Kd=29pM       // 5ma3.pdf (B|A)
5knm  3.30  2017  Kd=2uM        // 5iue.pdf (AB|D) biolayer interferometry (BLI) assay
5mk0  1.77  2017  Kd=3.1uM      // 5mjy.pdf (A|B) +/-0.1, Endofin
5w3x  2.00  2017  Kd=3.37uM     // 5w3t.pdf (A|B) [Different protein in assay: protein in binding assay is PopP2 C321A] assay in presence of IP6, AcCoA
5oob  2.79  2017  Kd=3.3uM      // 5oo6.pdf (CD|E) +/-1.1, NELF-E
5imm  1.20  2017  Kd=3.5nM      // 5imk.pdf (B|A) crystal form 1 with lower resolution
5ohp  2.80  2017  Kd=3.5uM      // 5ohk.pdf (A|B)
5l21  1.68  2017  Kd=3.7nM      // 5l21.pdf (A|B) HCA1-ciA-C2 (PDB: 5L21)
6b0a  2.50  2017  Kd=3.7nM      // 6azz.pdf (HL|A) biolayer interferometry
5v52  3.10  2017  Kd=3.7uM      // 5v52.pdf (B|C)
5x0w  3.00  2017  Kd=3.7uM      // 5x0w.pdf (E|F)
5my6  2.25  2017  Kd=3.99nM     // 5my6.pdf (A|B)
5o2s  3.22  2017  Kd=3.9nM      // 5o2s.pdf (A|B) GDP forms
5o4e  2.15  2017  Kd=3.9nM      // 5o4e.pdf (D|E)
5uwo  2.35  2017  Kd=3000nM     // 5uwh.pdf (C|D) protein2 is FMRP-1b NES Peptide.
5ma6  2.30  2017  Kd=303pM      // 5ma3.pdf (A|B)
5gwo  2.82  2017  Kd=30nM       // 5gwo.pdf (B|D) [Nonstandard assay: PH=8]
5tzp  1.35  2017  Kd=30nM       // 5tzp.pdf (A|B)
6b0g  1.90  2017  Kd=31nM       // 6azz.pdf (DC|E) biolayer interferometry
5mtj  1.95  2017  Kd=338nM      // 5mtj.pdf (A|B) Mb(Yes_1)/Yes SH2;determined by the yeast binding assay;
5oc7  1.65  2017  Kd=33nM       // 5oc7.pdf (A|C) +/-8 PH/Mb(Bcr-PH_4)
6azp  2.29  2017  Kd=35.1nM     // 6azp.pdf (A|B)
5v69  2.55  2017  Kd=35.9nM     // 5v5g.pdf (A|B) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant ME.4
5wos  2.45  2017  Kd=353nM      // 5wos.pdf (A|B)
5ma3  1.70  2017  Kd=38pM       // 5ma3.pdf (B|A)
5jds  1.70  2017  Kd=3nM        // 5jds.pdf (B|A) assay by differential scanning calorimetry (DSC)
5y1z  2.68  2017  Kd=4.3uM      // 5y1z.pdf (B|D)
5xjg  2.40  2017  Kd=4.52uM     // 5xjg.pdf (A|B) Vac8p-Nvj1p
6b0e  3.30  2017  Kd=41nM       // 6azz.pdf (BA|E) biolayer interferometry
5wuj  2.30  2017  Kd=422nM      // 5wuj.pdf (A|B)
5mu3  2.10  2017  Kd=43nM       // 5mu3.pdf (AB|C)
5nnp  2.60  2017  Kd=46.9nM     // 5nnp.pdf (A|B) ligand protein is HypK-THB
5uwu  2.24  2017  Kd=4600nM     // 5uwh.pdf (C|D) protein2 is SMAD4 NES Peptide.
5v5i  2.20  2017  Kd=463nM      // 5v5g.pdf (A|B) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.1
5gtb  2.87  2017  Kd=46uM       // 5gtb.pdf (A|B) [Different protein in assay: protein in assay is ARC6 (674-801)] [Different ligand in assay: ligand protein in assay is PDV2 (282-307)] ITC Kd data is for ARC6 (674-801) and PDV2 (282-307)
5ohm  3.80  2017  Kd=47pM       // 5ohm.pdf (E|H) (MST) binding assay, in paper code 5ohm is K6 Affimer: K6 diUb, but in RCSB is K33 Affimer: K33 diUb
5vko  1.80  2017  Kd=4nM        // 5vkl.pdf (A|B) [Different ligand in assay: ]
5tzn  2.60  2017  Kd=5.8uM      // 5tzn.pdf (W|G)
5ky9  1.83  2017  Kd=5.9uM      // 5kxh.pdf (A|B) [Nonstandard assay: 500uM GDP]
5ufe  2.30  2017  Kd=50.3nM     // 5ufe.pdf (A|B) Wild-type K-Ras(GNP)/R11.1.6 complex
5nqg  2.15  2017  Kd=50nM       // 5nqf.pdf (A|B)
5ma4  1.40  2017  Kd=52pM       // 5ma3.pdf (B|A)
5v6a  2.70  2017  Kd=53.2nM     // 5v5g.pdf (A|B) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant ME.2
5nvn  1.90  2017  Kd=55nM       // 5nvk.pdf (C|D)
5tl6  2.62  2017  Kd=57.6uM     // 5tl6.pdf (D|C) ligand is C-terminal domain of human ISG15
5oaq  1.95  2017  Kd=58nM       // 5oaq.pdf (A|L) [Different protein in assay: Non-Acyl-TEAD4] [Different ligand in assay: hYAP51-99] +/-3
5ufq  2.20  2017  Kd=6.4nM      // 5ufe.pdf (A|C) K-RasG12D(GNP)/R11.1.6 complex
5ky0  1.53  2017  Kd=6.5uM      // 5kxh.pdf (A|B) [Nonstandard assay: 500uM GDP]
6azz  2.40  2017  Kd=6.7nM      // 6azz.pdf (CB|A) biolayer interferometry
5o03  2.19  2017  Kd=60nM       // 5o02.pdf (A|D)
5j13  2.30  2017  Kd=60pM       // 5j11.pdf (CB|A) bio-layer interferometry (BLI) assay
5vcb  4.10  2017  Kd=62nM       // 5vcb.pdf (A|F) [Multiple sites: Kd1: 62+/-13nM; Kd2: 1.2+/=0.2uM] Kd=62+/-13nM, complex is Holo-ACPP:ACPS
5twa  1.85  2017  Kd=66nM       // 5twa.pdf (B|C) Kd=66+/-30nM, protein2 is LB-Bak.
5uwh  2.26  2017  Kd=670nM      // 5uwh.pdf (C|D) protein2 is Paxillin NES Peptide.
5h9b  2.25  2017  Kd=674.1nM    // 5h9b.pdf (A|B) [Nonstandard assay: MG2+, AMPPNP] Kd(dEAG-long)=674.1+/-82.4nM
5w0k  3.10  2017  Kd=68.8nM     // 5w0k.pdf (HL|A)
5mtm  2.41  2017  Kd=7.0nM      // 5mtj.pdf (A|B) +/-3.9, Mb(Lck_3)/Lck SH2
5xsq  2.60  2017  Kd=7.35nM     // 5xsq.pdf (C|D)
5lpu  2.10  2017  Kd=7.8uM      // 5lpu.pdf (B|D)
5m5e  2.30  2017  Kd=70pM       // 5m5e.pdf (BC|D) KDkin,
5xv8   NMR  2017  Kd=71.4nM     // 5xv8.pdf (A|B)
5vxz  2.30  2017  Kd=720fM      // 5vxz.pdf (A|C) On-rates were directly measured using the KinExA
5o0w  2.57  2017  Kd=73.83pM    // 5o0w.pdf (A|E)
5tez  1.70  2017  Kd=76uM       // 5tez.pdf (IJ|AC) Kd=76+/-4uM, complex is M1-HLA-A2/TCR F50
6b12  1.71  2017  Kd=8.1nM      // 6b12.pdf (A|C)
5ffo  3.49  2017  Kd=8.2nM      // 5ffg.pdf (B|D)
5xco  1.25  2017  Kd=8.9nM      // 5xco.pdf (A|B) KRas(G12D) mutant  WITH GDP and KRpep-2d
5imk  1.23  2017  Kd=850nM      // 5imk.pdf (B|A) crystal form 1 with lower resolution
5vz4  2.20  2017  Kd=8nM        // 5vz4.pdf (A|B)
5jw7  2.85  2017  Kd=9.09uM     // 5jw7.pdf (A|B) [Different protein in assay: protein in bioassay is SopA (163-782)] protein in bioassay is SopA (163-782)
5jjd  2.40  2017  Kd=9.2uM      // 5jjd.pdf (A|B)
5vag  1.90  2017  Kd=9.4nM      // 5vag.pdf (CB|A) BLI assay, pH-sensitive binding to HA; at PH 7.4, Kd=9.4nM; at PH=5.0, Kd=0.8nM
5omn  2.68  2017  Kd=9.5nM      // 5o02.pdf (B|C)
5xxy  2.90  2017  Kd=9.96nM     // 5xxy.pdf (HL|A) Assay by forteBio Octet K2 2-channel system, described in ref. 19
5nh3  2.35  2017  Kd=973pM      // 5ngv.pdf (HL|A)
5v5g  2.10  2017  Kd=9nM        // 5v5g.pdf (C|D) assay by Bio-Layer Interferometry (BLI), ligand is ubiquitin variant CC.4
5xku  1.78  2017  Kd~17.4pM     // 5xku.pdf (CB|A)
5ivx  2.10  2017  Kd~0.54uM     // 5ivx.pdf (EF|AP) ligand is P18-I10/H2-Dd, not P18-I10 peptide
5o74  2.50  2017  Kd~10uM       // 5o74.pdf (I|J) 10~30uM, in present of GDP
5ezo  3.63  2017  Kd~1nM        // 5ezi.pdf (HL|A) RCSB made a mistake, mark AL chain as antibody
5x60  2.69  2017  Ki=0.03uM     // 5h6q.pdf (AB|C) ligand is peptide 9
5h6q  2.53  2017  Ki=0.06uM     // 5h6q.pdf (AB|C) ligand is peptide 11
5ovw  2.65  2017  Ki=0.94nM     // 5ovw.pdf (F|L) competitive binding equilibria
5l6n  1.63  2017  Ki=3.05nM     // 5l6n.pdf (HL|I)
5uul  1.33  2017  Ki=4.8nM      // 5uuk.pdf (A|B)
5gim  2.09  2017  Ki=545pM      // 5gim.pdf (B|D)
5h6r  2.60  2017  Ki=6.3uM      // 5h6q.pdf (AB|C) ligand is peptide 13
5otx  2.00  2018  IC50=187nM    // 5otx.pdf (A|B) ligand is GLP-1 analogues 2; cAMP-dependent reporter gene assay
5w89  1.42  2018  IC50=25nM     // 5w89.pdf (A|B)
5yqz  3.00  2018  IC50=8.1nM    // 5yqz.pdf (R|P) [Incomplete ligand] ligand is NNC1702,IC50=8.1+/-1.9nM,ligand is incomplete in PDB
6dnq  2.35  2018  Kd=0.042uM    // 6dmx.pdf (B|E) KIX:c-Myb:HBZ(3-77) complex
5w08  2.60  2018  Kd=0.04uM     // 5w08.pdf (QR|D) ligand is K03.12 Fab, measured by biolayer interferometry
6c48  2.32  2018  Kd=0.04uM     // 6c48.pdf (AB|C) Kd for ITC assay is 0.04uM, Kd for FP assay is 0.53nM
6dmx  2.80  2018  Kd=0.11uM     // 6dmx.pdf (D|E) KIX:c-Myb:HBZ(3-56) complex
6h6y  1.58  2018  Kd=0.163nM    // 6h6y.pdf (D|H)
5otj  2.35  2018  Kd=0.17nM     // 5otj.pdf (BA|D)
5g15  2.06  2018  Kd=0.17uM     // 5g15.pdf (A|B) [Nonstandard assay: with AMPPCP] Kd(Mb1)=0.17+/-0.02uM
5vyf  2.90  2018  Kd=0.187nM    // 5vyf.pdf (HL|F) SPR data
6ehg  2.65  2018  Kd=0.24nM     // 6ehg.pdf (AB|C)
5yir  2.75  2018  Kd=0.27nM     // 5yip.pdf (B|H)
6mkz  2.65  2018  Kd=0.2nM      // 6mkz.pdf (C|B)
6ath  1.82  2018  Kd=0.33nM     // 6ath.pdf (AB|C)
6hul  2.55  2018  Kd=0.3uM      // 6hul.pdf (A|B)
6ddm  1.30  2018  Kd=0.42nM     // 6ddm.pdf (BA|C)
6aqr  2.10  2018  Kd=0.43uM     // 6aqr.pdf (A|D)
6bli  2.12  2018  Kd=0.52nM     // 6blh.pdf (GH|I) ligand is 45-mer G peptide
5wpa  2.29  2018  Kd=0.55uM     // 5wpa.pdf (A|B) sedimentation equilibrium experiments,  KD for heterodimer
5xj4  2.30  2018  Kd=0.667nM    // 5xj4.pdf (HL|A)
6b3m  3.92  2018  Kd=0.688nM    // 6b3m.pdf (YU|RQ) biolayer interferometry assay
6a7v  1.67  2018  Kd=0.6nM      // 6a7v.pdf (G|H)
6g04   NMR  2018  Kd=0.7uM      // 6g04.pdf (A|B) Kd for human source TSR2-N is 2uM
6ejg  2.82  2018  Kd=0.81nM     // 6ejg.pdf (A|C)
6hpr  1.70  2018  Kd=0.83uM     // 6hpr.pdf (A|CD)
6bck  2.70  2018  Kd=0.86nM     // 5wb9.pdf (HL|G)
6ejm  2.15  2018  Kd=0.86nM     // 6ejg.pdf (B|H)
6bkc  2.60  2018  Kd=0.8nM      // 6bkc.pdf (HL|E) KD values were determined by biolayer interferometry
6h9n  2.60  2018  Kd=0.8uM      // 6h9n.pdf (A|B)
6ddr  1.90  2018  Kd=0.94nM     // 6ddm.pdf (BA|C)
6fg8  1.25  2018  Kd=0.98uM     // 6fg8.pdf (A|B)
5y9j  2.05  2018  Kd=0.995nM    // 5y9j.pdf (HL|A)
5z78  1.76  2018  Kd=0.9uM      // 5z78.pdf (A|C)
6a67  2.33  2018  Kd=1.004nM    // 6a67.pdf (HL|A)
6cql  2.40  2018  Kd=1.16uM     // 6cph.pdf (DE|ABC) Kdeq values previously published (10)
5bk1  2.15  2018  Kd=1.1nM      // 5bk1.pdf (CD|B) in the absence of maltose
5o90  2.49  2018  Kd=1.1uM      // 5o90.pdf (A|B)
6co2  2.49  2018  Kd=1.2uM      // 6co1.pdf (B|C)
5nqw  3.40  2018  Kd=1.4nM      // 5nqw.pdf (B|C)
6dcn  2.44  2018  Kd=1.4uM      // 6dcn.pdf (B|C) MST Kd=1.4uM; SPR IC50=1.2uM
6bkb  2.80  2018  Kd=1.5nM      // 6bkb.pdf (HL|E) KD values were determined by biolayer interferometry
6f9s  3.03  2018  Kd=1.62uM     // 6f9s.pdf (A|B)
5xda  3.29  2018  Kd=1.6uM      // 5xda.pdf (D|J)
6fv0  2.29  2018  Kd=1.72uM     // 6fuz.pdf (A|F)
5nzz  2.60  2018  Kd=1.7uM      // 5nzz.pdf (C|H) [Different protein in assay: TAB1 in binding assay is pSer423]
6brs  2.30  2018  Kd=1.7uM      // 6b05.pdf (A|F) crystal of Ethylmercury phosphate soaked dataset
5yi8  2.00  2018  Kd=1.8uM      // 5yi8.pdf (A|B)
6b05  1.90  2018  Kd=1.9uM      // 6b05.pdf (A|B)
6arq  2.88  2018  Kd=10.2uM     // 6arq.pdf (A|D)
6cqr  3.04  2018  Kd=10.56uM    // 6cph.pdf (DE|ABC) Kdeq values previously published (10)
5w9a  2.74  2018  Kd=103uM      // 5w9a.pdf (B|D) binding by SV-AUC
5oen  2.92  2018  Kd=10nM       // 5oen.pdf (A|B) [Different protein in assay: ITC Kd is for STAT2 133-679] ITC Kd is for STAT2 133-679
6bkd  3.25  2018  Kd=113nM      // 6bkd.pdf (HL|E) KD values were determined by biolayer interferometry
5xqz  2.10  2018  Kd=12.3uM     // 5xqz.pdf (B|D)
6ff3  2.57  2018  Kd=13.6nM     // 6ff3.pdf (A|B)
6e3j  1.48  2018  Kd=13.98nM    // 6e3i.pdf (A|B) assay by yeast cell surface display
6bxc  2.50  2018  Kd=13nM       // 6bxa.pdf (A|C)
6mlk  2.45  2018  Kd=13nM       // 6mlk.pdf (HL|A) ELISA Kd=13nM, BLI Kd=16nM
6cqn  2.50  2018  Kd=14.33uM    // 6cph.pdf (DE|ABC) Kdeq values previously published (10)
5xwt  4.18  2018  Kd=14.4uM     // 5xwt.pdf (C|D)
6asr  2.36  2018  Kd=14.9uM     // 6asr.pdf (A|B)
5uv8  2.70  2018  Kd=140.6nM    // 5uv8.pdf (G|I) measured in saturation binding assays using radioiodinated cytokine
6bx5  3.00  2018  Kd=14nM       // 6bx4.pdf (B|D)
6bb4  2.10  2018  Kd=15.4nM     // 6bb4.pdf (HL|P)
5nt1  2.82  2018  Kd=16.1uM     // 5nt1.pdf (A|J) biolayer interferometry (BLI) assay
5w1m  3.91  2018  Kd=16.3nM     // 5w1g.pdf (BA|R)
6ii4  3.30  2018  Kd=16.6nM     // 6ii4.pdf (EF|C)
6fq0  2.50  2018  Kd=160nM      // 6fq0.pdf (C|D)
5xmh  2.80  2018  Kd=160uM      // 5xmh.pdf (DC|B)
6aaf  2.20  2018  Kd=161nM      // 6aaf.pdf (A|B)
6aod  1.80  2018  Kd=162pM      // 6aod.pdf (BA|C)
5uwc  2.40  2018  Kd=17.8nM     // 5uv8.pdf (G|I) measured in saturation binding assays using radioiodinated cytokine
5nl1  2.50  2018  Kd=174nM      // 5nl1.pdf (D|K)
6flc  2.00  2018  Kd=176.7nM    // 6fla.pdf (HL|G)
6bf4  2.38  2018  Kd=178nM      // 6bf4.pdf (HL|G) Kd for fully glycosylated HXB2 gp120, while no binding for deglycosylated HXB2 gp120
5xj3  3.20  2018  Kd=18.2nM     // 5xj3.pdf (JK|L)
6e2p  2.83  2018  Kd=18.7uM     // 6e2p.pdf (B|D) Biolayer Interferometry assay
5yc5  2.71  2018  Kd=180nM      // 5yc5.pdf (A|C) SPR Kd for peak 1
5utz  2.75  2018  Kd=1879pM     // 5utz.pdf (JK|I) further, Ab can inhibit IL-2 binding to IL-2R alpha or beta
5yoy  2.73  2018  Kd=18pM       // 5yoy.pdf (RO|J) measured using soluble form of TNFa and golimumab IgG
6ii9  3.50  2018  Kd=19.4nM     // 6ii4.pdf (HL|A)
5nmv  1.65  2018  Kd=1nM        // 5nmv.pdf (HL|K)
6flb  2.20  2018  Kd=1nM        // 6fla.pdf (HL|G)
6a3w  2.00  2018  Kd=2.3nM      // 6a3v.pdf (GH|I)
5ock  1.60  2018  Kd=2.3uM      // 5ock.pdf (HL|A) Human ACPA E4 Fab L/H, 217, 221
6mft  2.32  2018  Kd=2.3uM      // 6mft.pdf (HL|G) BLI binding data
5xln  1.90  2018  Kd=2.48uM     // 5xln.pdf (A|B)
5u8q  3.27  2018  Kd=2.4uM      // 5u8q.pdf (HL|A) Kd=2.4+/-0.5uM, IGF-I for IGF-1Rdeltabeta pre-complexed with Fv 24-60
6isc  2.20  2018  Kd=2.4uM      // 6isc.pdf (A|B)
5vu0  2.26  2018  Kd=2.5nM      // 5vu0.pdf (A|C)
5ywp  4.60  2018  Kd=2.91nM     // 5ywf.pdf (NM|C)
6i3f  2.55  2018  Kd=20.3nM     // 6i3f.pdf (A|B) Bio-layer interferometry assay
6fc3  1.75  2018  Kd=20nM       // 6fbz.pdf (A|B)
6eyo  3.70  2018  Kd=20pM       // 6eyn.pdf (IM|B)
6b8n  2.20  2018  Kd=210nM      // 6b8l.pdf (E|F) 1uM CaCl2 soak
6bx4  2.55  2018  Kd=210nM      // 6bx4.pdf (B|D)
5mr4  2.40  2018  Kd=220nM      // 5mr4.pdf (B|D) ligand is GFRa2 D1-D3
6mhr  2.80  2018  Kd=22nM       // 6mhr.pdf (DE|F)
6h0e  1.95  2018  Kd=240nM      // 6h06.pdf (AB|K) assay by octet biolayer interferometry
6gbu  3.44  2018  Kd=248nM      // 6gbu.pdf (C|D)
6imf  2.30  2018  Kd=24nM       // 6imf.pdf (A|B) use assay method as ref. 14
6byh  2.61  2018  Kd=25nM       // 6bva.pdf (AE|D)
5xiu  1.80  2018  Kd=25uM       // 5xis.pdf (A|B) [Different ligand in assay: ]
5ydr  2.00  2018  Kd=26.4uM     // 5ydr.pdf (A|B)
6cmg  2.70  2018  Kd=27.4nM     // 6cmg.pdf (CB|A) assay by BioLayer Interferometry
5xod  1.85  2018  Kd=28.1nM     // 5xoc.pdf (A|B)
5xnp  3.73  2018  Kd=281.8nM    // 5xnp.pdf (B|E)
5xis  1.78  2018  Kd=283uM      // 5xis.pdf (A|BC) [Different ligand in assay: assay use RNF168 UDM1-UM1, not full UDM1] crystal form I
6d01  3.20  2018  Kd=286nM      // 6d01.pdf (CD|I)
6fub  1.30  2018  Kd=29nM       // 6fu9.pdf (B|A) Pikm-HMA and AVR-PikE
6cwt  3.15  2018  Kd=2pM        // 6cvk.pdf (AB|E)
6fuz  2.70  2018  Kd=3.19uM     // 6fuz.pdf (A|N) ITC Kd for His6-KLC1 TPR and JIP1 C-term
6e3i  1.48  2018  Kd=3.21nM     // 6e3i.pdf (A|B) assay by yeast cell surface display
6e62  2.70  2018  Kd=3.2nM      // 6e62.pdf (BC|A) BLI assay
5oy9  3.60  2018  Kd=3.75uM     // 5oy9.pdf (A|D)
5yip  1.85  2018  Kd=3.7nM      // 5yip.pdf (A|B)
6e63  2.60  2018  Kd=3.7nM      // 6e62.pdf (BC|A) BLI assay
6gd5   NMR  2018  Kd=3.8nM      // 6gd5.pdf (A|B)
6bmt  2.40  2018  Kd=310nM      // 6bmt.pdf (A|B)
6fc2  1.92  2018  Kd=3400nM     // 6fbz.pdf (A|B)
5mzv  2.80  2018  Kd=36nM       // 5mzv.pdf (AB|C)
5nx3  2.30  2018  Kd=36pM       // 5nx1.pdf (A|C)
5kof  2.40  2018  Kd=37.6uM     // 5kof.pdf (A|C) Kd=37.6+/-6.6uM
6ii8  3.32  2018  Kd=386nM      // 6ii4.pdf (GI|A)
5ywr  1.47  2018  Kd=39nM       // 5ywr.pdf (A|B)
6fp7  1.58  2018  Kd=3nM        // 6fp7.pdf (A|B) mTFP1/DARPin 1238_E11 complex in space group P6522
6blh  2.00  2018  Kd=4.1nM      // 6blh.pdf (HL|G) ligand is 45-mer G peptide
5yis  2.20  2018  Kd=4.2nM      // 5yip.pdf (A|C)
6bw9  1.60  2018  Kd=4.39nM     // 6bw9.pdf (A|B) MST assay; code 6bvv and 6bwa in other crystal form
6h6z  2.09  2018  Kd=4.58nM     // 6h6y.pdf (A|D)
6fu9  1.20  2018  Kd=4.7nM      // 6fu9.pdf (A|B) Pikm-HMA and AVR-PikD
6avg  2.60  2018  Kd=40.6uM     // 6at5.pdf (CD|GP)
6f3z  2.00  2018  Kd=405nM      // 6f3z.pdf (C|D)
6bxa  2.30  2018  Kd=40nM       // 6bxa.pdf (B|D)
6gbg  2.80  2018  Kd=417nM      // 6gbg.pdf (D|A)
6c16  3.27  2018  Kd=421nM      // 6bva.pdf (AC|H)
6h71  2.31  2018  Kd=43.4nM     // 6h6y.pdf (A|C)
5w42  3.57  2018  Kd=44.3nM     // 5w42.pdf (HL|A) Kd values were determined by bio-layer interferometry
6fgo  2.50  2018  Kd=440nM      // 6fgo.pdf (A|E) (KD) of ZCa to Fc of human IgG1 in the presence of calcium is 440nM as estimated by the SPR analysis, which is in the
5vzm   NMR  2018  Kd=48.8uM     // 5vzm.pdf (A|B) ITC Kd=48.8uM, NMR Kd=27.2uM
6fhp  1.70  2018  Kd=48nM       // 6fhp.pdf (B|D)
6h06  2.63  2018  Kd=5.6uM      // 6h06.pdf (CD|G) assay by octet biolayer interferometry
6ddv  2.05  2018  Kd=5.78nM     // 6ddm.pdf (BA|C)
5xwd  2.89  2018  Kd=5.9nM      // 5xwd.pdf (HD|A)
6g10  1.35  2018  Kd=5.9nM      // 6fu9.pdf (B|C) Pikp1-HMA and AVR-PikD
6dsl   NMR  2018  Kd=500pM      // 6dsl.pdf (A|B)
5nx1  1.85  2018  Kd=5290pM     // 5nx1.pdf (A|B)
6a0z  2.33  2018  Kd=53nM       // 6a0x.pdf (HL|A)
5zxv  4.48  2018  Kd=57.6nM     // 5zxv.pdf (HL|A)
6aw2  2.68  2018  Kd=57nM       // 6aw2.pdf (A|B) [Nonstandard assay: PH=4.5]
6ewb  2.78  2018  Kd=59nM       // 6ewb.pdf (HL|B)
6fgb  2.90  2018  Kd=59pM       // 6fgb.pdf (HL|A)
5n48  1.60  2018  Kd=5nM        // 5n47.pdf (A|B) data from previous biochemical analysis
6cqq  2.80  2018  Kd=6.9uM      // 6cph.pdf (DE|ABC) Kdeq values previously published (10)
6mgp  2.13  2018  Kd=680nM      // 6mgp.pdf (B|Y)
6gbh  2.59  2018  Kd=69nM       // 6gbh.pdf (B|A)
6mi2  2.72  2018  Kd=69nM       // 6mhr.pdf (AB|C)
5oyl  2.25  2018  Kd=7.5uM      // 5oy9.pdf (A|D)
5yr0  1.90  2018  Kd=7.6uM      // 5yr0.pdf (A|B)
6fud  1.30  2018  Kd=73nM       // 6fu9.pdf (A|B) Pikm-HMA and AVR-PikA
6eg1  2.95  2018  Kd=76.6uM     // 6eg0.pdf (C|D)
6eg0  2.90  2018  Kd=77.7uM     // 6eg0.pdf (A|B)
5n47  3.00  2018  Kd=7nM        // 5n47.pdf (C|D) data from previous biochemical analysis
6cbp  2.17  2018  Kd=7uM        // 6cbj.pdf (P|A) BLI measurements
5mr5  2.00  2018  Kd=80nM       // 5mr4.pdf (B|D) ligand is GFRa2 D2-D3
5n7w  1.96  2018  Kd=80nM       // 5n7w.pdf (AB|Y) assay by Octet RED system (ForteBio)
6a3v  3.39  2018  Kd=85.6nM     // 6a3v.pdf (Q|R)
5wi9  2.70  2018  Kd=86pM       // 5wi9.pdf (FE|B)
5vmo  1.70  2018  Kd=887nM      // 5vmo.pdf (A|B)
5xoc  2.40  2018  Kd=8uM        // 5xoc.pdf (A|B)
6d13  3.06  2018  Kd=9.3nM      // 6d13.pdf (A|B) determined by bio-layer interferometry (BLI), RppH in surface and DapF in solution
6fe4  3.00  2018  Kd=9.6nM      // 6fe4.pdf (A|F)
6bva  2.66  2018  Kd=91nM       // 6bva.pdf (DE|B)
6ch3  2.68  2018  Kd~10uM       // 6ch2.pdf (A|B)
6ch2  2.70  2018  Kd~29uM       // 6ch2.pdf (C|F)
5mrv  1.85  2018  Ki=3.8uM      // 5mrv.pdf (A|C) Michaelis-Menten kinetic analysis, NvCI displays a typical competitive inhibition behavior
6gfi  2.30  2018  Ki=494pM      // 6gfi.pdf (A|E) competitive inhibition assay
5zvm  3.30  2019  IC50=0.21uM   // 5zvk.pdf (C|b) HR1(SARS)-EK1
6oao  3.50  2019  IC50=1.63nM   // 6oan.pdf (G|H)
6d68  2.36  2019  IC50=250nM    // 6d4p.pdf (A|C)
6oan  2.90  2019  IC50=4.88nM   // 6oan.pdf (A|B)
6d4p  2.11  2019  IC50=65nM     // 6d4p.pdf (A|C)
6dgf  2.34  2019  IC50=9.5nM    // 6dgf.pdf (A|B) UbV.2.6- USP2 complex
6mlm  3.50  2019  Kd<0.1nM      // 6mlm.pdf (KL|H)
6mam  4.10  2019  Kd<1pM        // 6mam.pdf (CD|LK)
6sak  2.00  2019  Kd=0.031uM    // 6sak.pdf (A|C) C129A mutation do not change too much affinity
6f0g  2.30  2019  Kd=0.055uM    // 6f0f.pdf (B|D) Kd(ip3)=0.055+/-0.02uM
6cwg  2.60  2019  Kd=0.102nM    // 6cwg.pdf (C|D)
6nmv  2.61  2019  Kd=0.123nM    // 6nmr.pdf (HL|S)
6jb8  1.65  2019  Kd=0.129nM    // 6jb2.pdf (A|B)
6nmt  1.83  2019  Kd=0.162nM    // 6nmr.pdf (BA|C)
6j4s  2.80  2019  Kd=0.16uM     // 6j4o.pdf (A|B) V2-SVBP complex
6q69  2.75  2019  Kd=0.17uM     // 6q67.pdf (A|B)
6nmr  2.42  2019  Kd=0.183nM    // 6nmr.pdf (HL|S)
6f0f  2.00  2019  Kd=0.18uM     // 6f0f.pdf (A|B) Kd(ip2_s)=0.18+/-0.04uM
6mvl  1.61  2019  Kd=0.18uM     // 6mvl.pdf (HL|A) pH-selective antibody, Kd at PH=6.7
6ird  2.81  2019  Kd=0.21uM     // 6ird.pdf (B|C) PLCb4 CC8KA-PBM and INADL PDZ89 complex
6dld  3.30  2019  Kd=0.24nM     // 6dld.pdf (A|B) affinity for IgLON5-fc/NEGR1-AP heterodimer
6p7s  3.49  2019  Kd=0.24nM     // 6p7s.pdf (A|B)
6n85  2.50  2019  Kd=0.24uM     // 6n85.pdf (B|M) [Different ligand in assay: Kd is for MBP-tagged transducin-alpha residues 333-350] Kd is for MBP-tagged transducin-alpha residues 333-350
6o1f  2.15  2019  Kd=0.25nM     // 6o1f.pdf (HL|AI)
5zqv  2.95  2019  Kd=0.26uM     // 5zqv.pdf (B|F) Kd(ITC)=0.26+/-0.03uM, PP1Calpha(6-299)
6jcs  3.18  2019  Kd=0.287uM    // 6jcs.pdf (A|R)
6ndz  2.26  2019  Kd=0.2nM      // 6ndz.pdf (A|B)
6jbt  2.47  2019  Kd=0.324nM    // 6jbt.pdf (HL|F)
6u2h  2.50  2019  Kd=0.33nM     // 6u2g.pdf (A|D) average affinity of two-state model
6qmq  2.50  2019  Kd=0.37uM     // 6qmp.pdf (BC|A)
6j6y  2.15  2019  Kd=0.3nM      // 6j6y.pdf (EF|D)
6j7w  2.60  2019  Kd=0.3nM      // 6j7w.pdf (A|C)
6nmu  2.55  2019  Kd=0.426nM    // 6nmr.pdf (HL|S) value 4,26 E-10 in the table should be 4.26 E-10
6n5w  2.15  2019  Kd=0.44uM     // 6n5w.pdf (AB|C) Kd=0.44uM for A domain of KCNQ2-4; Kd=0.24uM for B domain
6nms  2.11  2019  Kd=0.458nM    // 6nmr.pdf (HL|S)
6q0o  3.00  2019  Kd=0.4uM      // 6q0h.pdf (ZB|A)
6p7y  2.84  2019  Kd=0.56nM     // 6p7s.pdf (C|D)
6kbm  2.90  2019  Kd=0.60uM     // 6kbm.pdf (A|B)
6qj4  5.80  2019  Kd=0.63uM     // 6qj2.pdf (A|B)
5z2w  3.00  2019  Kd=0.67uM     // 5z2w.pdf (A|B) bio-layer interferometry (BLI) experiment
6j56  1.80  2019  Kd=0.67uM     // 6j56.pdf (B|D)
6q18  2.55  2019  Kd=0.6uM      // 6q0h.pdf (HL|A)
6r2g  1.90  2019  Kd=0.758pM    // 6r2g.pdf (A|C)
6qmp  2.00  2019  Kd=0.7uM      // 6qmp.pdf (BC|A)
6k0y  1.70  2019  Kd=0.892nM    // 6k0y.pdf (AB|C) glycosylated hPD-1 protein Kd=0.892nM, deglycosylated hPD-1 protein Kd=40.3nM
6gho  1.79  2019  Kd=0.8uM      // 6ghb.pdf (A|B)
6fg1  2.03  2019  Kd=0.9nM      // 6fg1.pdf (AD|HL)
6gku  1.91  2019  Kd=0.9nM      // 6gku.pdf (HL|A)
6iu7  1.90  2019  Kd=0.9nM      // 6iu7.pdf (A|B) microtiter-plate binding assay
6mud  2.69  2019  Kd=1.02uM     // 6mud.pdf (A|B) [Different ligand in assay: bioassay use hNav1.5 1773-1927, crystal use NaV 1.5 (1786-1922)] bioassay use hNav1.5 1773-1927, crystal use NaV 1.5 (1786-1922)
6jep  2.32  2019  Kd=1.06nM     // 6jep.pdf (KI|F) PH=7.5
6qms  1.80  2019  Kd=1.08uM     // 6qmp.pdf (BC|A)
6c83  2.55  2019  Kd=1.0uM      // 5g15.pdf (A|D) [Nonstandard assay: with AMPPCP] Kd(Mb2)=1.0+/-0.06uM
6qb6  2.24  2019  Kd=1.14uM     // 6qb3.pdf (HL|A)
6plk  2.30  2019  Kd=1.15nM     // 6plk.pdf (IM|F)
6nha  2.38  2019  Kd=1.19nM     // 6nha.pdf (HL|AB) Kd=1.19nM at pH= 7.4
5xkj  3.48  2019  Kd=1.1uM      // 5xkj.pdf (AC|E)
5zo2  3.29  2019  Kd=1.1uM      // 5zo2.pdf (C|B)
6og4  1.70  2019  Kd=1.29nM     // 6og4.pdf (A|C)
6mnr  2.20  2019  Kd=1.2nM      // 6mnq.pdf (HL|P)
5z7l  2.02  2019  Kd=1.2uM      // 5z7g.pdf (A|C) NDP52(10-126)/NAP1(33-75) complex
6gum  1.79  2019  Kd=1.2uM      // 6gum.pdf (A|B)
6in9  1.80  2019  Kd=1.2uM      // 6in7.pdf (B|C)
6e4z  2.20  2019  Kd=1.3nM      // 6e4z.pdf (HL|P)
6ne2  1.30  2019  Kd=1.3nM      // 6ndz.pdf (B|A)
5xjo  2.63  2019  Kd=1.3uM      // 5xjo.pdf (AC|E)
6kbn  3.20  2019  Kd=1.46uM     // 6kbm.pdf (C|D)
6msl  3.10  2019  Kd=1.4nM      // 6msl.pdf (AB|C)
6ne1  3.01  2019  Kd=1.4nM      // 6ndz.pdf (A|B)
6j14  1.40  2019  Kd=1.54nM     // 6j14.pdf (AB|G) humanized GY-14 for PD-1 Kd=2.21nM, chimeric GY-14 for PD-1 Kd=1.54nM
6ne4  1.65  2019  Kd=1.6nM      // 6ndz.pdf (B|A)
6uys  1.59  2019  Kd=1.6uM      // 6uys.pdf (A|B) Kd=1.6+/-0.1uM
6o39  1.80  2019  Kd=1.7nM      // 6o39.pdf (BA|C)
6ob1   NMR  2019  Kd=1.7uM      // 6ob1.pdf (AB|C)
6moe  2.09  2019  Kd=1.89nM     // 6moe.pdf (A|D)
6o3o  2.80  2019  Kd=1.8uM      // 6o3o.pdf (A|C)
6q0h  2.75  2019  Kd=1.8uM      // 6q0h.pdf (HL|A)
6cxg  2.30  2019  Kd=1.9nM      // 6cxg.pdf (MK|C) previously reported affinity data
6m7l  2.65  2019  Kd=10.4uM     // 6m7l.pdf (B|A)
6ire  3.25  2019  Kd=10.6nM     // 6ird.pdf (A|B) NORPA CC8KA-PBM and INAD PDZ45 complex; assay PH=7.8
6mnq  1.80  2019  Kd=10.9nM     // 6mnq.pdf (HL|P)
6fpg  1.80  2019  Kd=101.9nM    // 6fpg.pdf (G|H)
6h47  1.70  2019  Kd=10nM       // 6h46.pdf (A|B) ForteBio Octet Red384 bioassay
6i07  2.35  2019  Kd=10nM       // 6i07.pdf (A|C)
6on9  2.00  2019  Kd=10uM       // 6on9.pdf (A|B) ZIG-8-RIG-5 IG1-IG1 heterodimer, tetragonal form
6cug  2.40  2019  Kd=11.2uM     // 6cug.pdf (DE|A) Kd(CD1b-PC-BC8B)=11.2+/-2.2uM
6fg2  2.79  2019  Kd=11pM       // 6fg1.pdf (DE|MI)
6ivu   NMR  2019  Kd=11pM       // 6ivu.pdf (A|B)
6o8b  3.40  2019  Kd=11uM       // 6o8b.pdf (E|A)
6oor  2.45  2019  Kd=12.5nM     // 6oor.pdf (HL|A)
6h15  2.60  2019  Kd=12.8nM     // 6h15.pdf (A|C)
6iwa  2.40  2019  Kd=126nM      // 6iw8.pdf (A|C)
6m9k  2.30  2019  Kd=12uM       // 6m9k.pdf (C|F)
6oro  3.90  2019  Kd=12uM       // 6orn.pdf (HL|G) Germline Kd=12uM, BLI assay
6iw0  3.60  2019  Kd=13.5nM     // 6ivz.pdf (HL|A)
6mss  3.00  2019  Kd=14.6uM     // 6mra.pdf (AB|CD)
6dc9  3.00  2019  Kd=15.23nM    // 6dc7.pdf (IM|Q)
6dg5  2.52  2019  Kd=16.1nM     // 6dg5.pdf (BC|A)
6isu  1.87  2019  Kd=160nM      // 6isu.pdf (A|B)
6mba  1.80  2019  Kd=17nM       // 6mba.pdf (A|B)
6o07  2.70  2019  Kd=17nM       // 6o07.pdf (BC|A)
6iwd  1.80  2019  Kd=18.2nM     // 6iwd.pdf (A|B)
6ieb  2.41  2019  Kd=18.5nM     // 6iea.pdf (EF|B)
6j4o  2.30  2019  Kd=18nM       // 6j4o.pdf (A|B)
6jhw  2.04  2019  Kd=18nM       // 6jhw.pdf (A|B)
6phb  2.00  2019  Kd=19.2nM     // 6phb.pdf (BA|E)
6tzc  2.41  2019  Kd=1985nM     // 6tzc.pdf (AB|C)
6p50  2.90  2019  Kd=1nM        // 6p4y.pdf (HL|C)
6mun   NMR  2019  Kd=1uM        // 6mun.pdf (A|B) [Multiple sites: Kd for UIM-1 site is 1uM, Kd for UIM-2 site is 24.8uM] Kd for UIM-1 site is 1uM, Kd for UIM-2 site is 24.8uM
5z7g  2.30  2019  Kd=2.05uM     // 5z7g.pdf (A|D) TAX1BP1(1-121)/NAP1(33-75) complex
6iua  1.70  2019  Kd=2.0nM      // 6iu7.pdf (A|B) microtiter-plate binding assay
6gvk  1.55  2019  Kd=2.0uM      // 6gvk.pdf (A|B)
6uyu  1.66  2019  Kd=2.0uM      // 6uys.pdf (A|B) Kd=2.0+/-0.2uM
6qb3  1.90  2019  Kd=2.38uM     // 6qb3.pdf (A|X) ITC Kd=2.38uM, SPR Kd=17.1uM
6cxl  3.59  2019  Kd=2.4nM      // 6cxg.pdf (K|M) previously reported affinity data; why glycopeptide 10F5M not listed in PDB
6hhc  2.70  2019  Kd=2.4nM      // 6hhc.pdf (HL|A)
6phd  3.10  2019  Kd=2.5nM      // 6phb.pdf (HL|C)
6fto  1.60  2019  Kd=2.6nM      // 6fto.pdf (A|C)
6umt  1.99  2019  Kd=2.6nM      // 6umt.pdf (A|B)
6h2y  2.65  2019  Kd=2.7nM      // 6h2y.pdf (HL|D)
6k7o  3.00  2019  Kd=2.9nM      // 6k7o.pdf (DE|Q)
6d7g  2.75  2019  Kd=2.9uM      // 6d7g.pdf (DE|A) biolayer interferometry (BLI) assay
6jdj  2.60  2019  Kd=200nM      // 6jdj.pdf (B|C)
6r2s  3.04  2019  Kd=20pM       // 6r2s.pdf (BA|C)
6dfs  3.10  2019  Kd=21.4uM     // 6dfs.pdf (AB|CD)
6dc8  1.80  2019  Kd=21.5nM     // 6dc7.pdf (HL|P)
6j9l  1.78  2019  Kd=2115nM     // 6j9l.pdf (B|E)
6nfj  3.19  2019  Kd=211nM      // 6nfj.pdf (A|B) sKLB:Nb30:FGF19CT ternary structure
6nuc  1.90  2019  Kd=21nM       // 6nuc.pdf (AB|C)
6nuf  1.90  2019  Kd=21nM       // 6nuc.pdf (AB|C)
6k06  1.75  2019  Kd=227nM      // 6iw8.pdf (A|C)
6ous  3.40  2019  Kd=22pM       // 6ous.pdf (UV|JI) Pre-fusion F Protein Kd=22pM, Post-fusion F Protein Kd=1.35pM
6a78  2.10  2019  Kd=239nM      // 6a76.pdf (HL|A)
6nrw  2.40  2019  Kd=23uM       // 6nrq.pdf (A|B) when DIP-eta IG1 is captured on SPR chip; Kd=4uM when non-dimerizing Dpr1 is captured on SPR chip
6a6x  2.70  2019  Kd=25.8nM     // 6a6x.pdf (B|C)
6cxf  2.50  2019  Kd=252nM      // 6cw6.pdf (C|A) [Nonstandard assay: linking with alphaGSA[26,P5p]]
6gjq  2.49  2019  Kd=25nM       // 6gjq.pdf (G|H)
6im9  3.30  2019  Kd=25nM       // 6im9.pdf (A|B)
6j11  3.00  2019  Kd=25nM       // 6j11.pdf (HL|A)
6gwc  2.60  2019  Kd=270nM      // 6gwc.pdf (A|C)
6pxh  2.30  2019  Kd=28.0nM     // 6pxg.pdf (HL|B)
6oqq  2.10  2019  Kd=28nM       // 6oqq.pdf (A|B) [Different protein in assay: Calmodulin in binding assay is from human;] [Different ligand in assay: Kd for Legionella pneumophila SidJ D542A]
6iea  2.00  2019  Kd=295nM      // 6iea.pdf (HL|A)
6jb2  1.50  2019  Kd=295nM      // 6jb2.pdf (A|B)
6pnp  1.94  2019  Kd=299.2nM    // 6pnp.pdf (A|B)
6oc3  2.85  2019  Kd=2nM        // 6obz.pdf (AB|F)
6osw   NMR  2019  Kd=2uM        // 6osw.pdf (A|B)
6idx  1.70  2019  Kd=3.36uM     // 6idx.pdf (A|C)
6jjp  2.90  2019  Kd=3.55nM     // 6jjp.pdf (AB|C)
6ov2  3.20  2019  Kd=3.58nM     // 6ov2.pdf (A|B)
6e4y  2.24  2019  Kd=3.8uM      // 6e4y.pdf (HL|P)
6n6r  1.95  2019  Kd=3.8uM      // 6n6r.pdf (A|D)
6f2g  2.92  2019  Kd=3.9nM      // 6f2g.pdf (A|B) Kd=3.9+/-1.4nM
6obn  2.70  2019  Kd=30.4nM     // 6obn.pdf (A|C) No Mn2+ metal ion
6mc9  3.30  2019  Kd=305nM      // 6mc9.pdf (A|B)
6h46  2.22  2019  Kd=30nM       // 6h46.pdf (A|B) ForteBio Octet Red384 bioassay
6orq  4.40  2019  Kd=30nM       // 6orn.pdf (HL|G)
6h16  2.90  2019  Kd=31.8nM     // 6h15.pdf (A|B)
5ymy   NMR  2019  Kd=33.1nM     // 5ymy.pdf (AB|C) Rpn13NTD:K48-diUb complex
6iw8  2.80  2019  Kd=332nM      // 6iw8.pdf (A|C)
6fbx  1.64  2019  Kd=343nM      // 6fbx.pdf (A|B)
6dc3  3.50  2019  Kd=34nM       // 6dc3.pdf (HL|F) RSV F subtype A Kd=34nM; RSV F subtype B Kd<0.016nM
6oy4  2.45  2019  Kd=35nM       // 6oy4.pdf (DC|A)
6a6i  2.60  2019  Kd=36.1uM     // 6a6i.pdf (A|B)
6gtq  2.49  2019  Kd=367nM      // 6gtq.pdf (A|C)
6h3u  3.17  2019  Kd=36nM       // 6h3t.pdf (HL|B)
6j5f  1.80  2019  Kd=390nM      // 6j5d.pdf (HL|A)
6f0h  1.98  2019  Kd=3nM        // 6f0f.pdf (A|B) Kd(ip4)=3+/-1nM
6o3b  2.50  2019  Kd=4.5nM      // 6o39.pdf (BA|C)
6phc  2.90  2019  Kd=4.6nM      // 6phb.pdf (CD|E)
6r8x  2.04  2019  Kd=4.7pM      // 6r8x.pdf (CB|A) solution equilibrium titration measurements
6otc  1.70  2019  Kd=4.9nM      // 6otc.pdf (HL|A)
6her  1.20  2019  Kd=40nM       // 6her.pdf (A|B) Crystal 1 at pH 8.0
6s8s  2.21  2019  Kd=410nM      // 6s8r.pdf (A|B)
6j9h  2.31  2019  Kd=42nM       // 6j7b.pdf (C|D)
6oqk   NMR  2019  Kd=42nM       // 6oqj.pdf (A|B)
6gvl  2.05  2019  Kd=44uM       // 6gvk.pdf (A|B)
6j5d  1.80  2019  Kd=45.4nM     // 6j5d.pdf (HL|A)
6pnq  1.95  2019  Kd=49nM       // 6pnp.pdf (A|B)
6rhw  2.75  2019  Kd=4nM        // 6rhv.pdf (GH|C)
6thg  4.07  2019  Kd=4nM        // 6thg.pdf (E|F) binding was assessed by flow cytometry
6o3a  2.10  2019  Kd=5.2nM      // 6o39.pdf (BA|E)
6km7  1.80  2019  Kd=5.2uM      // 6km7.pdf (B|D)
6i2m  2.30  2019  Kd=5.31nM     // 6i2m.pdf (A|B)
6h3t  2.84  2019  Kd=5.4nM      // 6h3t.pdf (HL|A)
6u8c  2.61  2019  Kd=50nM       // 6u8c.pdf (HL|A)
6er6  1.56  2019  Kd=51nM       // 6er6.pdf (B|A)
6um5  4.20  2019  Kd=532nM      // 6um5.pdf (KL|I)
6uvo  2.90  2019  Kd=579pM      // 6uvo.pdf (HL|D)
6ihb  2.84  2019  Kd=57nM       // 6ihb.pdf (R|A)
6s53  2.80  2019  Kd=5uM        // 6s53.pdf (CD|A)
6jo8  3.50  2019  Kd=6.02uM     // 6jo8.pdf (AB|O)
6k4k  2.72  2019  Kd=6.51nM     // 6k4k.pdf (A|C)
6akm  2.30  2019  Kd=6.9uM      // 6akm.pdf (A|B)
5zau   NMR  2019  Kd=60nM       // 5zau.pdf (A|B)
6dkj  1.95  2019  Kd=61pM       // 6dkj.pdf (AB|D) Binding of hGIPR-Ab to human GIPR membranes measured using KinExA technology
6rhv  2.29  2019  Kd=63nM       // 6rhv.pdf (GH|C)
6o60  2.50  2019  Kd=69nM       // 6o60.pdf (CD|A)
6s29  1.99  2019  Kd=7.75nM     // 6s29.pdf (C|D)
6ppg  2.75  2019  Kd=7.78pM     // 6ppg.pdf (BA|G)
6mm6  2.39  2019  Kd=73.5uM     // 6mm6.pdf (E|F)
6ere  2.25  2019  Kd=73nM       // 6er6.pdf (B|C)
6iec  3.20  2019  Kd=743nM      // 6iea.pdf (FG|E)
6a79  2.31  2019  Kd=8.2nM      // 6a76.pdf (IM|B)
6jjw  2.40  2019  Kd=8.2nM      // 6jjw.pdf (A|U)
6p67  2.90  2019  Kd=8.7nM      // 6p4y.pdf (CD|J)
6kbr  2.00  2019  Kd=8.91pM     // 6kbr.pdf (A|C) KLK4-K41043 complex
6j9m  2.39  2019  Kd=81nM       // 6j9l.pdf (F|B)
6dca  2.60  2019  Kd=84.44nM    // 6dc7.pdf (HL|P)
6jwj  1.58  2019  Kd=85.7nM     // 6jwj.pdf (A|C)
6oel  3.10  2019  Kd=880nM      // 6oel.pdf (HL|BC)
6plm  2.59  2019  Kd=89.6nM     // 6plm.pdf (B|D)
6czo  2.95  2019  Kd=89nM       // 6czo.pdf (A|B)
6msu  3.11  2019  Kd=9.2nM      // 6msl.pdf (AB|C)
6pdx  3.99  2019  Kd=9.74pM     // 6pdx.pdf (HL|A)
6ivz  2.40  2019  Kd=9.7nM      // 6ivz.pdf (HL|A)
6ib8  1.65  2019  Kd=94nM       // 6ib8.pdf (A|C)
6oqj   NMR  2019  Kd=9nM        // 6oqj.pdf (A|B)
6uda  4.20  2019  Kd=9nM        // 6uda.pdf (CD|A) protein was generated in GnT1- cell line
6saz  3.00  2019  Ki=0.14nM     // 6saz.pdf (C|D) determined in vitro in a Varioskan Flash 3001 spectral plate reader
6ht9  3.10  2019  Ki=0.1nM      // 6ht9.pdf (C|D)
6dwh  2.00  2019  Ki=0.2nM      // 6dwh.pdf (D|J) wildtype BBKI
6bx8  1.98  2019  Ki=0.2uM      // 6bx8.pdf (A|B)
6dwf  1.94  2019  Ki=1.3nM      // 6dwf.pdf (B|H)
6n9d  2.67  2019  Ki=17.8pM     // 6mav.pdf (A|B)
6mav  2.37  2019  Ki=33.5pM     // 6mav.pdf (A|B)
6har  1.50  2019  Ki=61pM       // 6bx8.pdf (A|E)
